0001213900-23-087514.txt : 20231115 0001213900-23-087514.hdr.sgml : 20231115 20231115154042 ACCESSION NUMBER: 0001213900-23-087514 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231115 DATE AS OF CHANGE: 20231115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VS Trust CENTRAL INDEX KEY: 0001793497 STANDARD INDUSTRIAL CLASSIFICATION: [6221] IRS NUMBER: 846704517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41280 FILM NUMBER: 231410387 BUSINESS ADDRESS: STREET 1: 2000 PGA BOULEVARD STREET 2: SUITE 4440 CITY: PALM BEACH GARDENS STATE: FL ZIP: 33408 BUSINESS PHONE: 866-261-0273 MAIL ADDRESS: STREET 1: 2000 PGA BOULEVARD STREET 2: SUITE 4440 CITY: PALM BEACH GARDENS STATE: FL ZIP: 33408 10-Q 1 f10q0923_vstrust.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-Q

 

 

 

Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

for the quarterly period ended September 30, 2023.

 

or

 

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

for the transition period from                      to                     .

 

Commission file number: 001-34200

 

 

 

VS Trust

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   84-6704517
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

c/o Volatility Shares LLC

2000 PGA Boulevard, Suite 4440

Palm Beach Gardens, FL. 33408

(Address of principal executive offices) (Zip Code)

 

(866) 261-0273

(Registrant’s telephone number, including area code)

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading Symbol(s)

 

Name of each exchange

on which registered

-1x Short VIX Futures ETF   SVIX   Cboe BZX Exchange
2x Long VIX Futures ETF   UVIX   Cboe BZX Exchange

 

Securities registered pursuant to Section 12(g) of the Act: None

 

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer   Accelerated Filer
Non-Accelerated Filer   Smaller Reporting Company
      Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.). ☐ Yes No

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. ☒ Yes ☐ No

 

As of September 30, 2023, the registrant had 29,360,000 shares of common stock, $0 par value per share, outstanding.

 

 

 

 

 

VS Trust

 

Table of Contents
 
    Page
Part I. FINANCIAL INFORMATION    
Item 1. Financial Statements   1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   2
Item 3. Quantitative and Qualitative Disclosures About Market Risk   8
Item 4. Controls and Procedures   9
     
Part II. OTHER INFORMATION    
Item 1. Legal Proceedings   10
Item 1A. Risk Factors   10
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   10
Item 3. Defaults Upon Senior Securities   10
Item 4. Mine Safety Disclosures   10
Item 5. Other Information   10
Item 6. Exhibits   11

 

i

 

 

Part I. FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

Index
 
Documents   Page
Statements of Financial Condition, Schedule of Investments, Statements of Operations, Statements of Changes in Shareholders’ Equity, and Statements of Cash Flows:    
-1x Short VIX Futures ETF   F-8
2x Long VIX Futures ETF   F-10
VS Trust   F-12
Notes to Financial Statements   F-12

 

-1-

 

 

VS Trust

Statements of Assets and Liabilities

September 30, 2023 (Unaudited) and December 31, 2022

 

   -1x Short VIX
Futures ETF
   2x Long VIX
Futures ETF
   -1x Short VIX
Futures ETF
   2x Long VIX
Futures ETF
 
   September 30,
2023
   September 30,
2023
   December 31,
2022
   December 31,
2022
 
   (Unaudited)   (Unaudited)         
ASSETS                
Cash  $-   $-   $504,600   $- 
Investments in securities, at value*   7,673,680    24,356,501    -    8,250,285 
Interest receivable   40,015    112,405    12,909    50,483 
Prepaid expenses and other assets   24,989    42,198    10,295    15,666 
Receivable for shares sold   -    6,935,800    -    1,931,028 
Deposit at Broker for Futures   104,412,396    55,293,437    48,144,554    114,821,272 
Variation margin receivable   -    1,945,302    -    830,840 
Other receivable   -    2,081    571    579 
Total Assets  $112,151,080   $88,687,724   $48,672,929   $125,900,153 
                     
LIABILITIES                    
Payables                    
Variation margin payable  $1,327,607   $-   $187,030   $- 
Due to Other   -    6    -    - 
Fund shares redeemed   -    -    1,903,018    - 
Payable to Sponsor   111,877    125,640    54,374    176,838 
Administrative, accounting and custodian fees payable   17,968    25,664    15,869    19,957 
Professional fees payable   203,733    279,945    125,274    203,411 
Licensing and registration fees payable   33,799    53,324    8,761    11,181 
Total Liabilities   1,694,984    484,579    2,294,326    411,387 
NET ASSETS  $110,456,096   $88,203,145   $46,378,603   $125,488,766 
                     
NET ASSETS CONSIST OF:                    
Paid-in capital  $43,701,765   $374,688,877   $29,386,125   $203,182,472 
Total distributable earnings (accumulated deficit)   66,754,331    (286,485,732)   16,992,478    (77,693,706)
Net Assets  $110,456,096   $88,203,145   $46,378,603   $125,488,766 
                     
Net Asset Value (unlimited shares authorized):                    
Class I (unlimited shares authorized):                    
Net Assets  $110,456,096   $88,203,145   $46,378,603   $125,488,766 
Shares Outstanding^   3,940,000    25,420,000   3,170,000    21,450,000 
Net Asset Value, Offering and Redemption Price per Share  $28.03   $3.47  $14.63   $5.85 
Market Value per Share (Note 2)  $27.88   $3.49  $14.66   $5.82 
                     
* Investments in securities, at cost   7,673,680    24,356,501    -    8,250,285 

 

^No Par Value

 

See accompanying notes to financial statements.

 

F-1

 

 

VS Trust

Statements of Operations

For the Three Months Ended September 30, 2023 and September 30, 2022 (Unaudited)

 

   -1x Short VIX
Futures ETF
   2x Long VIX
Futures ETF
   -1x Short VIX
Futures ETF
   2x Long VIX
Futures ETF
 
   Quarter Ended   Quarter Ended   Quarter Ended   Quarter Ended 
   September 30,
2023
   September 30,
2023
   September 30,
2022
   September 30,
2022
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
INVESTMENT INCOME                
Income:                
Interest income  $86,183   $257,541   $43,411   $126,917 
Other Income   -    -    -    7 
Total Income   86,183    257,541    43,411    126,924 
                     
Expenses:                    
Management fees   293,542    365,111    146,457    464,768 
Administrative, accounting and custodian fees   27,917    28,148    15,332    25,723 
Professional fees   81,552    81,188    80,462    81,792 
Licensing and registration fees   7,688    13,740    27,963    34,070 
Broker interest expense   -    -    4,038    16,295 
Total Expenses   410,699    488,187    274,252    622,648 
Net Investment loss   (324,516)   (230,646)   (230,841)   (495,724)
                     
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FUTURES CONTRACTS                    
                     
Net realized gain (loss) on:                    
Futures   15,738,591    (42,049,000)   8,077,788    (22,686,413)
Net change in unrealized appreciation (depreciation) of:                    
Futures   (12,928,171)   30,931,703    (6,278,300)   20,574,735 
Net realized and unrealized gain (loss) on investments and futures contracts   2,810,420    (11,117,297)   1,799,488    (2,111,678)
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS                    
  $2,485,904   $(11,347,943)  $1,568,647   $(2,607,402)

 

See accompanying notes to financial statements.

 

F-2

 

 

VS Trust

Statements of Operations

For the Nine Months Ended September 30, 2023 and September 30, 2022 (Unaudited)

 

    -1x Short VIX
Futures ETF
    2x Long VIX
Futures ETF
    -1x Short VIX
Futures ETF
    2x Long VIX
Futures ETF
 
    Nine Months Ended     Nine Months Ended     For the
Period Ended
    For the
Period Ended
 
    September 30,
2023
    September 30,
2023
    September 30,
2022^
    September 30,
2022^
 
    (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
INVESTMENT INCOME                        
Income:                        
Interest income   $ 207,714     $ 691,812     $ 62,395     $ 143,699  
Other Income     -       -       61       160  
Total Income     207,714       691,812       62,455       143,859  
                                 
Expenses:                                
Management fees     688,455       1,284,769       310,019       575,991  
Administrative, accounting and custodian fees     74,725       90,847       39,233       49,590  
Professional fees     240,644       242,137       96,221       97,514  
Licensing and registration fees     57,822       58,561       68,358       74,437  
Broker interest expense     8,613       320       24,038       24,438  
Total Expenses     1,070,259       1,676,634       537,868       821,971  
Net Investment loss     (862,545 )     (984,822 )     (475,413 )     (678,112 )
                                 
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FUTURES CONTRACTS                                
                                 
Net realized gain (loss) on:                                
Futures     58,190,096       (228,151,397 )     3,500,659       (15,158,418 )
Net change in unrealized appreciation (depreciation) of:                            
Futures     (7,565,698 )     20,344,189       (5,577,769 )     20,593,993  
Net realized and unrealized gain (loss) on investments and futures contracts      50,624,398       (207,807,208 )     (2,077,111 )     5,435,575  
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS                                
    $ 49,761,853     $ (208,792,030 )   $ (2,552,524 )   $ 4,757,463  

 

^The Fund commenced operations on March 28, 2022.

 

See accompanying notes to financial statements.

 

F-3

 

 

VS Trust

Statement of Changes in Net Assets

For the Three Months Ended September 30, 2023 and September 30, 2022 (Unaudited)

 

   -1x Short VIX
Futures ETF
   2x Long VIX
Futures ETF
   -1x Short VIX
Futures ETF
   2x Long VIX
Futures ETF
 
   Quarter Ended   Quarter Ended   Quarter Ended   Quarter Ended 
   September 30,
2023
   September 30,
2023
   September 30,
2022
   September 30,
2022
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
INCREASE (DECREASE) IN NET ASSETS:                
OPERATIONS                
Net investment loss  $(324,516)  $(230,646)  $(230,841)  $(495,724)
Net realized gain (loss) on investments and futures contracts   15,738,591    (42,049,000)   8,077,788    (22,686,413)
Net change in unrealized appreciation (depreciation) of investments and futures contracts   (12,928,171)   30,931,703    (6,278,300)   20,574,735 
Net increase (decrease) in net assets resulting from operations   2,485,904    (11,347,943)   1,568,647    (2,607,402)
                     
CAPITAL SHARE TRANSACTIONS                    
Shares sold   68,508,308    91,271,140    37,128,501    148,158,278 
Shares redeemed   (32,840,529)   (77,058,854)   (29,971,993)   (112,204,673)
Net increase (decrease) in net assets from capital share transactions   35,667,779    14,212,286    7,156,508    35,953,605 
Total increase (decrease) in net assets   38,153,683    2,864,343    8,725,155    33,346,203 
                     
NET ASSETS                    
Beginning of Period   72,302,413    85,338,802    46,889,371    60,436,455 
End of Period  $110,456,096   $88,203,145   $55,614,526   $93,782,658 

 

See accompanying notes to financial statements.

 

F-4

 

 

VS Trust

Statement of Changes in Net Assets

For the Nine Months Ended September 30, 2023 and September 30, 2022 (Unaudited)

 

   -1x Short VIX
Futures ETF
   2x Long VIX
Futures ETF
   -1x Short VIX
Futures ETF
   2x Long VIX
Futures ETF
 
   Nine Months
Ended
   Nine Months
Ended
   For the
Period Ended
   For the
Period Ended
 
   September 30,
2023
   September 30,
2023
   September 30,
2022^
   September 30,
2022^
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
INCREASE (DECREASE) IN NET ASSETS:                
OPERATIONS                
Net investment loss  $(862,545)  $(984,822)  $(475,413)  $(678,112)
Net realized gain (loss) on investments and futures contracts   58,190,096    (228,151,397)   3,500,659    (15,158,418)
Net change in unrealized appreciation (depreciation) of investments and futures contracts   (7,565,698)   20,344,189    (5,577,769)   20,593,993 
Net increase (decrease) in net assets resulting from operations   49,761,853    (208,792,030)   (2,552,524)   4,757,463 
                     
CAPITAL SHARE TRANSACTIONS                    
Shares sold   187,008,767    369,331,697    169,115,707    252,892,858 
Shares redeemed   (172,693,127)   (197,825,288)   (110,948,657)   (163,867,663)
Net increase (decrease) in net assets from capital share transactions   14,315,640    171,506,409    58,167,050    89,025,195 
Total increase (decrease) in net assets   64,077,493    (37,285,621)   55,614,526    93,782,658 
                     
NET ASSETS                    
Beginning of Period   46,378,603    125,488,766    -    - 
End of Period  $110,456,096   $88,203,145   $55,614,526   $93,782,658 

 

^The Fund commenced operations on March 28, 2022.

 

See accompanying notes to financial statements.

 

F-5

 

 

VS Trust

Statements of Cash Flows

For the Three Months Ended September 30, 2023 and September 30, 2022 (Unaudited)

 

   -1x Short VIX
Futures ETF
   2x Long VIX
Futures ETF
   -1x Short VIX
Futures ETF
   2x Long VIX
Futures ETF
 
   Quarter Ended   Quarter Ended   Quarter Ended   Quarter Ended 
   September 30,
2023
   September 30,
2023
   September 30,
2022
   September 30,
2022
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
CASH FLOW FROM OPERATING ACTIVITIES                
Net increase (decrease) in net assets resulting from operations  $2,485,904   $(11,347,943)  $1,568,647   $(2,607,402)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities                    
Purchase of investments   (113,633,779)   (133,007,714)   (73,580,457)   (189,402,007)
Proceeds from sales or maturities of investments held   105,960,099    118,168,760    65,379,064    175,315,240 
Decrease (Increase) in Deposits at broker for futures contracts   (35,708,583)   28,009,343    3,665,556    (16,108,875)
Decrease (Increase) in Variation margin receivable   1,242,108    (1,945,302)   -    (1,274,983)
Decrease (Increase) in interest receivable   (26,812)   (47,053)   (13,363)   (57,469)
Decrease (Increase) in other receivables   253    (1,521)   (1,333)   - 
Decrease (Increase) in Prepaid expenses and other assets   9,391    (16,431)   -    - 
Decrease (Increase) in Due from Other   -    -    -    (4,743,330)
Increase (Decrease) in Due to Custodian   (1,023,713)   (2,874,781)   575,655    264,682 
Increase (Decrease) in Due to Other   -    6    -    - 
Increase (Decrease) in Variation margin payable   1,327,607    (3,406,049)   191,690    - 
Increase (Decrease) in Payable to Sponsor   41,257    (13,210)   (17,753)   107,134 
Increase (Decrease) in Administrative, accounting and custodian fees payable   3,262    7,567    16,555    27,319 
Increase (Decrease) in Professional fees payable   34,701    33,913    55,336    56,798 
Increase (Decrease) in Licensing and registration fees payable   10,872    14,275    14,922    21,029 
Net cash provided by (used in) operating activities   (39,277,433)   (6,426,140)   (2,145,481)   (38,401,864)
                     
CASH FLOW FROM FINANCING ACTIVITIES                    
Proceeds from shares sold, net of cost from shares purchased   72,117,962    85,350,046    32,683,591    150,498,756 
Cost of shares redeemed   (32,840,529)   (78,923,906)   (34,077,640)   (112,204,673)
Net cash provided by (used in) financing activities   39,277,433    6,426,140    (1,394,049)   38,294,083 
                     
NET INCREASE (DECREASE) IN CASH   -    -    (3,539,530)   (107,781)
Beginning of Period   -    -    3,539,530    107,781 
End of Period  $-   $-   $-   $- 

 

See accompanying notes to financial statements.

 

F-6

 

 

VS Trust

Statements of Cash Flows

For the Nine Months Ended September 30, 2023 and September 30, 2022 (Unaudited)

 

   -1x Short VIX
Futures ETF
   2x Long VIX
Futures ETF
   -1x Short VIX
Futures ETF
   2x Long VIX
Futures ETF
 
   Nine Months
Ended
   Nine Months
Ended
   For the
Period Ended
   For the
Period Ended
 
   September 30,
2023
   September 30,
2023
   September 30,
2022^
   September 30,
2022^
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
CASH FLOW FROM OPERATING ACTIVITIES                
Net increase (decrease) in net assets resulting from operations  $49,761,853   $(208,792,030)  $(2,552,524  $4,757,463
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities                    
Purchase of investments   (340,725,312)   (442,361,238)   (160,823,700)   (250,370,760)
Proceeds from sales or maturities of investments held   333,051,632    426,255,022    144,330,975    219,134,233 
Decrease (Increase) in Deposits at broker for futures contracts   (56,267,842)   59,527,835    (36,207,427   (56,663,638)
Decrease (Increase) in Variation margin receivable   -    (1,114,462)   -    (2,708,079)
Decrease (Increase) in interest receivable   (27,106)   (61,922)   (22,965)   (69,844)
Decrease (Increase) in other receivables   571    (1,502)   -   - 
Decrease (Increase) in Prepaid expenses and other assets   (14,694)   (26,532)   -    - 
Decrease (Increase) in Due from Other   -    -    -    (3,727,069)
Increase (Decrease) in Due to Custodian   -    6    575,655    264,682 
Increase (Decrease) in Due to Other   -    -    -    - 
Increase (Decrease) in Variation margin payable   1,140,577    -    774,721    - 
Increase (Decrease) in Payable to Sponsor   57,503    (51,198)   44,372   177,469 
Increase (Decrease) in Administrative, accounting and custodian fees payable   2,099    5,707    38,976    49,916 
Increase (Decrease) in Professional fees payable   78,459    76,534    70,547    71,973 
Increase (Decrease) in Licensing and registration fees payable   25,038    42,143    50,564    58,460 
 Net cash provided by (used in) operating activities   (12,917,222)   (166,501,637)   (53,722,139)   (89,025,193)
                     
CASH FLOW FROM FINANCING ACTIVITIES                    
Proceeds from shares sold, net of cost from shares purchased   187,008,767    364,326,925    164,670,796    252,892,856 
Cost of shares redeemed   (174,596,145)   (197,825,288)   (110,948,657)   (163,867,663)
Net cash provided by (used in) financing activities   12,412,622    166,501,637    53,722,139   89,025,193 
                     
NET INCREASE (DECREASE) IN CASH   (504,600   -    -   -
Beginning of Period   504,600    -    -    - 
End of Period  $-   $-   $-  $-

 

^The Fund commenced operations on March 28, 2022.

 

See accompanying notes to financial statements.

 

F-7

 

 

-1x Short VIX Futures ETF

Schedule of Investments

September 30, 2023 (Unaudited)

 

Shares      Fair Value 
SHORT TERM INVESTMENT - 6.95%    
Money Market Fund - 6.95%    
 7,673,680   First American Government Obligations Fund, 5.01% (a)  $7,673,680 
     TOTAL SHORT TERM INVESTMENT (Cost $7,673,680)  $7,673,680 
           
     TOTAL INVESTMENTS (Cost $7,673,680) 6.95%  $7,673,680 
     Other Assets in Excess of Liabilities - 93.05% (b)   102,782,416 
     TOTAL NET ASSETS - 100.0%  $110,456,096 

 

Percentages are stated as a percent of net assets.

 

(a)Represents annualized seven-day yield at September 30, 2023.
(b)$104,412,396 of cash is pledged as collateral for futures contracts.

 

-1x Short VIX Futures ETF

Short Futures Contracts

September 30, 2023 (Unaudited)

 

Contracts      Unrealized
Appreciation/
(Depreciation)
 
 (2,472)  CBOE VIX Futures  $(460,721)
     Expiring November 2023 (Underlying Face Amount at Market Value $44,891,520)     
 (3,709)  CBOE VIX Futures   (5,948,871)
     Expiring October 2023 (Underlying Face Amount at Market Value $65,538,030)     
        $(6,409,592)

 

See accompanying notes to financial statements.

 

F-8

 

 

-1x Short VIX Futures ETF

Schedule of Investments

December 31, 2022

 

Cash - 1.1% (a)  $504,600 
Other assets in excess of liabilities - 98.9% (a)   45,874,003 
TOTAL NET ASSETS - 100%  $46,378,603 

 

(a)$48,144,554 of cash os pledged as collateral for futures contracts

 

-1x Short VIX Futures ETF

Short Futures Contracts

December 31, 2022

 

Contracts      Unrealized Appreciation/
(Depreciation)
 
 (1,150)  CBOE VIX Futures  $1,058,570 
     Expiring January 2023 (Underlying Face Amount at Market Value $26,634,000)     
 (804)  CBOE VIX Futures   97,536 
     Expiring February 2023 (Underlying Face Amount at Market Value $19,754,280)  $1,156,106 

 

See accompanying notes to financial statements.

 

F-9

 

 

2x Long VIX Futures ETF

Schedule of Investments

September 30, 2023 (Unaudited)

 

Shares      Fair Value 
SHORT TERM INVESTMENT - 27.61%    
Money Market Fund - 27.61%    
 24,356,501   First American Government Obligations Fund, 5.00% (a)  $24,356,501 
     TOTAL SHORT TERM INVESTMENT (Cost $24,356,501)   24,356,501 
           
     TOTAL INVESTMENTS  (Cost $24,356,501) 27.61%   24,356,501 
     Other Assets in Excess of Liabilities - 72.39% (b)   63,846,644 
     TOTAL NET ASSETS - 100.0%  $88,203,145 

 

Percentages are stated as a percent of net assets.

 

(a)Represents annualized seven-day yield at September 30, 2023.
(b)$55,293,437 of cash is pledged as collateral for futures contracts.

 

2x Long VIX Futures ETF

Long Futures Contracts

September 30, 2023 (Unaudited)

 

Contracts      Unrealized Appreciation/
(Depreciation)
 
 3,945   CBOE VIX Futures  $674,595 
     Expiring November 2023 (Underlying Face Amount at Market Value $71,641,200)     
 5,918   CBOE VIX Futures   10,466,072 
     Expiring October 2023 (Underlying Face Amount at Market Value $104,571,060)  $11,140,667 

 

See accompanying notes to financial statements.

 

F-10

 

 

2x Long VIX Futures ETF

Schedule of Investments

December 31, 2022

 

Shares      Fair Value 
SHORT TERM INVESTMENT - 6.57%    
Money Market Fund - 6.57%    
 8,250,285   First American Government Obligations Fund, 4.105% (a)  $8,250,285 
     TOTAL SHORT TERM INVESTMENT (Cost $8,250,285)  $8,250,285 
           
     TOTAL INVESTMENTS(Cost $8,250,285) - 6.57%  $8,250,285 
 
    Other Assets in Excess of Liabilities - 93.43% (b)   117,238,481 
     TOTAL NET ASSETS - 100.0%  $125,488,766 

 

Percentages are stated as a percent of net assets.

 

(a)Represents annualized seven-day yield at December 31, 2022
(b)$114,821,272 of cash is pledged as collateral for futures contracts.

 

2x Long VIX Futures ETF

Long Futures Contracts

December 31, 2022

 

Contracts      Unrealized Appreciation/
(Depreciation)
 
 6,221   CBOE VIX Futures  $(8,416,975)
     Expiring January 2023 (Underlying Face Amount at Market Value $144,078,360)     
 4,355   CBOE VIX Futures   (786,547)
     Expiring February 2023 (Underlying Face Amount at Market Value $107,002,350)  $(9,203,522)

 

See accompanying notes to financial statements.

 

F-11

 

 

VS Trust

NOTES TO FINANCIAL STATEMENTS

September 30, 2023

(unaudited)

 

NOTE 1 – ORGANIZATION

 

VS Trust (the “Trust”) is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series (each, a “Fund” and collectively, the “Funds”). As of September 30, 2023, the following two series of the Trust have commenced investment operations: -1x Short VIX Futures ETF (“SVIX”) and 2x Long VIX Futures ETF (“UVIX”). Each of the Funds listed above issues common units of beneficial interest (“Shares”), which represent units of fractional undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (“Cboe BZX”).

 

The Funds’ inception of operation was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other than matters relating to its organization and the registration of each series under the Securities Act of 1933.

 

Each Fund’s investment exposure to VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each Fund to regulation under the Commodity Exchange Act of 1934 (“CEA”) and Commodity Futures Trading Commission (“CFTC”) rules. The Sponsor is registered as a Commodity Pool Operator (“CPO”) and the Fund will be operated in accordance with applicable CFTC rules. Registration as a CPO imposes additional compliance obligations on the Sponsor and the Funds related to additional laws, regulations and enforcement policies, which could increase compliance costs and may affect the operations and financial performance of the Funds.

 

Volatility Shares LLC (the “Sponsor”) is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust’s commodity pool operator. The Funds are commodity pools, as defined under the Commodity Exchange Act (the “CEA”), and the applicable regulations of the CFTC and are operated by the Sponsor, which is registered as a commodity pool operator with the CFTC. The Trust is not an investment company registered under the Investment Company Act of 1940.

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

 

Each Fund is an investment company, as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946 “Financial Services — Investment Companies.” As such, the Funds follow the investment company accounting and reporting guidance. The following is a summary of significant accounting policies followed by each Fund, as applicable, in preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

The accompanying unaudited financial statements were prepared in accordance with GAAP for interim financial information and with the instructions for Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). In the opinion of management, all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period.

 

Emerging growth company

 

The Trust is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year.

 

For as long as the Trust remains an “emerging growth company,” it may take advantage of certain exemptions from the various reporting requirements that are applicable to public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an “emerging growth company.”

 

F-12

 

 

Use of Estimates & Indemnifications

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

In the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications. The Trust’s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.

 

Basis of Presentation

 

Pursuant to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for the purchase of Shares in that Fund.

 

The cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated September 30, 2023 and December 31, 2022 and represents cash, but does not include short-term investments.

 

Final Net Asset Value for Fiscal Period

 

The cut-off times and the times of the calculation of the Funds’ final net asset value for creation and redemption of fund Shares for the three months ended September 30, 2023 were typically as follows. All times are Eastern Standard Time:

 

     Create/Redeem    NAV
Calculation
   NAV
Fund    Cut-off*(EST)    Time (EST)    Calculation Date
-1x Short VIX Futures ETF and    2:00 p.m.   4:00 p.m.    September 30, 2023
2x Long VIX Futures ETF    2:00 p.m.    4:00 p.m.    September 30, 2023

 

*Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended September 30, 2023.

 

Market value per Share is determined at the close of Cboe BZX and may be later than when the Funds’ NAV per Share is calculated.

 

For financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds’ final creation/redemption NAV for the three months ended September 30, 2023.

 

Investment Valuation

 

Short-term investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations are typically categorized as Level I in the fair value hierarchy.

 

Derivatives (e.g., futures contracts, options, swap agreements) are generally valued using independent sources and/or agreements with counterparties or other procedures as determined by the Sponsor. Futures contracts are generally valued at the last settled price on the applicable exchange on which that future trades. For financial reporting purposes, all futures contracts are generally valued at the last settled price. Futures contracts valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically categorized as Level II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as the basis for determining the market value of such position. Such fair value prices would generally be determined based on available inputs about the current value of the underlying financial instrument or commodity and would be based on principles that the Sponsor deems fair and equitable so long as such principles are consistent with industry standards. The Sponsor may fair value an asset of a Fund pursuant to the policies the Sponsor has adopted. Depending on the source and relevant significance of valuation inputs, these instruments may be classified as Level II or Level III in the fair value hierarchy.

 

F-13

 

 

Fair value pricing may require subjective determinations about the value of an investment. While the Funds’ policies are intended to result in a calculation of its respective Fund’s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial statements.

 

Fair Value of Financial Instruments

 

The Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds’ own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:

 

Level I – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

 

Level II – Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated inputs).

 

Level III – Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.

 

In some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement in its entirety.

 

Fair value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances indicate that a transaction is not orderly.

 

The following table summarizes the valuation of investments at September 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:

 

   September 30, 2023 (Unaudited)   December 31, 2022 
Fund  Level 1 -
Money
Market
Fund
   Level 2 -
Futures
Contracts*
   Total
September 30,
2023
   Level 1 -
Money
Market
Fund
   Level 2 -
Futures
Contracts*
   Total
December 31,
2022
 
-1x Short VIX Futures ETF  $7,673,680   $(6,409,592)  $1,264,088   $-   $1,156,106   $1,156,106 
2x Long VIX Futures ETF  $24,356,501    11,140,667    35,497,168    8,250,285    (9,203,522)   (953,237)
Total Trust  $32,030,181   $4,731,075   $36,761,256   $8,250,285   $(8,047,416)  $202,869 

 

*Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

 

The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.

 

Investment Transactions and Related Income

 

Investment transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between periods are reflected in the Statements of Operations.

 

Interest income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.

 

F-14

 

 

Brokerage Commissions and Futures Account Fees

 

Each Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (“NFA”) fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities for each Fund’s investment in U.S. Commodity Futures Trading Commission (“CFTC”) regulated investments. The effects of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). ). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more than 0.29% and 0.19%, for SVIX and UVIX, respectively, of each Fund’s average net assets annually.

 

Federal Income Tax

 

Each Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund’s Shares is required to take into account its allocable share of its Fund’s income, gain, loss, deductions and other items for its Fund’s taxable year ending with or within the beneficial owner’s taxable year.

 

Management of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.

 

NOTE 3 – INVESTMENTS

 

Short-Term Investments

 

The Funds may purchase U.S. Treasury Bills, agency securities, and other high-credit quality short-term fixed income or similar securities with original maturities of one year or less. A portion of these investments may be posted as collateral in connection with swap agreements, futures, and/or forward contracts.

 

Accounting for Derivative Instruments

 

In seeking to achieve each Fund’s investment objective, the Sponsor uses a mathematical approach to investing. Using this approach, the Sponsor determines the type, quantity and mix of investment positions, including derivative positions, which the Sponsor believes in combination, should produce returns consistent with a Fund’s objective.

 

All open derivative positions at period end are reflected on each respective Fund’s Schedule of Investments. Certain Funds utilized a varying level of derivative instruments in conjunction with investment securities in seeking to meet their investment objectives during the period. While the volume of open positions may vary on a daily basis as each Fund transacts derivatives contracts in order to achieve the appropriate exposure to meet its investment objective, the volume of these open positions relative to the net assets of each respective Fund at the date of this report is generally representative of open positions throughout the reporting period.

 

Following is a description of the derivative instruments used by the Funds during the reporting period, including the primary underlying risk exposures related to each instrument type.

 

Futures Contracts

 

The Funds may enter into futures contracts to gain exposure to changes in the value of, or as a substitute for investing directly in (or shorting), an underlying benchmark. A futures contract obligates the seller to deliver (and the purchaser to accept) the future delivery of a specified quantity and type of asset at a specified time and place. The contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the underlying commodity, if applicable, or by making an offsetting sale or purchase of an identical futures contract on the same or linked exchange before the designated date of delivery, or by cash settlement at expiration of contract.

 

Upon entering into a futures contract, each Fund is required to deposit and maintain as collateral at least such initial margin as required by the exchange on which the transaction is affected. The initial margin is segregated as cash and/or securities balances with brokers for futures contracts, as disclosed in the Statements of Financial Condition, and is restricted as to its use. The Funds that enter into futures contracts maintain collateral at the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund generally agrees to receive from or pay to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract. Such receipts or payments are known as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize a gain or loss upon closing of a futures transaction.

 

F-15

 

 

Futures contracts involve, to varying degrees, elements of market risk (specifically exchange rate sensitivity, commodity price risk or equity market volatility risk) and exposure to loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure each Fund has in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation between movements in the price of the futures contracts and the market value of the underlying Index or commodity and the possibility of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the Funds since futures contracts are exchange-traded and the credit risk resides with the Funds’ clearing broker or clearinghouse itself. Many futures exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund will be required to make daily cash payments of variation margin. The risk the Fund will be unable to close out a futures position will be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.

 

Option Contracts

 

An option is a contract that gives the buyer the right, but not the obligation, to buy or sell a specified quantity of a commodity or other instrument at a specific (or strike) price within a specified period of time, regardless of the market price of that instrument. There are two types of options: calls and puts. A call option conveys to the option buyer the right to purchase a particular futures contract at a stated price at any time during the life of the option. A put option conveys to the option buyer the right to sell a particular futures contract at a stated price at any time during the life of the option. Options written by a Fund may be wholly or partially covered (meaning that the Fund holds an offsetting position) or uncovered. In the case of the purchase of an option, the risk of loss of an investor’s entire investment (i.e., the premium paid plus transaction charges) reflects the nature of an option as a wasting asset that may become worthless when the option expires. Where an option is written or granted (i.e., sold) uncovered, the seller may be liable to pay substantial additional margin, and the risk of loss is unlimited, as the seller will be obligated to deliver, or take delivery of, an asset at a predetermined price which may, upon exercise of the option, be significantly different from the market value.

 

When a Fund writes a call or put, an amount equal to the premium received is recorded and subsequently marked to market to reflect the current value of the option written. Premiums received from writing options which expire are treated as realized gains. Premiums received from writing options which are exercised or closed are added to the proceeds or offset against amounts paid on the underlying futures, swap or security transaction to determine the realized gain (loss).

 

When a Fund purchases an option, the Fund pays a premium which is included as an asset on the Statement of Financial Condition and subsequently marked to market to reflect the current value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk associated with purchasing put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised or closed are added to the amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized gain (loss) when the underlying transaction is executed.

 

Certain options transactions may subject the writer (seller) to unlimited risk of loss in the event of an increase in the price of the contract to be purchased or delivered. The value of a Fund’s options transactions, if any, will be affected by, among other things, changes in the value of a Fund’s underlying benchmark relative to the strike price, changes in interest rates, changes in the actual and implied volatility of the Fund’s underlying benchmark, and the remaining time until the options expire, or any combination thereof. The value of the options should not be expected to increase or decrease at the same rate as the level of the Fund’s underlying benchmark, which may contribute to tracking error. Options may be less liquid than certain other securities. A Fund’s ability to trade options will be dependent on the willingness of counterparties to trade such options with the Fund. In a less liquid market for options, a Fund may have difficulty closing out certain option positions at desired times and prices. A Fund may experience substantial downside from specific option positions and certain option positions may expire worthless. Over-the-counter options generally are not assignable except by agreement between the parties concerned, and no party or purchaser has any obligation to permit such assignments. The over-the-counter market for options is relatively illiquid, particularly for relatively small transactions. The use of options transactions exposes a Fund to liquidity risk and counterparty credit risk, and in certain circumstances may expose the Fund to unlimited risk of loss. The Funds may buy and sell options on futures contracts, which may present even greater volatility and risk of loss.

 

Swap Agreements

 

The Funds may enter into swap agreements for purposes of pursuing their investment objectives or as a substitute for investing directly in (or shorting) an underlying Index or to create an economic hedge against a position. Swap agreements are two-party contracts that have traditionally been entered into primarily with institutional investors in over-the-counter (“OTC”) markets for a specified period, ranging from a day to more than one year. However, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) provides for significant reforms of the OTC derivative markets, including a requirement to execute certain swap transactions on a CFTC-regulated market and/or to clear such transactions through a CFTC-regulated central clearing organization. In a standard swap transaction, two parties agree to exchange the returns earned or realized on a particular predetermined investment, instrument or Index in exchange for a fixed or floating rate of return in respect of a predetermined notional amount. Transaction or commission costs are reflected in the benchmark level at which the transaction is entered into. The gross returns to be exchanged are calculated with respect to a notional amount and the benchmark returns to which the swap is linked. Swap agreements do not involve the delivery of underlying instruments.

 

F-16

 

 

Generally, swap agreements entered into by the Funds calculate and settle the obligations of the parties to the agreement on a “net basis” with a single payment. Consequently, each Fund’s current obligations (or rights) under a swap agreement will generally be equal only to the net amount to be paid or received under the agreement based on the relative values of such obligations (or rights) (the “net amount”). In a typical swap agreement entered into by UVIX, the would be entitled to settlement payments in the event the level of the benchmark increases and would be required to make payments to the swap counterparties in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount the Funds may pay. In a typical swap agreement entered into by SVIX, the Fund would be required to make payments to the swap counterparties in the event the level of the benchmark increases and would be entitled to settlement payments in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount the Funds may pay.

 

The net amount of the excess, if any, of each Fund’s obligations over its entitlements with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the counterparty in a segregated account by the Funds’ Custodian. The net amount of the excess, if any, of each Fund’s entitlements over its obligations with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the Fund in a segregated account by a third party custodian. Until a swap agreement is settled in cash, the gain or loss on the notional amount less any transaction costs or trading spreads payable by each Fund on the notional amount are recorded as “unrealized appreciation or depreciation on swap agreements” and, when cash is exchanged, the gain or loss realized is recorded as “realized gains or losses on swap agreements.” Swap agreements are generally valued at the last settled price of the benchmark referenced asset.

 

Swap agreements contain various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net positions owed to the party under the agreement. This could cause a Fund to have to enter into a new transaction with the same counterparty, enter into a transaction with a different counterparty or seek to achieve its investment objective through any number of different investments or investment techniques.

 

Swap agreements involve, to varying degrees, elements of market risk and exposure to loss in excess of the unrealized gain/loss reflected. The notional amounts reflect the extent of the total investment exposure each Fund has under the swap agreement, which may exceed the NAV of each Fund. Additional risks associated with the use of swap agreements are imperfect correlations between movements in the notional amount and the price of the underlying reference Index and the inability of counterparties to perform. Each Fund bears the risk of loss of the amount expected to be received under a swap agreement in the event of the default or bankruptcy of a swap agreement counterparty. A Fund will typically enter into swap agreements only with major global financial institutions. The creditworthiness of each of the firms that is a party to a swap agreement is monitored by the Sponsor. The Sponsor may use various techniques to minimize credit risk including early termination and payment, using different counterparties, limiting the net amount due from any individual counterparty and generally requiring collateral to be posted by the counterparty in an amount approximately equal to that owed to the Funds. Outstanding swap agreements contractually terminate within one month but may be terminated without penalty by either party at any time. Upon termination, the Fund is obligated to pay or receive the “unrealized appreciation or depreciation” amount.

 

The Funds, as applicable, collateralize swap agreements by segregating or designating cash and/or certain securities as indicated on the Statements of Financial Condition or Schedules of Investments. As noted above, collateral posted in connection with OTC derivative transactions is held for the benefit of the counterparty in a segregated tri-party account at the Custodian to protect the counterparty against non-payment by the Funds. The collateral held in this account is restricted as to its use. In the event of a default by the counterparty, the Funds will seek withdrawal of this collateral from the segregated account and may incur certain costs in exercising its right with respect to the collateral. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, the Funds may experience significant delays in obtaining any recovery in a bankruptcy or other reorganizational proceeding. The Funds may obtain only limited recovery or may obtain no recovery in such circumstances.

 

The Funds remain subject to credit risk with respect to the amount they expect to receive from counterparties. However, the Funds have sought to mitigate these risks in connection with OTC swaps by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily, in an amount approximately equal to what the counterparty owes the Fund, subject to certain minimum thresholds. In the event of a bankruptcy of a counterparty, such Fund will have direct access to the collateral received from the counterparty, generally as of the day prior to the bankruptcy, because there is a one day time lag between the Fund’s request for collateral and the delivery of such collateral. To the extent any such collateral is insufficient, the Funds will be exposed to counterparty risk as described above, including the possible delays in recovering amounts as a result of bankruptcy proceedings.

 

F-17

 

 

The counterparty/credit risk for cleared derivative transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted for each counterparty to a cleared derivative contract and, in effect, guarantees the parties’ performance under the contract as each party to a trade looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.

 

Fair Values of Derivative Instruments as of September 30, 2023 (Unaudited)  
        Asset Derivatives     Liability Derivatives  
Derivatives Not
Accounted for as
Hedging Instruments
  Fund   Statements of
Financial
Condition Location
  Unrealized
Appreciation*
    Statements of
Financial
Condition Location
  Unrealized
Depreciation*
 
VIX Futures Contracts                            
    -1x Short VIX Futures ETF       $ -         $ (6,409,592)  
    2x Long VIX Futures ETF         11,140,667           -  
    Total Trust       $ 11,140,667         $ (6,409,592  

 

  * Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

 

Fair Values of Derivative Instruments as of December 31, 2022  
        Asset Derivatives     Liability Derivatives  
Derivatives Not
Accounted for as
Hedging Instruments
  Fund   Statements of
Financial
Condition Location
  Unrealized
Appreciation*
    Statements of
Financial
Condition Location
  Unrealized
Depreciation*
 
VIX Futures Contracts                            
    -1x Short VIX Futures ETF       $ 1,156,106         $ -  
    2x Long VIX Futures ETF         -           (9,203,522 )
    Total Trust       $ 1,156,106         $   (9,203,522 )

 

* Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

 

F-18

 

 

The Effect of Derivative Instruments on the Statement of Operations  
For the Three Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited)  
                                 
Derivatives Not
Accounted for as Hedging Instruments
  Location of Gain (Loss) on Derivatives Recognized in Income   Fund   Realized Gain
(Loss) on
Derivatives Recognized
in Income
September 30,
2023
    Change in
Unrealized
Appreciation
(Depreciation)
on Derivatives
Recognized
in Income
September 30,
2023*
    Realized Gain
(Loss) on
Derivatives
Recognized
in Income
September 30,
2022
    Change in
Unrealized
Appreciation
(Depreciation)
on Derivatives
Recognized
in Income
Sepetember 30,
2022*
 
VIX Futures Contracts   Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts                                    
        -1x Short VIX Futures ETF   $ 15,738,591     $ (12,928,171 )   $ 8,077,788   $ (6,278,300 )
        2x Long VIX Futures ETF     (42,049,000 )     30,931,703       (22,686,413 )     20,574,735
        Total Trust   $ (26,310,409 )   $ 18,003,532     $ (14,608,625 )   $ 14,296,435  

 

* Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

 

The Effect of Derivative Instruments on the Statement of Operations  
For the Nine Months Ended September 30, 2023 (Unaudited) and September 30, 2022^ (Unaudited)  
                                 
Derivatives Not
Accounted for as Hedging Instruments
  Location of Gain (Loss) on Derivatives Recognized in Income   Fund   Realized Gain
(Loss) on
Derivatives
Recognized
in Income
September 30,
2023
    Change in
Unrealized
Appreciation
(Depreciation)
on Derivatives
Recognized in
Income
September 30,
2023*
    Realized Gain
(Loss) on
Derivatives
Recognized
in Income
September 30,
2022
    Change in
Unrealized
Appreciation
(Depreciation)
on Derivatives
Recognized
in Income
September 30,
2022*
 
VIX Futures Contracts   Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts                                    
        -1x Short VIX Futures ETF   $ 58,190,096      $ (7,565,698 )   $ 3,500,659     $ (5,577,769 )
        2x Long VIX Futures ETF     (228,151,397 )     20,344,189       (15,158,418 )     20,593,993  
        Total Trust   $ (169,961,301 )   $ 12,778,491     $ (11,657,759 )   $ 15,016,224  

 

* Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.
^The Fund commenced operations on March 28, 2022.

 

F-19

 

 

Offsetting Assets and Liabilities

 

Each Fund is subject to master netting agreements or similar arrangements that allow for amounts owed between each Fund and the counterparty to be netted upon an early termination. The party that has the larger payable pays the excess of the larger amount over the smaller amount to the other party. The master netting agreements or similar arrangements do not apply to amounts owed to/from different counterparties. As described above, the Funds utilize derivative instruments to achieve their investment objective during the year. The amounts shown in the Statements of Financial Condition do not take into consideration the effects of legally enforceable master netting agreements or similar arrangements.

 

For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund’s derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related collateral received or pledged by the Funds as of September 30, 2023 and December 31, 2022.

 

Fair Values of Derivative Instruments as of September 30, 2023 (Unaudited) 
         
   Assets   Liabilities 
Fund  Gross
Amounts of
Recognized
Assets
presented
in the
Statements
of Financial
Condition
   Gross
Amounts
Offset
in the
Statements
of Financial
Condition
   Net Amounts
of Assets
presented
in the
Statements
of Financial
Condition
   Gross
Amounts of
Recognized
Liabilities
presented
in the
Statements
of Financial
Condition
   Gross
Amounts
Offset
in the
Statements
of Financial
Condition
   Net Amounts
of Liabilities
presented
in the
Statements
of Financial
Condition
 
-1x Short VIX Futures ETF  $-   $          -   $-   $1,327,607   $          -   $1,327,607 
2x Long VIX Futures ETF   1,945,302    -    1,945,302    -    -    - 

 

Fair Values of Derivative Instruments as of December 31, 2022 
         
   Assets   Liabilities 
Fund  Gross
Amounts of
Recognized
Assets
presented
in the
Statements
of Financial
Condition
   Gross
Amounts
Offset
in the
Statements
of Financial
Condition
   Net Amounts
of Assets
presented
in the
Statements
of Financial
Condition
   Gross
Amounts of
Recognized
Liabilities
presented
in the
Statements
of Financial
Condition
   Gross
Amounts
Offset
in the
Statements
of Financial
Condition
   Net Amounts
of Liabilities
presented
in the
Statements
of Financial
Condition
 
-1x Short VIX Futures ETF  $-   $          -   $-   $187,030   $             -   $187,030 
2x Long VIX Futures ETF   830,840    -    830,840    -    -    - 

 

Asset (Liability) amounts shown in the table below represent amounts owed to (by) the Funds for the derivative-related investments at September 30, 2023 and December 31, 2022. These amounts may be collateralized by cash or financial instruments, segregated for the benefit of the Funds or the counterparties, depending on whether the related contracts are in an appreciated or depreciated position at period end. Amounts shown in the column labeled “Net Amount” represent the uncollateralized portions of these amounts at period end. These amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement, as further described above under the caption “Accounting for Derivative Instruments”.

 

F-20

 

 

Gross Amounts Not Offset in the Statements of Financial Condition as of September 30, 2023 (Unaudited) 
                 
Fund  Amounts of
Recognized
Assets /
(Liabilities)
presented
in the
Statements
of Financial
Condition
   Financial
Instruments
for the Benefit
of (the Funds) / the
Counterparties
   Cash
Collateral for
the Benefit of
(the Funds) / the
Counterparties
   Net Amount 
-1x Short VIX Futures ETF  $(1,327,607)  $          -   $         -   $(1,327,607)
2x Long VIX Futures ETF   1,945,302    -    -    1,945,302 

 

Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022 
                 
Fund  Amounts of
Recognized
Assets /
(Liabilities)
presented
in the
Statements
of Financial
Condition
   Financial
Instruments
for the Benefit
of (the Funds) / the
Counterparties
   Cash
Collateral for
the Benefit of
(the Funds) / the
Counterparties
   Net Amount 
-1x Short VIX Futures ETF  $(187,030)  $          -   $         -   $(187,030)
2x Long VIX Futures ETF   830,840    -    -    830,840 

 

NOTE 4 – AGREEMENTS

 

SVIX pays the Sponsor a management fee (the “Management Fee”), monthly in arrears, in an amount equal to 1.35% per annum of its average daily net assets. UVIX pays the Sponsor a Management Fee, monthly in arrears, in an amount equal to 1.65% per annum of its average daily net assets. “Average daily net assets” is calculated by dividing the month-end net assets of each Fund by the number of calendar days in such month.

 

No other Management Fee is paid by the Funds. The Management Fee is paid in consideration of the Sponsor’s trading advisory services and the other services provided to the Fund that the Sponsor pays directly.

 

Pursuant to the Sponsor Agreement between Sponsor and the Trust, on behalf of the Funds, the Sponsor oversees and pays Penserra Capital Management, LLC. (“Commodity Sub-Adviser”) for its services as Commodity Sub-Adviser. The Commodity Sub-Adviser is paid by the Sponsor an annual sub-advisory fee of 0.20% based on each Fund’s average daily net assets (total assets of the Fund, minus the sum of its accrued liabilities). The Funds do not directly pay the Commodity Sub-Adviser.

 

Non-Recurring Fees and Expenses

 

Each Fund pays all its non-recurring and unusual fees and expenses, if any, as determined by the Sponsor. Non-recurring and unusual fees and expenses are fees and expenses that are unexpected or unusual in nature, such as legal claims and liabilities, litigation costs or indemnification or other material expenses which are not currently anticipated obligations of the Funds.

 

The Administrator, Transfer Agent and Custodian

 

U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services (“Fund Services”), an indirect subsidiary of U.S. Bancorp, serves as the Fund’s fund accountant, administrator and transfer agent pursuant to certain fund accounting servicing, fund administration servicing and transfer agent servicing agreements. U.S. Bank National Association, a subsidiary of U.S. Bancorp and parent company of Fund Services, intends to serve as the Fund’s custodian pursuant to a custody agreement.

 

F-21

 

 

The Marketing Agent

 

Foreside Fund Services, LLC (the “Marketing Agent”) serves as the Marketing Agent of the Funds. Its principal duties are: (i) to work with the Transfer Agent to review and approve orders placed by Authorized Participants and transmitted to the Transfer Agent; (ii) maintain copies of confirmations of Creation Unit creation and redemption order acceptances; (iii) maintain telephonic, facsimile and/or access to direct computer communications links with the Transfer Agent; and (iv) review and approve, prior to use, all Trust marketing materials for compliance with applicable SEC and FINRA advertising rules.

 

The Marketing Agent retains all marketing materials separately for the Funds, at their offices located at Three Canal Plaza, Suite 100 Portland, Maine 04101.

 

As compensation for the services it provides, the Marketing Agent receives a fee from the Funds.

 

NOTE 5 – OFFERING COSTS

 

Offering costs will be amortized by the Funds over a twelve month period on a straight-line basis beginning once the fund commences operations. The Sponsor will not charge its Management Fee in the first year of operations of a Fund in an amount equal to the offering costs. Normal and expected expenses incurred in connection with the continuous offering of Shares of a Fund after the commencement of its trading operations will be paid by the Sponsor.

 

NOTE 6 – CREATION AND REDEMPTION OF CREATION UNITS

 

Each Fund issues and redeems shares from time to time, but only in one or more Creation Units. A Creation Unit is a block of at least 10,000 Shares of a Fund. Creation Units may be created or redeemed only by Authorized Participants.

 

Except when aggregated in Creation Units, the Shares are not redeemable securities. Retail investors, therefore, generally will not be able to purchase or redeem Shares directly from or with a Fund. Rather, most retail investors will purchase or sell Shares in the secondary market with the assistance of a broker. Thus, some of the information contained in these Notes to Financial Statements—such as references to the Transaction Fees imposed on purchases and redemptions is not relevant to retail investors.

 

Transaction Fees on Creation and Redemption Transactions

 

The manner by which Creation Units are purchased or redeemed is governed by the terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook. By placing a purchase order, an Authorized Participant agrees to: (1) deposit cash with the Custodian; and (2) if permitted by the Sponsor in its sole discretion, enter into or arrange for an exchange of futures contract for related position or block trade with the relevant fund whereby the Authorized Participant would also transfer to such Fund a number and type of exchange-traded futures contracts at or near the closing settlement price for such contracts on the purchase order date.

 

Authorized Participants may pay a fee up to 0.20% of the value of each order they place with each order to create or redeem a Creation Unit in order to compensate the Administrator, the Custodian and the Transfer Agent of each Fund and its Shares, for services in processing the creation and redemption of Creation Units and to offset the costs of increasing or decreasing derivative positions, unless the transaction fee is waived or otherwise adjusted by the Sponsor. The Sponsor provides such Authorized Participant with prompt notice in advance of any such waiver or adjustment of the transaction fee. Authorized Participants may sell the Shares included in the Creation Units they purchase from the Funds to other investors in the secondary market.

 

Transaction fees for the three months ended September 30, 2023 and September 30, 2022 were as follows:

 

Fund  Three
Months
Ended
September 30,
2023
(Unaudited)
   Three
Months
Ended
September 30,
2022
(Unaudited)
 
-1x Short VIX Futures ETF  $30,396   $20,124 
2x Long VIX Futures ETF   50,484    78,086 
Total Trust  $80,880   $98,210 

 

F-22

 

 

Transaction fees for the nine months ended September 30, 2023 and September 30, 2022 were as follows:

 

Fund  Nine Months
Ended
September 30,
2023
(Unaudited)
   Period
Ended
September 30,
2022^
(Unaudited)
 
-1x Short VIX Futures ETF  $107,878   $83,994 
2x Long VIX Futures ETF   170,097    124,991 
Total Trust  $277,975   $208,985 

 

^The Fund commenced operations on March 28, 2022.

 

NOTE 7 – FINANCIAL HIGHLIGHTS

 

Selected data is for a Share outstanding throughout the Three Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited):

 

   -1x Short VIX Futures ETF   2x Long VIX Futures ETF   -1x Short VIX Futures ETF   2x Long VIX Futures ETF 
   Quarter Ended   Quarter Ended   Quarter Ended   Quarter Ended 
   September 30,
2023
   September 30,
2023
   September 30,
2022
   September 30,
2022
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Net Asset Value, Beginning of Period  $28.13   $4.44   $10.40   $85.60 
Net investment loss (1)   (0.11)   (0.01)   (0.06)   (2.38)
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts (2)   0.01    (0.96)   (0.00)   (13.87)
Net Increase (Decrease) in Net Asset Value Resulting from Operations   (0.10)   (0.97)   (0.06)   (16.25)
Net Asset Value, End of Period  $28.03   $3.47   $10.34   $69.35 
Market Value Per Share, at September 30, 2023 and September 30, 2022  $27.88   $3.49   $10.52   $67.00 
Total Return at Net Asset Value (4)   -0.36%   -21.85%   -0.58%   -18.97%
Total Return at Market Value (4)   -0.68%   -21.75%   -0.87%   -18.21%
                     
Ratios to Average Net Assets: (5)                    
Expense ratio (6)   1.89%   2.21%   2.34%   2.35%
Net Investment Loss   -1.49%   -1.04%   -2.06%   -1.93%

 

(1)Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.
(2)Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.
(3)Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.
(4)Percentages are not annualized for the period ended September 30, 2023 and September 30, 2022
(5)Percentages are annualized.
(6)The expense ratio would be 1.89% and 2.21% respectively, for the three months ended September 30, 2023, and 2.23% and 2.27% for the three months ended September 30, 2022 if brokerage commissions and futures and futures account fees were excluded.

 

See accompanying notes to financial statements.

 

F-23

 

 

Selected data is for a Share outstanding throughout the Nine Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited):

 

   -1x Short VIX Futures ETF   2x Long VIX Futures ETF   -1x Short VIX Futures ETF   2x Long VIX Futures ETF 
   Nine Months
Ended
   Nine Months
Ended
   For the
Period Ended
   For the
Period Ended
 
   September 30,
2023
   September 30,
2023
   September 30,
2022^
   September 30,
2022^
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Net Asset Value, Beginning of Period  $14.63   $29.25   $15.00   $75.00 
Net investment loss (1)   (0.27)   (0.07)   (0.12)   (0.60)
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts (2)   13.67    (25.71)   (4.54)   (5.05)
Net Increase (Decrease) in Net Asset Value Resulting from Operations   13.40    (25.78)   (4.66)   (5.65)
Net Asset Value, End of Period  $28.03   $3.47   $10.34   $69.35 
Market Value Per Share, at September 30, 2023 and September 30, 2022  $27.88   $3.49   $10.52   $67.00 
Total Return at Net Asset Value (4)   91.59%   -88.14%   -31.07%   -7.53%
Total Return at Market Value (4)   90.18%   -88.01%   -29.87%   -10.67%
                     
Ratios to Average Net Assets: (5)                    
Expense ratio (6)   2.10%   2.15%   2.33%   2.34%
Net Investment Loss   -1.69%   -1.26%   -2.06%   -1.93%

 

^The Fund commenced operations on March 28, 2022.

 

(1)Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.
(2)Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.
(3)Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.
(4)Percentages are not annualized for the periods ended September 30, 2023 and September 30, 2022
(5)Percentages are annualized.
(6)The expense ratio would be 2.08% and 2.15% respectively, for the nine months ended September 30, 2023, and 2.23% and 2.27% for the period ended September 30, 2022, if brokerage commissions and futures and futures account fees were excluded.

 

See accompanying notes to financial statements.

 

F-24

 

 

NOTE 8 – RISK

 

Correlation and Compounding Risk

 

The Funds do not seek to achieve their stated investment objective over a period of time greater than a single day (as measured from NAV calculation time to NAV calculation time). The return of a Fund for a period longer than a single day is the result of its return for each day compounded over the period and usually will differ in amount and possibly even direction from the inverse (-1x) or two times (2x) the return of the Fund’s benchmark for the period. A Fund will lose money if its benchmark performance is flat over time, and it is possible for a Fund to lose money over time even if the performance of its benchmark increases in the case of UVIX (or decreases in the case of SVIX), as a result of daily rebalancing, the benchmark’s volatility, compounding, and other factors. Compounding is the cumulative effect of applying investment gains and losses and income to the principal amount invested over time. Gains or losses experienced over a given period will increase or reduce the principal amount invested from which the subsequent period’s returns are calculated. The effects of compounding will likely cause the performance of a Fund to differ from the Fund’s stated multiple times the return of its benchmark for the same period. The effect of compounding becomes more pronounced as benchmark volatility and holding period increase. The impact of compounding will impact each shareholder differently depending on the period of time an investment in a Fund is held and the volatility of the benchmark during the holding period of an investment in the Fund. Longer holding periods, higher benchmark volatility, inverse exposure and greater leverage each affect the impact of compounding on a Fund’s returns. Daily compounding of a Fund’s investment returns can dramatically and adversely affect its longer-term performance during periods of high volatility. Volatility may be at least as important to a Fund’s return for a period as the return of the Fund’s underlying benchmark.

 

Each Fund uses leverage and should produce daily returns that are more volatile than that of its benchmark. For example, the daily return of UVIX should be approximately two times as volatile on a daily basis as is the return of a fund with an objective of matching the same benchmark. The daily return of SVIX is designed to return the inverse (-1x) of the return that would be expected of a fund with an objective of matching the same benchmark. The Funds are not appropriate for all investors and present significant risks not applicable to other types of funds. The Funds use leverage and are riskier than similarly benchmarked exchange-traded funds that do not use leverage. An investor should only consider an investment in a Fund if he or she understands the consequences of seeking daily leveraged or daily inverse investment results. Shareholders who invest in the Funds should actively manage and monitor their investments, as frequently as daily.

 

While the Funds seek to meet their investment objectives, there is no guarantee they will do so. Factors that may affect a Fund’s ability to meet its investment objective include: (1) the Sponsor’s ability to purchase and sell Financial Instruments in a manner that correlates to a Fund’s objective; (2) an imperfect correlation between the performance of Financial Instruments held by a Fund and the performance of the applicable benchmark; (3) bid-ask spreads on such Financial Instruments; (4) fees, expenses, transaction costs, financing costs associated with the use of Financial Instruments and commission costs; (5) holding or trading instruments in a market that has become illiquid or disrupted; (6) a Fund’s Share prices being rounded to the nearest cent and/or valuation methodology; (7) changes to a benchmark Index that are not disseminated in advance; (8) the need to conform a Fund’s portfolio holdings to comply with investment restrictions or policies or regulatory or tax law requirements; (9) early and unanticipated closings of the markets on which the holdings of a Fund trade, resulting in the inability of the Fund to execute intended portfolio transactions; (10) accounting standards; and (11) differences caused by a Fund obtaining exposure to only a representative sample of the components of a benchmark, over weighting or under weighting certain components of a benchmark or obtaining exposure to assets that are not included in a benchmark.

 

F-25

 

 

A number of factors may affect a Fund’s ability to achieve a high degree of correlation with its benchmark, and there can be no guarantee that a Fund will achieve a high degree of correlation. Failure to achieve a high degree of correlation may prevent a Fund from achieving its investment objective. In order to achieve a high degree of correlation with their underlying benchmarks, the Funds seek to rebalance their portfolios daily to keep exposure consistent with their investment objectives. Being materially under- or over-exposed to the benchmark may prevent such Funds from achieving a high degree of correlation with such benchmark. Market disruptions or closure, large amounts of assets into or out of the Funds, regulatory restrictions, extreme market volatility, and other factors will adversely affect such Funds’ ability to adjust exposure to requisite levels. The target amount of portfolio exposure is impacted dynamically by the benchmarks’ movements during each day. Other things being equal, more significant movement in the value of its benchmark up or down will require more significant adjustments to a Fund’s portfolio. Because of this, it is unlikely that the Funds will be perfectly exposed (i.e., --1x, -2x, as applicable) to its benchmark at the end of each day, and the likelihood of being materially under- or over-exposed is higher on days when the benchmark levels are volatile near the close of the trading day.

 

Each Fund seeks to rebalance its portfolio on a daily basis. The time and manner in which a Fund rebalances its portfolio may vary from day to day depending upon market conditions and other circumstances at the discretion of the Sponsor. Unlike other funds that do not rebalance their portfolios as frequently, each Fund may be subject to increased trading costs associated with daily portfolio rebalancing in order to maintain appropriate exposure to the underlying benchmarks.

 

Counterparty Risk

 

Each Fund may use derivatives such as swap agreements and forward contracts (collectively referred to herein as “derivatives”) in the manner described herein as a means to achieve their respective investment objectives. The use of derivatives by a Fund exposes the Fund to counterparty risks.

 

Regulatory Treatment

 

Derivatives are generally traded in OTC markets and have only recently become subject to comprehensive regulation in the United States. Cash-settled forwards are generally regulated as “swaps”, whereas physically settled forwards are generally not subject to regulation (in the case of commodities other than currencies) or subject to the federal securities laws (in the case of securities). Title VII of the Dodd-Frank Act (“Title VII”) created a regulatory regime for derivatives, with the CFTC responsible for the regulation of swaps and the SEC responsible for the regulation of “security-based swaps.” The SEC requirements have largely yet to be made effective, but the CFTC requirements are largely in place. The CFTC requirements have included rules for some of the types of transactions in which the Funds will engage, including mandatory clearing and exchange trading, reporting, and margin for OTC swaps. Title VII also created new categories of regulated market participants, such as “swap dealers,” “security-based swap dealers,” “major swap participants,” and “major security-based swap participants” who are, or will be, subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The regulatory requirements under Title VII continue to be developed and there may be further modifications that could materially and adversely impact the Funds, the markets in which a Fund trades and the counterparties with which the Fund engages in transactions.

 

As noted, the CFTC rules may not apply to all of the swap agreements and forward contracts entered into by the Funds. Investors, therefore, may not receive the protection of CFTC regulation or the statutory scheme of the Commodity Exchange Act (the “CEA”) in connection with each Fund’s swap agreements or forward contracts. The lack of regulation in these markets could expose investors to significant losses under certain circumstances, including in the event of trading abuses or financial failure by participants.

 

F-26

 

 

Counterparty Credit Risk

 

The Funds will be subject to the credit risk of the counterparties to the derivatives. In the case of cleared derivatives, the Funds will have credit risk to the clearing corporation in a similar manner as the Funds would for futures contracts. In the case of OTC derivatives, the Funds will be subject to the credit risk of the counterparty to the transaction – typically a single bank or financial institution. As a result, a Fund is subject to increased credit risk with respect to the amount it expects to receive from counterparties to OTC derivatives entered into as part of that Fund’s principal investment strategy. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, a Fund could suffer significant losses on these contracts and the value of an investor’s investment in a Fund may decline.

 

The Funds have sought to mitigate these risks by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily, subject to certain minimum thresholds. However, there are no limitations on the percentage of assets each Fund may invest in swap agreements or forward contracts with a particular counterparty. To the extent any such collateral is insufficient or there are delays in accessing the collateral, the Funds will be exposed to counterparty risk as described above, including possible delays in recovering amounts as a result of bankruptcy proceedings. The Funds typically enter into transactions only with major global financial institutions.

 

OTC derivatives of the type that may be utilized by the Funds are generally less liquid than futures contracts because they are not traded on an exchange, do not have uniform terms and conditions, and are generally entered into based upon the creditworthiness of the parties and the availability of credit support, such as collateral, and in general, are not transferable without the consent of the counterparty. These agreements contain various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net positions owed to the party under the agreement. For example, if the level of the Fund’s benchmark has a dramatic intraday move that would cause a material decline in the Fund’s NAV, the terms of the swap may permit the counterparty to immediately close out the transaction with the Fund. In that event, it may not be possible for the Fund to enter into another swap or to invest in other Financial Instruments necessary to achieve the desired exposure consistent with the Fund’s objective. This, in turn, may prevent the Fund from achieving its investment objective, particularly if the level of the Fund’s benchmark reverses all or part of its intraday move by the end of the day.

 

In addition, cleared derivatives benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. To the extent the Fund enters into cleared swap transactions, the Fund will deposit collateral with a FCM in cleared swaps customer accounts, which are required by CFTC regulations to be separate from its proprietary collateral posted for cleared swaps transactions. Cleared swap customer collateral is subject to regulations that closely parallel the regulations governing customer segregated funds for futures transactions but provide certain additional protections to cleared swaps collateral in the event of a clearing broker or clearing broker customer default. For example, in the event of a default of both the clearing broker and a customer of the clearing broker, a clearing house is only permitted to access the cleared swaps collateral in the legally separate (but operationally comingled) account of the defaulting cleared swap customer of the clearing broker, as opposed to the treatment of customer segregated funds, under which the clearing house may access all of the commingled customer segregated funds of a defaulting clearing broker. Derivatives entered into directly between two counterparties do not necessarily benefit from such protections, particularly if entered into with an entity that is not registered as a “swap dealer” with the CFTC. This exposes the Funds to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem, thus causing the Funds to suffer a loss.

 

The Sponsor regularly reviews the performance of its counterparties for, among other things, creditworthiness and execution quality. In addition, the Sponsor periodically considers the addition of new counterparties and the counterparties used by a Fund may change at any time. Each day, the Funds disclose their portfolio holdings as of the prior Business Day. Each Fund’s portfolio holdings identifies its counterparties, as applicable. This portfolio holdings information may be accessed through the web on the Sponsor’s website at www.volatilityshares.com.

 

F-27

 

 

Each counterparty and/or any of its affiliates may be an Authorized Participant or shareholder of a Fund, subject to applicable law.

 

The counterparty risk for cleared derivatives transactions is generally lower than for OTC derivatives. Once a transaction is cleared, the clearing organization is substituted and is a Fund’s counterparty on the derivative. The clearing organization guarantees the performance of the other side of the derivative. Nevertheless, some risk remains, as there is no assurance that the clearing organization, or its members, will satisfy its obligations to a Fund.

 

Leverage Risk

 

The Funds may utilize leverage in seeking to achieve their respective investment objectives and will lose more money in market environments adverse to their respective daily investment objectives than funds that do not employ leverage. The use of leveraged and/or inverse leveraged positions increases the risk of total loss of an investor’s investment, even over periods as short as a single day.

 

For example, because UVIX includes a two times (2x) multiplier, a single-day movement in the relevant benchmark approaching 50% at any point in the day could result in the total loss or almost total loss of an investor’s investment if that movement is contrary to the investment objective of the Fund in which an investor has invested, even if such Fund’s benchmark subsequently moves in an opposite direction, eliminating all or a portion of the movement. This would be the case with downward single-day or intraday movements in the underlying benchmark of a Fund or upward single-day or intraday movements in the benchmark of a Fund, even if the underlying benchmark maintains a level greater than zero at all times.

 

Liquidity Risk

 

Financial Instruments cannot always be liquidated at the desired price. It is difficult to execute a trade at a specific price when there is a relatively small volume of buy and sell orders in a market. A market disruption can also make it difficult to liquidate a position or find a swap or forward contract counterparty at a reasonable cost. Market illiquidity may cause losses for the Funds. The large size of the positions which the Funds may acquire increases the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred while trying to do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically invest in Financial Instruments related to one benchmark, which in many cases is highly concentrated.

 

“Contango” and “Backwardation” Risk

 

The Funds typically hold futures contracts. As the futures contracts near expiration, they are generally replaced by contracts that have a later expiration. Thus, for example, a contract purchased and held in November 2019 may specify a January 2020 expiration. As that contract nears expiration, it may be replaced by selling the January 2020 contract and purchasing the contract expiring in March 2020. This process is referred to as “rolling.” Rolling may have a positive or negative impact on performance. For example, historically, the prices of certain types of futures contracts have frequently been higher for contracts with shorter-term expirations than for contracts with longer-term expirations, which is referred to as “backwardation.” In these circumstances, absent other factors, the sale of the January 2020 contract would take place at a price that is higher than the price at which the March 2020 contract is purchased, thereby creating a gain in connection with rolling. While certain types of futures contracts have historically exhibited consistent periods of backwardation, backwardation will likely not exist in these markets at all times.

 

Since the introduction of VIX futures contracts, there have frequently been periods where VIX futures prices reflect higher expected volatility levels further out in time. This can result in a loss from “rolling” the VIX futures to maintain the constant weighted average maturity of the applicable Fund benchmark. Losses from exchanging a lower priced VIX future for a higher priced longer-term future in the rolling process could adversely affect the value of a Fund and, accordingly, decrease the return of a Fund.

 

F-28

 

 

Natural Disaster/Epidemic Risk

 

Natural or environmental disasters, such as earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease, including pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and markets and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster and health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays, shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding results on the operating performance of the Funds and their investments. A climate of uncertainty and panic, including the contagion of infectious viruses or diseases, may adversely affect global, regional, and local economies and reduce the availability of potential investment opportunities, and increases the difficulty of performing due diligence and modeling market conditions, potentially reducing the accuracy of financial projections. Under these circumstances, the Funds may have difficulty achieving their investment objectives which may adversely impact performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual companies (including, but not limited to, the Funds’ Sponsor and third party service providers), sectors, industries, markets, securities and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the value of the Funds’ investments. These factors can cause substantial market volatility, exchange trading suspensions and closures and can impact the ability of the Funds to complete redemptions and otherwise affect Fund performance and Fund trading in the secondary market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long such events will last and whether they will continue or recur cannot be predicted. Impacts from these events could have significant impact on a Fund’s performance, resulting in losses to your investment.

 

Risk that Current Assumptions and Expectations Could Become Outdated As a Result of Global Economic Shocks

 

The onset of the novel coronavirus (COVID-19) has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow and contain the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies as economic activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at least equal to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market in the fastest such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US, oil experienced shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as of the date hereof may cause the underlying assumptions and expectations of the Funds to become outdated quickly or inaccurate, resulting in significant losses.

 

NOTE 9 – SUBSEQUENT EVENTS

 

Management has evaluated the possibility of subsequent events existing in the Trust’s and the Funds’ financial statements through the date the financial statements were issued. On September 22, 2023, the Trust announced a 1-for-10 reverse share split (a “Reverse Split”) of the shares of beneficial interest of 2x Long VIX Futures ETF (ticker symbol: UVIX). The Reverse Split was effective prior to market open on October 11, 2023, when the fund began trading at its post-split price. The Reverse Split increased the price per share of the fund with a proportionate decrease in the number of shares outstanding. Therefore, the Reverse Split did not change the aggregate net asset value of a shareholder’s investment at the time of the Reverse Split.

 

For UVIX shareholders who held a quantity of shares that was not an exact multiple of the Reverse Split ratio (i.e., not a multiple of 10), the Reverse Split resulted in the creation of a fractional share. Post-Reverse Split fractional shares were made available to be redeemed for cash and sent to the shareholder’s broker of record. This redemption may have caused some shareholders to realize gains or losses, which could have been a taxable event for those shareholders.

 

F-29

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

This information should be read in conjunction with the financial statements and notes to the financial statements included with this Quarterly Report on Form 10-Q. The discussion and analysis that follows may contain statements that relate to future events or future performance. In some cases, such forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “intend,” “project,” “seek” or the negative of these terms or other comparable terminology. None of the Trust, the Sponsor, the Trustee, or the Administrator assumes responsibility for the accuracy or completeness of any forward-looking statements. Except as expressly required by federal securities laws, none of the Trust, the Sponsor, the Trustee, or the Administrator is under a duty to update any of the forward-looking statements to conform such statements to actual results or to a change in expectations or predictions.

 

Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risk and changes in circumstances that are difficult to predict and many of which are outside of the Funds’ control. The Funds’ forward-looking statements are not guarantees of future results and conditions and important factors, risks and uncertainties in the markets for financial instruments that the Funds trade, in the markets for related physical commodities, in the legal and regulatory regimes applicable to the Sponsor, the Funds, and the Funds’ service providers, and in the broader economy may cause the Funds’ actual results to differ materially from those expressed in forward-looking statements.

 

Introduction

 

VS Trust (the “Trust”) is a Delaware statutory trust formed on October 24, 2019 and is currently organized into two separate series (each, a “Fund” and collectively, the “Funds”). As of September 30, 2022, the following two series of the Trust have commenced investment operations: -1x Short VIX Futures ETF and 2x Long VIX Futures ETF. Each of the Funds listed above issues common units of beneficial interest (“Shares”), which represent units of fractional undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (“Cboe BZX”).

 

The Trust had no operations prior to March 28, 2022, other than matters relating to its organization, the registration of each series under the Securities Act of 1933, as amended.

 

The Sponsor also serves as the Trust’s commodity pool operator. Wilmington Trust Company serves as the Trustee of the Trust (the “Trustee”). The Funds are commodity pools, as defined under the Commodity Exchange Act (the “CEA”), and the applicable regulations of the Commodity Futures Trading Commission (the “CFTC”) and are operated by the Sponsor, a commodity pool operator registered with the CFTC. The Trust is not an investment company registered under the Investment Company Act of 1940, as amended.

 

SVIX seeks daily investment results, before fees and expenses, that correspond to the performance of the Short VIX Futures Index (the “Short Index”) for a single day, not for any other period. UVIX seeks daily investment results, before fees and expenses, that correspond to twice the performance of the Long VIX Futures Index (the “Long Index”). A “single day” is measured from the time a Fund calculates its net asset value (“NAV”) to the time of the Fund’s next NAV calculation. The NAV calculation time for a Fund typically is 4:00 p.m. (Eastern Time).

 

The Funds seek to achieve their investment objective through the appropriate amount of exposure to the VIX futures contracts included in their respective index. The Funds also have the ability to engage in options transactions, swaps, forward contracts and other instruments in order to achieve their investment objective, in the manner and to the extent described herein.

 

SVIX is not benchmarked to the inverse of, and UVIX is not benchmarked to twice, the widely referenced VIX. The Short Index and the inverse of the VIX are separate measurements and can be expected to perform very differently. The Long Index and twice the VIX also are separate measurements and can be expected to perform very differently. As such, SVIX can be expected to perform very differently from the inverse (-1x) of the performance of the VIX over any period, and UVIX can be expected to perform very differently from twice (2x) of the performance of the VIX over any period.

 

-2-

 

 

The Funds continuously offer and redeem Shares in blocks of at least 10,000 Shares (each such block, a “Creation Unit”). Only Authorized Participants (as defined herein) may purchase and redeem Shares from a Fund and then only in Creation Units. An Authorized Participant is an entity that has entered into an Authorized Participant Agreement with the Trust and Volatility Shares LLC (the “Sponsor”). Shares are offered on a continuous basis to Authorized Participants in Creation Units at NAV. Authorized Participants may then offer to the public, from time to time, Shares from any Creation Unit they create at a per-Share market price. The form of Authorized Participant Agreement and the related Authorized Participant Procedures Handbook set forth the terms and conditions under which an Authorized Participant may purchase or redeem a Creation Unit. Authorized Participants will not receive from a Fund, the Sponsor, or any of their affiliates, any fee or other compensation in connection with their sale of Shares to the public. An Authorized Participant may receive commissions or fees from investors who purchase Shares through their commission or fee-based brokerage accounts.

 

The form of Authorized Participant Agreement and related Authorized Participant Handbook set forth the terms and conditions under which an Authorized Participant may purchase or redeem a Creation Unit. Authorized Participants do not receive from any Fund, the Sponsor, or any of their affiliates, any underwriting fees or compensation in connection with their sale of Shares to the public. The Sponsor maintains a website at www.volatilityshares.com, through which monthly account statements and the Trust’s Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “1934 Act”), can be accessed free of charge, as soon as reasonably practicable after such material is electronically filed with, or furnished to, the U.S. Securities and Exchange Commission (the “SEC”). Additional information regarding the Trust may also be found on the SEC’s EDGAR database at www.sec.gov.

 

Liquidity and Capital Resources

 

In order to collateralize derivatives positions in indices, commodities or currencies, a portion of the NAV of each Fund is held in cash and/or U.S. Treasury securities, agency securities, or other high credit quality short term fixed-income or similar securities (such as shares of money market funds, bank deposits, bank money market accounts, certain variable rate-demand notes and repurchase agreements collateralized by government securities. A portion of these investments may be posted as collateral in connection with swap agreements, futures, and/or forward contracts. The percentage that U.S. Treasury bills and other short-term fixed-income securities bear to the shareholders’ equity of each Fund varies from period to period as the market values of the underlying swaps, futures contracts and forward contracts change.

 

Interest Income for the three months ended September 30, 2023 and September 30, 2022 were as follows:

 

Fund  Three Months
Ended
September 30,
2023
   Three Months
Ended
September 30,
2022
 
-1x Short VIX Futures ETF  $86,183   $43,411 
2x Long VIX Futures ETF   257,541    126,917 
Total Trust  $343,724   $170,328 

 

Interest Income for the nine months ended September 30, 2023 and September 30, 2022 were as follows:

 

Fund  Nine Months
Ended
September 30,
2023
   For the
Period Ended
September 30,
2022^
 
-1x Short VIX Futures ETF  $207,714   $62,395 
2x Long VIX Futures ETF   691,812    143,699 
Total Trust  $899,526   $206,094 

 

^The Fund commenced operations on March 28, 2022.

 

-3-

 

 

Futures Contracts

 

A futures contract is a standardized contract traded on, or subject to the rules of, an exchange that calls for the future delivery of a specified quantity and type of a particular underlying asset at a specified time and place or alternatively may call for cash settlement. Futures contracts are traded on a wide variety of underlying assets, including bonds, interest rates, agricultural products, stock indexes, currencies, energy, metals, economic indicators and statistical measures. The notional size and calendar term futures contracts on a particular underlying asset are identical and are not subject to any negotiation, other than with respect to price and the number of contracts traded between the buyer and seller. A Fund generally deposits cash and/or securities with an FCM for its open positions in futures contracts, which may, in turn, transfer such deposits to the clearinghouse to protect the clearing house against non-payment by the Fund. The clearing house becomes substituted for each counterparty to a futures contract, and, in effect, guarantees performance. In addition, the FCM may require a Fund to deposit collateral in excess of the clearing house’s margin requirements for the FCM’s own protection.

 

Certain futures contracts, including stock index contracts, VIX futures contracts and certain commodity futures contracts settle in cash. The cash settlement amount reflects the difference between the contract purchase/sale price and the contract settlement price. The cash settlement mechanism avoids the potential for either side to have to deliver the underlying asset. For other futures contracts, the contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the underlying asset or by making an offsetting sale or purchase of an identical futures contract on the same or linked exchange before the designated date of delivery. The difference between the price at which the futures contract is purchased or sold and the price paid for the offsetting sale or purchase, after allowance for brokerage commissions and exchange fees, constitutes the profit or loss to the trader.

 

Futures contracts involve, to varying degrees, elements of market risk and exposure to loss in excess of the amounts of variation margin, which are the amounts of cash that a Fund agrees to pay to or receive from FCMs equal to the daily fluctuation in the value of a futures contract. Additional risks associated with the use of futures contracts are imperfect correlation between movements in the price of the futures contracts and the level of the underlying benchmark and the possibility of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to a Fund since futures contracts are exchange traded and the exchange’s clearing house, as counterparty to all exchange-traded futures contracts, effectively guarantees futures contracts against default. Many futures exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If trading is not possible or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund may be required to make daily cash payments of variation margin.

 

Futures Account Agreements

 

Each Fund has entered into a written agreement (each, a “Futures Account Agreement”) with one or more FCMs governing the terms of futures transactions of a Fund cleared by such FCM. Each FCM has its own agreement and other documentation used for establishing customer relationships. As such, the terms of the Futures Account Agreement and other documentation that a Fund has with a particular FCM may differ in material respects from that with another FCM.

 

Most Futures Account Agreements do not require the FCM to enter into new transactions or maintain existing transactions with a Fund. In general, each FCM is permitted to terminate its agreement with a Fund at any time in its sole discretion. In addition, an FCM generally will have the discretion to set margin requirements and/or position limits that would be in addition to any margin requirements and/or position limits required by applicable law, set by the exchange, or set by the clearing house that clears the futures contracts in which a Fund transacts. As a result, a Fund’s ability to engage in futures transactions or maintain open positions in such contracts will be dependent on the willingness of its FCMs to continue to accept or maintain such transactions on terms that are economically appropriate for a Fund’s investment strategy.

 

 

-4-

 

 

When a Fund has an open futures contract position, it is subject to at least daily variation margin calls by an FCM that could be substantial in the event of adverse price movements. Because futures contracts may require only a small initial investment in the form of a deposit or margin, they may involve a high degree of leverage. A Fund with open positions is subject to maintenance or variance margin on its open positions. If a Fund has insufficient cash to meet daily variation margin requirements, it may need to sell Financial Instruments at a time when such sales are disadvantageous. Futures markets are highly volatile and the use of or exposure to futures contracts may increase volatility of a Fund’s NAV.

 

Margin posted by a Fund to an FCM typically will be held by relevant exchange’s clearing house (in the case of clearing house-required margin) or the FCM (in the case of “house” margin requirements of the FCM). In the event that market movements favorable to a Fund result in the Fund having posted more margin than is required, the Fund typically would have a right to return of margin from the FCM. However, the timing of such return may be uncertain. As a result, it is possible that a Fund may face liquidity constraints including potential delays in its ability to pay redemption proceeds, where margin is not immediately returned by an FCM.

 

In the event that a Fund fails to comply with its obligations under a Futures Account Agreement (including, for example, failing to deliver the margin required by an FCM on a timely basis), the Futures Account Agreement typically will provide the FCM with broad discretion to take remedial action against the Fund. Among other things, the FCM typically will have the right, upon the occurrence of such a failure by a Fund, to terminate any or all futures contracts in the Fund’s account with that FCM, to sell the collateral posted as margin by the Fund, to close out any open positions of the Fund in whole or in part, and to cancel any or all pending transactions with the Fund. Futures Account Agreements typically provide that the Fund will remain liable for paying to the relevant FCM, on demand, the amount of any deficiency in a Fund’s account with that FCM.

 

The Futures Account Agreement between the Fund and an FCM generally requires the Fund to indemnify and hold harmless the FCM, its directors, officers, employees, agents and affiliates (collectively, “indemnified persons”) from and against all claims, damages, losses and costs (including reasonable attorneys’ fees) incurred by the indemnified persons, in connection with: (1) any failure by the Fund to perform its obligations under the Futures Account Agreement and the FCM’s exercise of its rights and remedies thereunder; (2) any failure by the Fund to comply with applicable law; (3) any action reasonably taken by the indemnified persons pursuant to the Futures Account Agreement to comply with applicable law; and (4) any actions taken by the FCM in reliance on instructions, notices and other communications that the FCM and its relevant personnel, as applicable, reasonably believes to originate from a person authorized to act on behalf of the Fund.

 

To the extent that the Fund trades in futures contracts on U.S. exchanges, the assets deposited by the Fund with the FCMs (or another eligible financial institution, as applicable) as margin must be segregated pursuant to the regulations of the CFTC. Such segregated funds may be invested only in a limited range of instruments — principally U.S. government obligations to margin futures and forward contract positions.

 

Options

 

An option is a contract that gives the purchaser of the option, in return for the premium paid, the right to buy an underlying reference instrument, such as a specified security index, or other instrument, from the writer of the option (in the case of a call option), or to sell a specified reference instrument to the writer of the option (in the case of a put option) at a designated price during the term of the option. The premium paid by the buyer of an option will reflect, among other things, the relationship of the exercise price to the market price and the volatility of the underlying reference instrument, the remaining term of the option, supply, demand or interest rates. An American style put or call option may be exercised at any time during the option period while a European style put or call option may be exercised only upon expiration or during a fixed period prior thereto. Put and call options are traded on national securities exchanges and in the OTC market. Options traded on national securities exchanges are within the jurisdiction of the SEC or other appropriate national securities regulator, as are securities traded on such exchanges. As a result, many of the protections provided to traders on organized exchanges will be available with respect to such transactions. In particular, all option positions entered into on a national securities exchange in the United States are cleared and guaranteed by the Options Clearing Corporation, thereby reducing the risk of counterparty default. Furthermore, a liquid secondary market in options traded on a national securities exchange may be more readily available than in the OTC market, potentially permitting a Fund to liquidate open positions at a profit prior to exercise or expiration, or to limit losses in the event of adverse market movements. There is no assurance, however, that higher than anticipated trading activity or other unforeseen events might not temporarily render the capabilities of the Options Clearing Corporation inadequate, and thereby result in the exchange instituting special procedures which may interfere with the timely execution of a Fund’s orders to close out open options positions.

 

-5-

 

 

Swap Agreements

 

Swaps are contracts that have traditionally been entered into primarily by institutional investors in OTC markets for a specified period ranging from a day to many years. Certain types of swaps may be cleared, and certain types are, in fact, required to be cleared. The types of swaps that may be cleared are generally limited to only swaps where the most liquidity exists and a clearing organization is willing to clear the trade on standardized terms. Swaps with customized terms or those for which significant market liquidity does not exist are generally not able to be cleared.

 

In a standard swap transaction, the parties agree to exchange the returns on, among other things, a particular predetermined security, commodity, interest rate, or index for a fixed or floating rate of return (the “interest rate leg,” which will also include the cost of borrowing for short swaps) in respect of a predetermined notional amount. The notional amount of the swap reflects the extent of a Fund’s total investment exposure under the swap.

 

In the case of futures contracts-based indexes, such as those used by a Fund, the reference interest rate typically is zero, although a financing spread or fee is generally still applied. Transaction or commission costs are reflected in the benchmark level at which the transaction is entered into. The gross returns to be exchanged are calculated with respect to the notional amount and the benchmark returns to which the swap is linked. Swaps are usually closed out on a net basis, i.e., the two payment streams are netted out in a cash settlement on the payment date specified in the agreement, with the parties receiving or paying, as the case may be, only the net amount of the two payments. Thus, while the notional amount reflects a Fund’s total investment exposure under the swap (i.e., the entire face amount or principal of a swap), the net amount is the Fund’s current obligations (or rights) under the swap. That is the amount to be paid or received under the agreement based on the relative values of the positions held by each party to the agreement on any given termination date.

 

Swaps may also expose a Fund to liquidity risk. Although a Fund may have the ability to terminate a swap at any time, doing so may subject the Fund to certain early termination charges. In addition, there may not be a liquid market within which to dispose of an outstanding swap even if a permitted disposal might avoid an early termination charge. Uncleared swaps generally are not assignable except by agreement between the parties to the swap, and generally no party or purchaser has any obligation to permit such assignments.

 

Swaps involve, to varying degrees, elements of market risk and exposure to loss in excess of the amount which would be reflected on a Fund’s Statement of Financial Condition. In addition to market risk and other risks, the use of swaps also comes with counterparty credit risk — i.e., the inability of a counterparty to a swap to perform its obligations. A Fund that invests in swaps bears the risk of loss of the net amount, if any, expected to be received under a swap agreement in the event of the default or bankruptcy of a swap counterparty. A Fund enters or intends to enter into swaps only with major, global financial institutions. However, there are no limitations on the percentage of its assets a Fund may invest in swaps with a particular counterparty.

 

A Fund that invests in swaps may use various techniques to minimize counterparty credit risk. A Fund that invests in swaps generally enters into arrangements with its counterparties whereby both sides exchange collateral on a mark-to-market basis. In addition, the Fund may post “initial margin” or “independent amount” to counterparties in swaps. Such collateral serves as protection for the counterparty in the event of a failure by the Fund and is in addition to any mark-to-market collateral that (i.e., the Fund may post initial margin to the counterparty even where the counterparty would owe money to the Fund if the swap were to be terminated). The amount of initial margin posted by the Fund may vary depending on the risk profile of the swap. The collateral, whether for mark-to-market or for initial margin, generally consists of cash and/or securities.

 

Collateral posted by a Fund to a counterparty in connection with uncleared derivatives transactions is generally held for the benefit of the counterparty in a segregated tri-party account at a third-party custodian to protect the counterparty against non-payment by the Fund. In the event of a default by a Fund where the counterparty is owed money in the uncleared swap transaction, such counterparty will seek withdrawal of this collateral from the segregated account.

 

Collateral posted by the counterparty to a Fund is typically held for the benefit of the Fund in a segregated tri-party account at a third-party custodian. In the event of a default by the counterparty where the Fund is owed money in the uncleared swap transaction, the Fund will seek withdrawal of this collateral from the segregated account. The Fund may incur certain costs exercising its right with respect to the collateral.

 

Notwithstanding the use of collateral arrangements, to the extent any collateral provided to a Fund is insufficient or there are delays in accessing the collateral, a Fund will be exposed to counterparty risk as described above, including possible delays in recovering amounts as a result of bankruptcy proceedings.

 

-6-

 

 

Off-Balance Sheet Arrangements and Contractual Obligations

 

As of September 30, 2022, the Funds have not used, nor do they expect to use in the future, special purpose entities to facilitate off-balance sheet financing arrangements and have no loan guarantee arrangements or off-balance sheet arrangements of any kind other than agreements entered into in the normal course of business, which may include indemnification provisions related to certain risks service providers undertake in performing services which are in the best interests of the Funds. While each Fund’s exposure under such indemnification provisions cannot be estimated, these general business indemnifications are not expected to have a material impact on a Fund’s financial position.

 

Management fee payments made to the Sponsor are calculated as a fixed percentage of each Fund’s NAV. As such, the Sponsor cannot anticipate the payment amounts that will be required under these arrangements for future periods as NAVs are not known until a future date. The agreement with the Sponsor may be terminated by either party upon 30 days written notice to the other party.

 

Critical Accounting Policies

 

Preparation of the financial statements and related disclosures in compliance with accounting principles generally accepted in the United States of America requires the application of appropriate accounting rules and guidance, as well as the use of estimates. The Trust’s and the Funds’ application of these policies involves judgments and actual results may differ from the estimates used.

 

Each Fund has significant exposure to Financial Instruments. The Funds hold a significant portion of their assets in futures, all of which are recorded on a trade date basis and at fair value in the financial statements, with changes in fair value reported in the Statements of Operations.

 

The use of fair value to measure Financial Instruments, with related unrealized gains or losses recognized in earnings in each period, is fundamental to the Trust’s and the Funds’ financial statements. The fair value of a Financial Instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price).

 

For financial reporting purposes, the Funds value investments based upon the closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ from those used in the calculation of certain Funds’ final creation/redemption NAV for the period ended September 30, 2023.

 

Short-term investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price using information provided by a third-party pricing service or market quotations.

 

Derivatives (e.g., futures contracts, options, swap agreements) are generally valued using independent sources and/or agreements with counterparties or other procedures as determined by the Sponsor. Futures contracts, are generally valued at the last settled price on the applicable exchange on which that future trades. Futures contracts valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically categorized as Level II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as the basis for determining the market value of such position. Such fair value prices would be generally determined based on available inputs about the current value of the underlying financial instrument or commodity and would be based on principles that the Sponsor deems fair and equitable so long as such principles are consistent with normal industry standards. The Sponsor may fair value an asset of a Fund pursuant to the policies the Sponsor has adopted, which are consistent with normal industry standards. Depending on the source and relevant significance of valuation inputs, these instruments may be classified as Level II or Level III in the fair value hierarchy.

 

-7-

 

 

Fair value pricing may require subjective determinations about the value of an investment. While each Fund’s policy is intended to result in a calculation of the Fund’s NAV that fairly reflects investment values as of the time of pricing, the Funds cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that the Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale).

 

The prices used by a Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial statements.

 

The Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.

 

Discounts on short-term securities purchased are amortized and reflected as Interest Income in the Statements of Operations.

 

Realized gains (losses) and changes in unrealized gain (loss) on open investments are determined on a specific identification basis and recognized in the Statements of Operations in the period in which the contract is closed or the changes occur, respectively.

 

Each Fund pays its respective brokerage commissions, including applicable exchange fees, NFA fees, give up fees, pit futures account fees and other transaction related fees and expenses charged in connection with trading activities for each Fund’s investment in U.S. Commodity Futures Trading Commission regulated investments. Brokerage commissions on futures contracts are recognized on a half-turn basis. The Sponsor is currently paying brokerage commissions in VIX futures contracts exceed variable create/redeem fees collected by more than 0.02% of the Fund’s average net assets annually.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Quantitative Disclosure

 

Equity Market Volatility Sensitivity

 

Each of the Funds is exposed to certain risks pertaining to the use of Financial Instruments. Each Fund is exposed to equity market volatility risk through its holdings of Financial Instruments.

 

The tables below provide information about each Fund’s Financial Instruments. As of September 30, 2023 and December 31, 2022, each of the Fund’s positions were as follows:

 

-1x Short VIX Futures ETF

 

As of September 30, 2023, SVIX was exposed to inverse equity market volatility risk through its holding of VIX futures contracts. The following tables provide information about the Fund’s positions in VIX futures contracts as of September 30, 2023 and December 31, 2022, which were sensitive to equity market volatility risk.

 

Futures Positions as of September 30, 2023 
Contract  Long or Short  Expiration  Contracts   Valuation
Price
   Contract
Multiplier
   Notional
Amount at
Value
 
VIX Futures (Cboe)  Short  November, 2023   (2,472)   18.16    1,000    (44,891,520)
VIX Futures (Cboe)  Short  October, 2023   (3,709)   17.67    1,000    (65,538,030)

 

Futures Positions as of December 31, 2022  
Contract   Long or Short   Expiration   Contracts     Valuation Price     Contract Multiplier     Notional Amount at Value  
VIX Futures (Cboe)   Short   January, 2023     (1,150 )   $ 23.16       1,000     $ (26,634,000 )
VIX Futures (Cboe)   Short   February, 2023     (804 )     24.57       1,000       (19,754,280 )

 

-8-

 

 

The short futures notional values are calculated by multiplying the number of contracts held times the valuation price times the contract multiplier. The short notional values will increase (decrease) proportionally with decreases (increases) in the price of the futures contract. Additional gains (losses) associated with these contracts will be equal to any such subsequent decreases (increases) in short notional values, before accounting for spreads or transaction or financing costs. The Fund will generally attempt to adjust its position in Financial Instruments each day to have -$1.00 of short exposure to the Index for every $1.00 of net assets. Future period returns, before fees and expenses, cannot be estimated simply by estimating the return of the Index and multiplying by negative one-half. See “Item 1A. Risk Factors” in the Annual Report on Form 10-K for additional information regarding performance for periods longer than a single day.

 

2x Long VIX Futures ETF

 

As of September 30, 2023, UVIX was exposed to equity market volatility risk through its holding of VIX futures contracts. The following tables provide information about the Fund’s positions in these Financial Instruments as of September 30, 2023 and December 31, 2022, which were sensitive to equity market volatility risk.

 

Futures Positions as of September 30, 2023 
Contract  Long or Short  Expiration  Contracts   Valuation Price   Contract Multiplier   Notional Amount at Value 
VIX Futures (Cboe)  Long  November, 2023   3,945    18.16    1,000    71,641,200 
VIX Futures (Cboe)  Long  October, 2023   5,918    17.67    1,000    104,571,060 

 

Futures Positions as of December 31, 2022 
Contract  Long or Short  Expiration  Contracts   Valuation Price   Contract Multiplier   Notional Amount at Value 
VIX Futures (Cboe)  Long  January, 2023   6,221   $23.16    1,000   $144,078,360 
VIX Futures (Cboe)  Long  February, 2023   4,355    24.57    1,000    107,002,350 

 

The futures notional values are calculated by multiplying the number of contracts held times the valuation price times the contract multiplier. The swap notional values are calculated by multiplying the number of units times the closing level of the Index. These notional values will increase (decrease) proportionally with increases (decreases) in the price of the futures contract or the level of the Index, as applicable. Additional gains (losses) associated with these contracts will be equal to any such subsequent increases (decreases) in notional values, before accounting for spreads or transaction or financing costs. The Fund will generally attempt to adjust its positions in Financial Instruments each day to have $2.00 of exposure to the Index for every $1.00 of net assets. Future period returns, before fees and expenses, cannot be estimated simply by estimating the return of the Index and multiplying by one and one-half. See “Item 1A. Risk Factors” in the Annual Report on Form 10-K.

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

Under the supervision and with the participation of the principal executive officer and principal financial officer of the Trust, Trust management has evaluated the effectiveness of the Trust’s and the Funds’ disclosure controls and procedures, and have concluded that the disclosure controls and procedures of the Trust and the Funds (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “1934 Act”)) were effective, as of March 31, 2022, including providing reasonable assurance that information required to be disclosed in the reports that the Trust files or submits under the 1934 Act on behalf of the Trust and the Funds is recorded, processed, summarized and reported, within the time periods specified in the applicable rules and forms, and that such information is accumulated and communicated to management, including the principal executive officer and principal financial officer, of the Trust as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in the Trust’s or the Funds’ internal control over financial reporting that occurred during the quarter ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, the Trust’s or the Funds’ internal control over financial reporting.

 

Certifications

 

The certifications by the Principal Executive Officer and Principal Financial Officer of the Trust required by Section 302 and Section 906 of the Sarbanes-Oxley Act of 2002, which are filed or furnished as exhibits to this Quarterly Report on Form 10-Q, apply both to the Trust taken as a whole and each Fund, and the Principal Executive Officer and Principal Financial Officer of the Trust are certifying both as to the Trust taken as a whole and each Fund.

 

-9-

 

 

Part II. OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

None.

 

Item 1A. Risk Factors.

 

Investments in futures contracts are subject to current position limits and accountability levels established by the exchanges. Accordingly, the Sponsor and the Funds may be required to reduce the size of outstanding positions or be restricted from entering into new positions that would otherwise be taken for a Fund or not trade in certain markets on behalf of the Fund in order to comply with those limits or any future limits. These restrictions, if implemented, could limit the ability of each Fund to invest in additional futures contracts, add to existing positions in the desired amount, or create additional Creation Units and could otherwise have a significant negative impact on Fund operations and performance, decreasing a Fund’s correlation to the performance of its benchmark, and otherwise preventing a Fund from achieving its investment objective.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

a)None.

 

b)Not applicable.

 

Title of Securities Registered  Amount
Registered
as of
September 30,
2023
  Shares Sold
For the
Three Months
Ended
September 30,
2023
   Sale Price of
Shares Sold
For the Three
Months Ended
September 30,
2023
 
-1x Short VIX Futures ETF  Unlimited   2,480,000    68,508,308 
2x Long VIX Futures ETF  Unlimited   26,690,000    91,271,140 
Total Trust      29,170,000    159,779,448 

 

Title of Securities Registered  Amount
Registered
as of
September 30,
2023
  Shares Sold
For the
Nine Months
Ended
September 30,
2023
   Sale Price of
Shares Sold
For the Nine
Months Ended
September 30,
2023
 
-1x Short VIX Futures ETF  Unlimited   9,640,000    187,008,767 
2x Long VIX Futures ETF  Unlimited   49,370,000    369,331,697 
Total Trust      59,010,000    556,340,464 

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

-10-

 

 

Item 6. Exhibits.

 

Exhibit No.    
31.1*   Description of Document Certification by Principal Executive Officer of the Trust Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
     
31.2*   Description of Document Certification by Principal Financial Officer of the Trust Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
     
32.1*   Description of Document Certification by Principal Executive Officer of the Trust Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 under the Securities Exchange Act of 1934
     
32.2*   Description of Document Certification by Principal Financial Officer of the Trust Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 under the Securities Exchange Act of 1934
     
101.INS   Inline XBRL Instance Document (1)
     
101.SCH   Inline XBRL Taxonomy Extension Schema (1)
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase (1)
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase (1)
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase (1)
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase (1)
     
104.1   Cover Page Interactive Data File - The cover page interactive data file does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.

 

*Filed herewith.

 

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

-11-

 

 

Signatures

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

VS Trust  
   
/s/ Justin Young  
By: Justin Young  
  Principal Executive Officer  
   
Date: November 15, 2023  
   
/s/ Justin Young  
By: Justin Young  
  Principal Financial and Accounting Officer  
   
Date: November 15, 2023  

 

-12-

 

Investments in securities, at cost 0.0657 $(6,409,592) $11,140,667 $(6,409,592 $1,156,106 $1,156,106 $(9,203,522) false --12-31 Q3 0001793497 0001793497 2023-01-01 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2023-01-01 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2023-01-01 2023-09-30 0001793497 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2023-07-01 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2023-07-01 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-07-01 2022-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-07-01 2022-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2023-01-01 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2023-01-01 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-01-01 2022-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-01-01 2022-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2023-06-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2023-06-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-06-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-06-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2021-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2021-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:FirstAmericanGovernmentObligationsFundMember 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2023-01-01 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2023-01-01 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2023-01-01 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2022-12-31 0001793497 2022-01-01 2022-12-31 0001793497 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2022-01-01 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2022-01-01 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:FirstAmericanGovernmentObligationsFundMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2023-01-01 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2023-01-01 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:FirstAmericanGovernmentObligationsFundMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2022-12-31 0001793497 cik0001793497:SVIXMember 2023-09-30 0001793497 cik0001793497:UVIXMember 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001793497 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001793497 cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001793497 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember cik0001793497:AssetDerivativesMember cik0001793497:StatementsOfFinancialConditionLocationMember 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember cik0001793497:AssetDerivativesMember cik0001793497:UnrealizedAppreciationMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:AssetDerivativesMember cik0001793497:StatementsOfFinancialConditionLocationMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:AssetDerivativesMember cik0001793497:UnrealizedAppreciationMember 2023-09-30 0001793497 cik0001793497:AssetDerivativesMember cik0001793497:StatementsOfFinancialConditionLocationMember 2023-09-30 0001793497 cik0001793497:AssetDerivativesMember cik0001793497:UnrealizedAppreciationMember 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember cik0001793497:LiabilityDerivativesMember cik0001793497:StatementsOfFinancialConditionLocationMember 2022-12-31 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember cik0001793497:LiabilityDerivativesMember cik0001793497:UnrealizedDepreciationMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:LiabilityDerivativesMember cik0001793497:StatementsOfFinancialConditionLocationMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:LiabilityDerivativesMember cik0001793497:UnrealizedDepreciationMember 2022-12-31 0001793497 cik0001793497:LiabilityDerivativesMember cik0001793497:StatementsOfFinancialConditionLocationMember 2022-12-31 0001793497 cik0001793497:LiabilityDerivativesMember cik0001793497:UnrealizedDepreciationMember 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2023-07-01 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2022-07-01 2022-09-30 0001793497 2023-07-01 2023-09-30 0001793497 2022-07-01 2022-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2022-01-01 2022-09-30 0001793497 2022-01-01 2022-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember us-gaap:OtherAssetsMember 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember us-gaap:OtherLiabilitiesMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:OtherAssetsMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:OtherLiabilitiesMember 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember us-gaap:OtherAssetsMember 2022-12-31 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember us-gaap:OtherLiabilitiesMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:OtherAssetsMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:OtherLiabilitiesMember 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:SVIXMember 2023-09-30 0001793497 cik0001793497:UVIXMember 2023-09-30 0001793497 srt:MinimumMember 2023-07-01 2023-09-30 0001793497 srt:MaximumMember 2023-07-01 2023-09-30 0001793497 srt:MinimumMember 2022-07-01 2022-09-30 0001793497 srt:MaximumMember 2022-07-01 2022-09-30 0001793497 srt:MinimumMember 2023-01-01 2023-09-30 0001793497 srt:MaximumMember 2023-01-01 2023-09-30 0001793497 srt:MinimumMember 2022-01-01 2022-09-30 0001793497 srt:MaximumMember 2022-01-01 2022-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2023-06-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2022-06-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2023-07-01 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2022-07-01 2022-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2022-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2022-12-31 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2021-12-31 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2023-01-01 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2022-01-01 2022-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
EX-31.1 2 f10q0923ex31-1_vstrust.htm CERTIFICATION

Exhibit 31.1

 

Certification of Principal Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Justin Young, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of VS Trust and each of its Funds;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 15, 2023 By: /s/ Justin Young
  Name:  Justin Young
  Title: Principal Executive Officer
    VS Trust
EX-31.2 3 f10q0923ex31-2_vstrust.htm CERTIFICATION

Exhibit 31.2

 

Certification of Principal Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Justin Young, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of VS Trust and each of its Funds;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

November 15, 2023 By: /s/ Justin Young
  Name:  Justin Young
  Title: Principal Financial and Accounting Officer
    VS Trust

 

EX-32.1 4 f10q0923ex32-1_vstrust.htm CERTIFICATION

Exhibit 32.1

 

Certification of Principal Executive Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with this Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Report”) of VS Trust (the “Registrant”) and each of its Funds, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Justin Young, the Principal Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

November 15, 2023 By: /s/ Justin Young
  Name:  Justin Young
  Title: Principal Executive Officer
    VS Trust

 

EX-32.2 5 f10q0923ex32-2_vstrust.htm CERTIFICATION

Exhibit 32.2

 

Certification of Principal Financial Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with this Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Report”) of VS Trust (the “Registrant”) and each of its Funds, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Justin Young, the Principal Financial and Accounting Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

(3)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(4)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: November 15, 2023 By: /s/ Justin Young
  Name:  Justin Young
  Title: Principal Financial and Accounting Officer
    VS Trust
EX-101.SCH 6 cik0001793497-20230930.xsd XBRL SCHEMA FILE 001 - Statement - Statements of Assets and Liabilities (Unaudited) link:presentationLink link:definitionLink link:calculationLink 001 - Statement - Statements of Assets and Liabilities (Unaudited) Alternate 0 link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Statement of Changes in Net Assets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Schedule of Investments (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Schedule of Investments (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Investments link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Agreements link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Offering Costs link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Creation and Redemption of Creation Units link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Financial Highlights link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Risk link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Investments (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Creation and Redemption of Creation Units (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Financial Highlights (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Investments (Details) - Schedule of Fair Value of Derivative Instruments link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Investments (Details) - Schedule of Effect of Derivative Instruments on the Statement of Operations link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Investments (Details) - Schedule of Pledged by Funds Fair Values of Derivative Instruments link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Investments (Details) - Schedule of Gross Amounts Not Offset in the Statements of Financial Condition link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Agreements (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Creation and Redemption of Creation Units (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Financial Highlights (Details) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Financial Highlights (Details) - Schedule of Share Outstanding link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Risk (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 cik0001793497-20230930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 cik0001793497-20230930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 cik0001793497-20230930_lab.xml XBRL LABEL FILE EX-101.PRE 10 cik0001793497-20230930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document And Entity Information
9 Months Ended
Sep. 30, 2023
shares
Document Information Line Items  
Entity Registrant Name VS Trust
Document Type 10-Q
Current Fiscal Year End Date --12-31
Entity Common Stock, Shares Outstanding 29,360,000
Amendment Flag false
Entity Central Index Key 0001793497
Entity Current Reporting Status Yes
Entity Filer Category Non-accelerated Filer
Document Period End Date Sep. 30, 2023
Document Fiscal Year Focus 2023
Document Fiscal Period Focus Q3
Entity Small Business true
Entity Emerging Growth Company true
Entity Shell Company false
Entity Ex Transition Period false
Document Quarterly Report true
Document Transition Report false
Entity File Number 001-34200
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 84-6704517
Entity Address, Address Line One 2000 PGA Boulevard
Entity Address, Address Line Two Suite 4440
Entity Address, City or Town Palm Beach Gardens
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33408
City Area Code (866)
Local Phone Number 261-0273
Entity Interactive Data Current Yes
-1x Short VIX Futures ETF  
Document Information Line Items  
Trading Symbol SVIX
Title of 12(b) Security -1x Short VIX Futures ETF
Security Exchange Name CboeBZX
2x Long VIX Futures ETF  
Document Information Line Items  
Trading Symbol UVIX
Title of 12(b) Security 2x Long VIX Futures ETF
Security Exchange Name CboeBZX
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Statements of Assets and Liabilities (Unaudited) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
-1x Short VIX Futures ETF    
ASSETS    
Cash $ 504,600
Investments in securities, at value [1] 7,673,680
Interest receivable 40,015 12,909
Prepaid expenses and other assets 24,989 10,295
Receivable for shares sold  
Deposit at Broker for Futures 104,412,396 48,144,554
Variation margin receivable
Other receivable 571
Total Assets 112,151,080 48,672,929
Payables    
Variation margin payable 1,327,607 187,030
Due to Other  
Payable to Broker 1,903,018
Payable to Sponsor 111,877 54,374
Administrative, accounting and custodian fees payable 17,968 15,869
Professional fees payable 203,733 125,274
Licensing and registration fees payable 33,799 8,761
Total Liabilities 1,694,984 2,294,326
NET ASSETS 110,456,096 46,378,603
NET ASSETS CONSIST OF:    
Paid-in capital 43,701,765 29,386,125
Total distributable earnings (accumulated deficit) 66,754,331 16,992,478
Net Assets 110,456,096 46,378,603
Class I (unlimited shares authorized):    
Net Assets $ 110,456,096 $ 46,378,603
Shares Outstanding (in Shares) [2] 3,940,000 3,170,000
Net Asset Value, Offering and Redemption Price per Share (in Dollars per share) $ 28.03 $ 14.63
Market Value per Share (Note 2) (in Dollars per share) $ 27.88 $ 14.66
Investments in securities, at cost $ 7,673,680
2x Long VIX Futures ETF    
ASSETS    
Cash
Investments in securities, at value [1] 24,356,501 8,250,285
Interest receivable 112,405 50,483
Prepaid expenses and other assets 42,198 15,666
Receivable for shares sold 6,935,800 1,931,028
Deposit at Broker for Futures 55,293,437 114,821,272
Variation margin receivable 1,945,302 830,840
Other receivable 2,081 579
Total Assets 88,687,724 125,900,153
Payables    
Variation margin payable  
Due to Other 6
Payable to Broker
Payable to Sponsor 125,640 176,838
Administrative, accounting and custodian fees payable 25,664 19,957
Professional fees payable 279,945 203,411
Licensing and registration fees payable 53,324 11,181
Total Liabilities 484,579 411,387
NET ASSETS 88,203,145 125,488,766
NET ASSETS CONSIST OF:    
Paid-in capital 374,688,877 203,182,472
Total distributable earnings (accumulated deficit) (286,485,732) (77,693,706)
Net Assets 88,203,145 125,488,766
Class I (unlimited shares authorized):    
Net Assets $ 88,203,145 $ 125,488,766
Shares Outstanding (in Shares) [2] 25,420,000 21,450,000
Net Asset Value, Offering and Redemption Price per Share (in Dollars per share) $ 3.47 $ 5.85
Market Value per Share (Note 2) (in Dollars per share) $ 3.49 $ 5.82
Investments in securities, at cost $ 24,356,501 $ 8,250,285
[1] Investments in securities, at cost
[2] No Par Value
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
1x Short VIX Futures ETF        
Income:        
Interest income $ 86,183 $ 43,411 $ 207,714 $ 62,395
Other Income   61
Total Income 86,183 43,411 207,714 62,455
Expenses:        
Management fees 293,542 146,457 688,455 310,019
Administrative, accounting and custodian fees 27,917 15,332 74,725 39,233
Professional fees 81,552 80,462 240,644 96,221
Licensing and registration fees 7,688 27,963 57,822 68,358
Broker interest expense 4,038 8,613 24,038
Total Expenses 410,699 274,252 1,070,259 537,868
Net Investment loss (324,516) (230,841) (862,545) (475,413)
Net realized gain (loss) on:        
Futures 15,738,591 8,077,788 58,190,096 3,500,659
Net change in unrealized appreciation (depreciation) of:        
Futures (12,928,171) (6,278,300) (7,565,698) (5,577,769)
Net realized and unrealized gain (loss) on investments and futures contracts 2,810,420 1,799,488 50,624,398 (2,077,111)
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS 2,485,904 1,568,647 49,761,853 (2,552,524)
2x Long VIX Futures ETF        
Income:        
Interest income 257,541 126,917 691,812 143,699
Other Income 7   160
Total Income 257,541 126,924 691,812 143,859
Expenses:        
Management fees 365,111 464,768 1,284,769 575,991
Administrative, accounting and custodian fees 28,148 25,723 90,847 49,590
Professional fees 81,188 81,792 242,137 97,514
Licensing and registration fees 13,740 34,070 58,561 74,437
Broker interest expense 16,295 320 24,438
Total Expenses 488,187 622,648 1,676,634 821,971
Net Investment loss (230,646) (495,724) (984,822) (678,112)
Net realized gain (loss) on:        
Futures (42,049,000) (22,686,413) (228,151,397) (15,158,418)
Net change in unrealized appreciation (depreciation) of:        
Futures 30,931,703 20,574,735 20,344,189 20,593,993
Net realized and unrealized gain (loss) on investments and futures contracts (11,117,297) (2,111,678) (207,807,208) 5,435,575
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS $ (11,347,943) $ (2,607,402) $ (208,792,030) $ 4,757,463
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Statement of Changes in Net Assets (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
-1x Short VIX Futures ETF        
OPERATIONS        
Net investment loss $ (324,516) $ (230,841) $ (862,545) $ (475,413)
Net realized gain (loss) on investments and futures contracts 15,738,591 8,077,788 58,190,096 3,500,659
Net change in unrealized appreciation (depreciation) of investments and futures contracts (12,928,171) (6,278,300) (7,565,698) (5,577,769)
Net increase (decrease) in net assets resulting from operations 2,485,904 1,568,647 49,761,853 (2,552,524)
CAPITAL SHARE TRANSACTIONS        
Shares sold 68,508,308 37,128,501 187,008,767 169,115,707
Shares redeemed (32,840,529) (29,971,993) (172,693,127) (110,948,657)
Net increase (decrease) in net assets from capital share transactions 35,667,779 7,156,508 14,315,640 58,167,050
Total increase (decrease) in net assets 38,153,683 8,725,155 64,077,493 55,614,526
NET ASSETS        
Beginning of Period 72,302,413 46,889,371 46,378,603  
End of Period 110,456,096 55,614,526 110,456,096 55,614,526
2x Long VIX Futures ETF        
OPERATIONS        
Net investment loss (230,646) (495,724) (984,822) (678,112)
Net realized gain (loss) on investments and futures contracts (42,049,000) (22,686,413) (228,151,397) (15,158,418)
Net change in unrealized appreciation (depreciation) of investments and futures contracts 30,931,703 20,574,735 20,344,189 20,593,993
Net increase (decrease) in net assets resulting from operations (11,347,943) (2,607,402) (208,792,030) 4,757,463
CAPITAL SHARE TRANSACTIONS        
Shares sold 91,271,140 148,158,278 369,331,697 252,892,858
Shares redeemed (77,058,854) (112,204,673) (197,825,288) (163,867,663)
Net increase (decrease) in net assets from capital share transactions 14,212,286 35,953,605 171,506,409 89,025,195
Total increase (decrease) in net assets 2,864,343 33,346,203 (37,285,621) 93,782,658
NET ASSETS        
Beginning of Period 85,338,802 60,436,455 125,488,766  
End of Period $ 88,203,145 $ 93,782,658 $ 88,203,145 $ 93,782,658
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
-1x Short VIX Futures ETF        
CASH FLOW FROM OPERATING ACTIVITIES        
Net increase (decrease) in net assets resulting from operations $ 2,485,904 $ 1,568,647 $ 49,761,853 $ (2,552,524)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities        
Purchase of investments (113,633,779) (73,580,457) (340,725,312) (160,823,700)
Proceeds from sales or maturities of investments held 105,960,099 65,379,064 333,051,632 144,330,975
Decrease (Increase) in Deposits at broker for futures contracts (35,708,583) 3,665,556 (56,267,842) (36,207,427)
Decrease (Increase) in Variation margin receivable 1,242,108    
Decrease (Increase) in interest receivable (26,812) (13,363) (27,106) (22,965)
Decrease (Increase) in other receivables 253 (1,333) 571  
Decrease (Increase) in Prepaid expenses and other assets 9,391   (14,694)
Decrease (Increase) in Due from Other    
Increase (Decrease) in Due to Custodian (1,023,713) 575,655   575,655
Increase (Decrease) in Due to Other    
Increase (Decrease) in Variation margin payable 1,327,607 191,690 1,140,577 774,721
Increase (Decrease) in Payable to Sponsor 41,257 (17,753) 57,503 44,372
Increase (Decrease) in Administrative, accounting and custodian fees payable 3,262 16,555 2,099 38,976
Increase (Decrease) in Professional fees payable 34,701 55,336 78,459 70,547
Increase (Decrease) in Licensing and registration fees payable 10,872 14,922 25,038 50,564
Net cash provided by (used in) operating activities (39,277,433) (2,145,481) (12,917,222) (53,722,139)
CASH FLOW FROM FINANCING ACTIVITIES        
Proceeds from shares sold, net of cost from shares purchased 72,117,962 32,683,591 187,008,767 164,670,796
Cost of shares redeemed (32,840,529) (34,077,640) (174,596,145) (110,948,657)
Net cash provided by (used in) financing activities 39,277,433 (1,394,049) 12,412,622 53,722,139
NET INCREASE (DECREASE) IN CASH   (3,539,530) (504,600)  
Beginning of Period 3,539,530 504,600
End of Period
2x Long VIX Futures ETF        
CASH FLOW FROM OPERATING ACTIVITIES        
Net increase (decrease) in net assets resulting from operations (11,347,943) (2,607,402) (208,792,030) 4,757,463
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities        
Purchase of investments (133,007,714) (189,402,007) (442,361,238) (250,370,760)
Proceeds from sales or maturities of investments held 118,168,760 175,315,240 426,255,022 219,134,233
Decrease (Increase) in Deposits at broker for futures contracts 28,009,343 (16,108,875) 59,527,835 (56,663,638)
Decrease (Increase) in Variation margin receivable (1,945,302) (1,274,983) (1,114,462) (2,708,079)
Decrease (Increase) in interest receivable (47,053) (57,469) (61,922) (69,844)
Decrease (Increase) in other receivables (1,521)   (1,502)
Decrease (Increase) in Prepaid expenses and other assets (16,431)   (26,532)
Decrease (Increase) in Due from Other (4,743,330)   (3,727,069)
Increase (Decrease) in Due to Custodian (2,874,781) 264,682 6 264,682
Increase (Decrease) in Due to Other 6      
Increase (Decrease) in Variation margin payable (3,406,049)  
Increase (Decrease) in Payable to Sponsor (13,210) 107,134 (51,198) 177,469
Increase (Decrease) in Administrative, accounting and custodian fees payable 7,567 27,319 5,707 49,916
Increase (Decrease) in Professional fees payable 33,913 56,798 76,534 71,973
Increase (Decrease) in Licensing and registration fees payable 14,275 21,029 42,143 58,460
Net cash provided by (used in) operating activities (6,426,140) (38,401,864) (166,501,637) (89,025,193)
CASH FLOW FROM FINANCING ACTIVITIES        
Proceeds from shares sold, net of cost from shares purchased 85,350,046 150,498,756 364,326,925 252,892,856
Cost of shares redeemed (78,923,906) (112,204,673) (197,825,288) (163,867,663)
Net cash provided by (used in) financing activities 6,426,140 38,294,083 166,501,637 89,025,193
NET INCREASE (DECREASE) IN CASH   (107,781)    
Beginning of Period 107,781
End of Period
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Investments (Unaudited) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
TOTAL SHORT TERM INVESTMENT $ 24,356,501  
Unrealized Appreciation/ (Depreciation)   $ 1,156,106
-1 x Short VIX Futures ETF [Member]    
TOTAL SHORT TERM INVESTMENT 7,673,680  
TOTAL INVESTMENTS 7,673,680  
Cost 102,782,416 45,874,003 [1]
TOTAL NET ASSETS - 100% 110,456,096 46,378,603
Unrealized Appreciation/ (Depreciation) (6,409,592)  
Cash - 1.1% (a) [1]   504,600
-1 x Short VIX Futures ETF [Member] | CBOE VIX Futures [Member]    
Fair Value (2,472) (1,150)
Unrealized Appreciation/ (Depreciation) (460,721) 1,058,570
-1 x Short VIX Futures ETF [Member] | CBOE VIX Futures [Member]    
Fair Value (3,709) (804)
Unrealized Appreciation/ (Depreciation) (5,948,871) 97,536
2x Long VIX Futures ETF [Member]    
TOTAL SHORT TERM INVESTMENT   8,250,285
TOTAL INVESTMENTS 24,356,501 8,250,285
Cost 63,846,644 [2] 117,238,481 [3]
TOTAL NET ASSETS - 100% 88,203,145 125,488,766
2x Long VIX Futures ETF [Member] | CBOE VIX Futures [Member]    
Fair Value 3,945 6,221
Unrealized Appreciation/ (Depreciation) 674,595 (8,416,975)
Unrealized Appreciation/ (Depreciation)   (9,203,522)
2x Long VIX Futures ETF [Member] | CBOE VIX Futures [Member]    
Fair Value 5,918 4,355
Unrealized Appreciation/ (Depreciation) 10,466,072 (786,547)
Unrealized Appreciation/ (Depreciation) 11,140,667  
First American Government Obligations Fund [Member] | -1 x Short VIX Futures ETF [Member]    
First American Government Obligations Fund [4] 7,673,680  
First American Government Obligations Fund [Member] | 2x Long VIX Futures ETF [Member]    
First American Government Obligations Fund $ 24,356,501 [2] $ 8,250,285
[1] $48,144,554 of cash os pledged as collateral for futures contracts
[2] $55,293,437 of cash is pledged as collateral for futures contracts.
[3] $114,821,272 of cash is pledged as collateral for futures contracts.
[4] Represents annualized seven-day yield at September 30, 2023.
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Investments (Unaudited) (Parentheticals) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Other assets in excess of liabilities   98.90%
Total net assets, percentage 100.00% 100.00%
-1 x Short VIX Futures ETF [Member]    
Money market fund, percentage 6.95%  
Cost (in Dollars) $ 7,673,680  
Other assets in excess of liabilities 93.05%  
Cash (in Dollars)   $ 1.1
2x Long VIX Futures ETF [Member]    
Money market fund, percentage 27.61% 6.57%
Cost (in Dollars) $ 24,356,501  
Other assets in excess of liabilities [1] 72.39% 6.57%
Total net assets, percentage 100.00% 100.00%
First American Government Obligations Fund [Member] | -1 x Short VIX Futures ETF [Member]    
Money market fund, percentage 5.01%  
First American Government Obligations Fund [Member] | 2x Long VIX Futures ETF [Member]    
Money market fund, percentage 5.00%  
[1] $104,412,396 of cash is pledged as collateral for futures contracts.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Organization
9 Months Ended
Sep. 30, 2023
Organization [Abstract]  
ORGANIZATION

NOTE 1 – ORGANIZATION

 

VS Trust (the “Trust”) is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series (each, a “Fund” and collectively, the “Funds”). As of September 30, 2023, the following two series of the Trust have commenced investment operations: -1x Short VIX Futures ETF (“SVIX”) and 2x Long VIX Futures ETF (“UVIX”). Each of the Funds listed above issues common units of beneficial interest (“Shares”), which represent units of fractional undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (“Cboe BZX”).

 

The Funds’ inception of operation was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other than matters relating to its organization and the registration of each series under the Securities Act of 1933.

 

Each Fund’s investment exposure to VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each Fund to regulation under the Commodity Exchange Act of 1934 (“CEA”) and Commodity Futures Trading Commission (“CFTC”) rules. The Sponsor is registered as a Commodity Pool Operator (“CPO”) and the Fund will be operated in accordance with applicable CFTC rules. Registration as a CPO imposes additional compliance obligations on the Sponsor and the Funds related to additional laws, regulations and enforcement policies, which could increase compliance costs and may affect the operations and financial performance of the Funds.

 

Volatility Shares LLC (the “Sponsor”) is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust’s commodity pool operator. The Funds are commodity pools, as defined under the Commodity Exchange Act (the “CEA”), and the applicable regulations of the CFTC and are operated by the Sponsor, which is registered as a commodity pool operator with the CFTC. The Trust is not an investment company registered under the Investment Company Act of 1940.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Significant Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

 

Each Fund is an investment company, as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946 “Financial Services — Investment Companies.” As such, the Funds follow the investment company accounting and reporting guidance. The following is a summary of significant accounting policies followed by each Fund, as applicable, in preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

The accompanying unaudited financial statements were prepared in accordance with GAAP for interim financial information and with the instructions for Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). In the opinion of management, all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period.

 

Emerging growth company

 

The Trust is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year.

 

For as long as the Trust remains an “emerging growth company,” it may take advantage of certain exemptions from the various reporting requirements that are applicable to public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an “emerging growth company.”

 

Use of Estimates & Indemnifications

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

In the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications. The Trust’s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.

 

Basis of Presentation

 

Pursuant to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for the purchase of Shares in that Fund.

 

The cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated September 30, 2023 and December 31, 2022 and represents cash, but does not include short-term investments.

 

Final Net Asset Value for Fiscal Period

 

The cut-off times and the times of the calculation of the Funds’ final net asset value for creation and redemption of fund Shares for the three months ended September 30, 2023 were typically as follows. All times are Eastern Standard Time:

 

     Create/Redeem    NAV
Calculation
   NAV
Fund    Cut-off*(EST)    Time (EST)    Calculation Date
-1x Short VIX Futures ETF and    2:00 p.m.   4:00 p.m.    September 30, 2023
2x Long VIX Futures ETF    2:00 p.m.    4:00 p.m.    September 30, 2023

 

*Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended September 30, 2023.

 

Market value per Share is determined at the close of Cboe BZX and may be later than when the Funds’ NAV per Share is calculated.

 

For financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds’ final creation/redemption NAV for the three months ended September 30, 2023.

 

Investment Valuation

 

Short-term investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations are typically categorized as Level I in the fair value hierarchy.

 

Derivatives (e.g., futures contracts, options, swap agreements) are generally valued using independent sources and/or agreements with counterparties or other procedures as determined by the Sponsor. Futures contracts are generally valued at the last settled price on the applicable exchange on which that future trades. For financial reporting purposes, all futures contracts are generally valued at the last settled price. Futures contracts valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically categorized as Level II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as the basis for determining the market value of such position. Such fair value prices would generally be determined based on available inputs about the current value of the underlying financial instrument or commodity and would be based on principles that the Sponsor deems fair and equitable so long as such principles are consistent with industry standards. The Sponsor may fair value an asset of a Fund pursuant to the policies the Sponsor has adopted. Depending on the source and relevant significance of valuation inputs, these instruments may be classified as Level II or Level III in the fair value hierarchy.

 

Fair value pricing may require subjective determinations about the value of an investment. While the Funds’ policies are intended to result in a calculation of its respective Fund’s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial statements.

 

Fair Value of Financial Instruments

 

The Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds’ own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:

 

Level I – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

 

Level II – Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated inputs).

 

Level III – Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.

 

In some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement in its entirety.

 

Fair value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances indicate that a transaction is not orderly.

 

The following table summarizes the valuation of investments at September 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:

 

   September 30, 2023 (Unaudited)   December 31, 2022 
Fund  Level 1 -
Money
Market
Fund
   Level 2 -
Futures
Contracts*
   Total
September 30,
2023
   Level 1 -
Money
Market
Fund
   Level 2 -
Futures
Contracts*
   Total
December 31,
2022
 
-1x Short VIX Futures ETF  $7,673,680   $(6,409,592)  $1,264,088   $-   $1,156,106   $1,156,106 
2x Long VIX Futures ETF  $24,356,501    11,140,667    35,497,168    8,250,285    (9,203,522)   (953,237)
Total Trust  $32,030,181   $4,731,075   $36,761,256   $8,250,285   $(8,047,416)  $202,869 

 

*Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

 

The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.

 

Investment Transactions and Related Income

 

Investment transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between periods are reflected in the Statements of Operations.

 

Interest income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.

 

Brokerage Commissions and Futures Account Fees

 

Each Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (“NFA”) fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities for each Fund’s investment in U.S. Commodity Futures Trading Commission (“CFTC”) regulated investments. The effects of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). ). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more than 0.29% and 0.19%, for SVIX and UVIX, respectively, of each Fund’s average net assets annually.

 

Federal Income Tax

 

Each Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund’s Shares is required to take into account its allocable share of its Fund’s income, gain, loss, deductions and other items for its Fund’s taxable year ending with or within the beneficial owner’s taxable year.

 

Management of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Investments
9 Months Ended
Sep. 30, 2023
Investments [Abstract]  
INVESTMENTS

NOTE 3 – INVESTMENTS

 

Short-Term Investments

 

The Funds may purchase U.S. Treasury Bills, agency securities, and other high-credit quality short-term fixed income or similar securities with original maturities of one year or less. A portion of these investments may be posted as collateral in connection with swap agreements, futures, and/or forward contracts.

 

Accounting for Derivative Instruments

 

In seeking to achieve each Fund’s investment objective, the Sponsor uses a mathematical approach to investing. Using this approach, the Sponsor determines the type, quantity and mix of investment positions, including derivative positions, which the Sponsor believes in combination, should produce returns consistent with a Fund’s objective.

 

All open derivative positions at period end are reflected on each respective Fund’s Schedule of Investments. Certain Funds utilized a varying level of derivative instruments in conjunction with investment securities in seeking to meet their investment objectives during the period. While the volume of open positions may vary on a daily basis as each Fund transacts derivatives contracts in order to achieve the appropriate exposure to meet its investment objective, the volume of these open positions relative to the net assets of each respective Fund at the date of this report is generally representative of open positions throughout the reporting period.

 

Following is a description of the derivative instruments used by the Funds during the reporting period, including the primary underlying risk exposures related to each instrument type.

 

Futures Contracts

 

The Funds may enter into futures contracts to gain exposure to changes in the value of, or as a substitute for investing directly in (or shorting), an underlying benchmark. A futures contract obligates the seller to deliver (and the purchaser to accept) the future delivery of a specified quantity and type of asset at a specified time and place. The contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the underlying commodity, if applicable, or by making an offsetting sale or purchase of an identical futures contract on the same or linked exchange before the designated date of delivery, or by cash settlement at expiration of contract.

 

Upon entering into a futures contract, each Fund is required to deposit and maintain as collateral at least such initial margin as required by the exchange on which the transaction is affected. The initial margin is segregated as cash and/or securities balances with brokers for futures contracts, as disclosed in the Statements of Financial Condition, and is restricted as to its use. The Funds that enter into futures contracts maintain collateral at the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund generally agrees to receive from or pay to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract. Such receipts or payments are known as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize a gain or loss upon closing of a futures transaction.

 

Futures contracts involve, to varying degrees, elements of market risk (specifically exchange rate sensitivity, commodity price risk or equity market volatility risk) and exposure to loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure each Fund has in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation between movements in the price of the futures contracts and the market value of the underlying Index or commodity and the possibility of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the Funds since futures contracts are exchange-traded and the credit risk resides with the Funds’ clearing broker or clearinghouse itself. Many futures exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund will be required to make daily cash payments of variation margin. The risk the Fund will be unable to close out a futures position will be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.

 

Option Contracts

 

An option is a contract that gives the buyer the right, but not the obligation, to buy or sell a specified quantity of a commodity or other instrument at a specific (or strike) price within a specified period of time, regardless of the market price of that instrument. There are two types of options: calls and puts. A call option conveys to the option buyer the right to purchase a particular futures contract at a stated price at any time during the life of the option. A put option conveys to the option buyer the right to sell a particular futures contract at a stated price at any time during the life of the option. Options written by a Fund may be wholly or partially covered (meaning that the Fund holds an offsetting position) or uncovered. In the case of the purchase of an option, the risk of loss of an investor’s entire investment (i.e., the premium paid plus transaction charges) reflects the nature of an option as a wasting asset that may become worthless when the option expires. Where an option is written or granted (i.e., sold) uncovered, the seller may be liable to pay substantial additional margin, and the risk of loss is unlimited, as the seller will be obligated to deliver, or take delivery of, an asset at a predetermined price which may, upon exercise of the option, be significantly different from the market value.

 

When a Fund writes a call or put, an amount equal to the premium received is recorded and subsequently marked to market to reflect the current value of the option written. Premiums received from writing options which expire are treated as realized gains. Premiums received from writing options which are exercised or closed are added to the proceeds or offset against amounts paid on the underlying futures, swap or security transaction to determine the realized gain (loss).

 

When a Fund purchases an option, the Fund pays a premium which is included as an asset on the Statement of Financial Condition and subsequently marked to market to reflect the current value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk associated with purchasing put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised or closed are added to the amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized gain (loss) when the underlying transaction is executed.

 

Certain options transactions may subject the writer (seller) to unlimited risk of loss in the event of an increase in the price of the contract to be purchased or delivered. The value of a Fund’s options transactions, if any, will be affected by, among other things, changes in the value of a Fund’s underlying benchmark relative to the strike price, changes in interest rates, changes in the actual and implied volatility of the Fund’s underlying benchmark, and the remaining time until the options expire, or any combination thereof. The value of the options should not be expected to increase or decrease at the same rate as the level of the Fund’s underlying benchmark, which may contribute to tracking error. Options may be less liquid than certain other securities. A Fund’s ability to trade options will be dependent on the willingness of counterparties to trade such options with the Fund. In a less liquid market for options, a Fund may have difficulty closing out certain option positions at desired times and prices. A Fund may experience substantial downside from specific option positions and certain option positions may expire worthless. Over-the-counter options generally are not assignable except by agreement between the parties concerned, and no party or purchaser has any obligation to permit such assignments. The over-the-counter market for options is relatively illiquid, particularly for relatively small transactions. The use of options transactions exposes a Fund to liquidity risk and counterparty credit risk, and in certain circumstances may expose the Fund to unlimited risk of loss. The Funds may buy and sell options on futures contracts, which may present even greater volatility and risk of loss.

 

Swap Agreements

 

The Funds may enter into swap agreements for purposes of pursuing their investment objectives or as a substitute for investing directly in (or shorting) an underlying Index or to create an economic hedge against a position. Swap agreements are two-party contracts that have traditionally been entered into primarily with institutional investors in over-the-counter (“OTC”) markets for a specified period, ranging from a day to more than one year. However, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) provides for significant reforms of the OTC derivative markets, including a requirement to execute certain swap transactions on a CFTC-regulated market and/or to clear such transactions through a CFTC-regulated central clearing organization. In a standard swap transaction, two parties agree to exchange the returns earned or realized on a particular predetermined investment, instrument or Index in exchange for a fixed or floating rate of return in respect of a predetermined notional amount. Transaction or commission costs are reflected in the benchmark level at which the transaction is entered into. The gross returns to be exchanged are calculated with respect to a notional amount and the benchmark returns to which the swap is linked. Swap agreements do not involve the delivery of underlying instruments.

 

Generally, swap agreements entered into by the Funds calculate and settle the obligations of the parties to the agreement on a “net basis” with a single payment. Consequently, each Fund’s current obligations (or rights) under a swap agreement will generally be equal only to the net amount to be paid or received under the agreement based on the relative values of such obligations (or rights) (the “net amount”). In a typical swap agreement entered into by UVIX, the would be entitled to settlement payments in the event the level of the benchmark increases and would be required to make payments to the swap counterparties in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount the Funds may pay. In a typical swap agreement entered into by SVIX, the Fund would be required to make payments to the swap counterparties in the event the level of the benchmark increases and would be entitled to settlement payments in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount the Funds may pay.

 

The net amount of the excess, if any, of each Fund’s obligations over its entitlements with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the counterparty in a segregated account by the Funds’ Custodian. The net amount of the excess, if any, of each Fund’s entitlements over its obligations with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the Fund in a segregated account by a third party custodian. Until a swap agreement is settled in cash, the gain or loss on the notional amount less any transaction costs or trading spreads payable by each Fund on the notional amount are recorded as “unrealized appreciation or depreciation on swap agreements” and, when cash is exchanged, the gain or loss realized is recorded as “realized gains or losses on swap agreements.” Swap agreements are generally valued at the last settled price of the benchmark referenced asset.

 

Swap agreements contain various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net positions owed to the party under the agreement. This could cause a Fund to have to enter into a new transaction with the same counterparty, enter into a transaction with a different counterparty or seek to achieve its investment objective through any number of different investments or investment techniques.

 

Swap agreements involve, to varying degrees, elements of market risk and exposure to loss in excess of the unrealized gain/loss reflected. The notional amounts reflect the extent of the total investment exposure each Fund has under the swap agreement, which may exceed the NAV of each Fund. Additional risks associated with the use of swap agreements are imperfect correlations between movements in the notional amount and the price of the underlying reference Index and the inability of counterparties to perform. Each Fund bears the risk of loss of the amount expected to be received under a swap agreement in the event of the default or bankruptcy of a swap agreement counterparty. A Fund will typically enter into swap agreements only with major global financial institutions. The creditworthiness of each of the firms that is a party to a swap agreement is monitored by the Sponsor. The Sponsor may use various techniques to minimize credit risk including early termination and payment, using different counterparties, limiting the net amount due from any individual counterparty and generally requiring collateral to be posted by the counterparty in an amount approximately equal to that owed to the Funds. Outstanding swap agreements contractually terminate within one month but may be terminated without penalty by either party at any time. Upon termination, the Fund is obligated to pay or receive the “unrealized appreciation or depreciation” amount.

 

The Funds, as applicable, collateralize swap agreements by segregating or designating cash and/or certain securities as indicated on the Statements of Financial Condition or Schedules of Investments. As noted above, collateral posted in connection with OTC derivative transactions is held for the benefit of the counterparty in a segregated tri-party account at the Custodian to protect the counterparty against non-payment by the Funds. The collateral held in this account is restricted as to its use. In the event of a default by the counterparty, the Funds will seek withdrawal of this collateral from the segregated account and may incur certain costs in exercising its right with respect to the collateral. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, the Funds may experience significant delays in obtaining any recovery in a bankruptcy or other reorganizational proceeding. The Funds may obtain only limited recovery or may obtain no recovery in such circumstances.

 

The Funds remain subject to credit risk with respect to the amount they expect to receive from counterparties. However, the Funds have sought to mitigate these risks in connection with OTC swaps by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily, in an amount approximately equal to what the counterparty owes the Fund, subject to certain minimum thresholds. In the event of a bankruptcy of a counterparty, such Fund will have direct access to the collateral received from the counterparty, generally as of the day prior to the bankruptcy, because there is a one day time lag between the Fund’s request for collateral and the delivery of such collateral. To the extent any such collateral is insufficient, the Funds will be exposed to counterparty risk as described above, including the possible delays in recovering amounts as a result of bankruptcy proceedings.

 

The counterparty/credit risk for cleared derivative transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted for each counterparty to a cleared derivative contract and, in effect, guarantees the parties’ performance under the contract as each party to a trade looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.

 

Fair Values of Derivative Instruments as of September 30, 2023 (Unaudited)  
        Asset Derivatives     Liability Derivatives  
Derivatives Not
Accounted for as
Hedging Instruments
  Fund   Statements of
Financial
Condition Location
  Unrealized
Appreciation*
    Statements of
Financial
Condition Location
  Unrealized
Depreciation*
 
VIX Futures Contracts                            
    -1x Short VIX Futures ETF       $ -         $ (6,409,592)  
    2x Long VIX Futures ETF         11,140,667           -  
    Total Trust       $ 11,140,667         $ (6,409,592  

 

  * Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

 

Fair Values of Derivative Instruments as of December 31, 2022  
        Asset Derivatives     Liability Derivatives  
Derivatives Not
Accounted for as
Hedging Instruments
  Fund   Statements of
Financial
Condition Location
  Unrealized
Appreciation*
    Statements of
Financial
Condition Location
  Unrealized
Depreciation*
 
VIX Futures Contracts                            
    -1x Short VIX Futures ETF       $ 1,156,106         $ -  
    2x Long VIX Futures ETF         -           (9,203,522 )
    Total Trust       $ 1,156,106         $   (9,203,522 )

 

* Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

 

The Effect of Derivative Instruments on the Statement of Operations  
For the Three Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited)  
                                 
Derivatives Not
Accounted for as Hedging Instruments
  Location of Gain (Loss) on Derivatives Recognized in Income   Fund   Realized Gain
(Loss) on
Derivatives Recognized
in Income
September 30,
2023
    Change in
Unrealized
Appreciation
(Depreciation)
on Derivatives
Recognized
in Income
September 30,
2023*
    Realized Gain
(Loss) on
Derivatives
Recognized
in Income
September 30,
2022
    Change in
Unrealized
Appreciation
(Depreciation)
on Derivatives
Recognized
in Income
Sepetember 30,
2022*
 
VIX Futures Contracts   Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts                                    
        -1x Short VIX Futures ETF   $ 15,738,591     $ (12,928,171 )   $ 8,077,788   $ (6,278,300 )
        2x Long VIX Futures ETF     (42,049,000 )     30,931,703       (22,686,413 )     20,574,735
        Total Trust   $ (26,310,409 )   $ 18,003,532     $ (14,608,625 )   $ 14,296,435  

 

* Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

 

The Effect of Derivative Instruments on the Statement of Operations  
For the Nine Months Ended September 30, 2023 (Unaudited) and September 30, 2022^ (Unaudited)  
                                 
Derivatives Not
Accounted for as Hedging Instruments
  Location of Gain (Loss) on Derivatives Recognized in Income   Fund   Realized Gain
(Loss) on
Derivatives
Recognized
in Income
September 30,
2023
    Change in
Unrealized
Appreciation
(Depreciation)
on Derivatives
Recognized in
Income
September 30,
2023*
    Realized Gain
(Loss) on
Derivatives
Recognized
in Income
September 30,
2022
    Change in
Unrealized
Appreciation
(Depreciation)
on Derivatives
Recognized
in Income
September 30,
2022*
 
VIX Futures Contracts   Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts                                    
        -1x Short VIX Futures ETF   $ 58,190,096      $ (7,565,698 )   $ 3,500,659     $ (5,577,769 )
        2x Long VIX Futures ETF     (228,151,397 )     20,344,189       (15,158,418 )     20,593,993  
        Total Trust   $ (169,961,301 )   $ 12,778,491     $ (11,657,759 )   $ 15,016,224  

 

* Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

Offsetting Assets and Liabilities

 

Each Fund is subject to master netting agreements or similar arrangements that allow for amounts owed between each Fund and the counterparty to be netted upon an early termination. The party that has the larger payable pays the excess of the larger amount over the smaller amount to the other party. The master netting agreements or similar arrangements do not apply to amounts owed to/from different counterparties. As described above, the Funds utilize derivative instruments to achieve their investment objective during the year. The amounts shown in the Statements of Financial Condition do not take into consideration the effects of legally enforceable master netting agreements or similar arrangements.

 

For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund’s derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related collateral received or pledged by the Funds as of September 30, 2023 and December 31, 2022.

 

Fair Values of Derivative Instruments as of September 30, 2023 (Unaudited) 
         
   Assets   Liabilities 
Fund  Gross
Amounts of
Recognized
Assets
presented
in the
Statements
of Financial
Condition
   Gross
Amounts
Offset
in the
Statements
of Financial
Condition
   Net Amounts
of Assets
presented
in the
Statements
of Financial
Condition
   Gross
Amounts of
Recognized
Liabilities
presented
in the
Statements
of Financial
Condition
   Gross
Amounts
Offset
in the
Statements
of Financial
Condition
   Net Amounts
of Liabilities
presented
in the
Statements
of Financial
Condition
 
-1x Short VIX Futures ETF  $-   $          -   $-   $1,327,607   $          -   $1,327,607 
2x Long VIX Futures ETF   1,945,302    -    1,945,302    -    -    - 

 

Fair Values of Derivative Instruments as of December 31, 2022 
         
   Assets   Liabilities 
Fund  Gross
Amounts of
Recognized
Assets
presented
in the
Statements
of Financial
Condition
   Gross
Amounts
Offset
in the
Statements
of Financial
Condition
   Net Amounts
of Assets
presented
in the
Statements
of Financial
Condition
   Gross
Amounts of
Recognized
Liabilities
presented
in the
Statements
of Financial
Condition
   Gross
Amounts
Offset
in the
Statements
of Financial
Condition
   Net Amounts
of Liabilities
presented
in the
Statements
of Financial
Condition
 
-1x Short VIX Futures ETF  $-   $          -   $-   $187,030   $             -   $187,030 
2x Long VIX Futures ETF   830,840    -    830,840    -    -    - 

 

Asset (Liability) amounts shown in the table below represent amounts owed to (by) the Funds for the derivative-related investments at September 30, 2023 and December 31, 2022. These amounts may be collateralized by cash or financial instruments, segregated for the benefit of the Funds or the counterparties, depending on whether the related contracts are in an appreciated or depreciated position at period end. Amounts shown in the column labeled “Net Amount” represent the uncollateralized portions of these amounts at period end. These amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement, as further described above under the caption “Accounting for Derivative Instruments”.

 

Gross Amounts Not Offset in the Statements of Financial Condition as of September 30, 2023 (Unaudited) 
                 
Fund  Amounts of
Recognized
Assets /
(Liabilities)
presented
in the
Statements
of Financial
Condition
   Financial
Instruments
for the Benefit
of (the Funds) / the
Counterparties
   Cash
Collateral for
the Benefit of
(the Funds) / the
Counterparties
   Net Amount 
-1x Short VIX Futures ETF  $(1,327,607)  $          -   $         -   $(1,327,607)
2x Long VIX Futures ETF   1,945,302    -    -    1,945,302 

 

Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022 
                 
Fund  Amounts of
Recognized
Assets /
(Liabilities)
presented
in the
Statements
of Financial
Condition
   Financial
Instruments
for the Benefit
of (the Funds) / the
Counterparties
   Cash
Collateral for
the Benefit of
(the Funds) / the
Counterparties
   Net Amount 
-1x Short VIX Futures ETF  $(187,030)  $          -   $         -   $(187,030)
2x Long VIX Futures ETF   830,840    -    -    830,840 
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Agreements
9 Months Ended
Sep. 30, 2023
CollateralizedAgreementsAbstract  
AGREEMENTS

NOTE 4 – AGREEMENTS

 

SVIX pays the Sponsor a management fee (the “Management Fee”), monthly in arrears, in an amount equal to 1.35% per annum of its average daily net assets. UVIX pays the Sponsor a Management Fee, monthly in arrears, in an amount equal to 1.65% per annum of its average daily net assets. “Average daily net assets” is calculated by dividing the month-end net assets of each Fund by the number of calendar days in such month.

 

No other Management Fee is paid by the Funds. The Management Fee is paid in consideration of the Sponsor’s trading advisory services and the other services provided to the Fund that the Sponsor pays directly.

 

Pursuant to the Sponsor Agreement between Sponsor and the Trust, on behalf of the Funds, the Sponsor oversees and pays Penserra Capital Management, LLC. (“Commodity Sub-Adviser”) for its services as Commodity Sub-Adviser. The Commodity Sub-Adviser is paid by the Sponsor an annual sub-advisory fee of 0.20% based on each Fund’s average daily net assets (total assets of the Fund, minus the sum of its accrued liabilities). The Funds do not directly pay the Commodity Sub-Adviser.

 

Non-Recurring Fees and Expenses

 

Each Fund pays all its non-recurring and unusual fees and expenses, if any, as determined by the Sponsor. Non-recurring and unusual fees and expenses are fees and expenses that are unexpected or unusual in nature, such as legal claims and liabilities, litigation costs or indemnification or other material expenses which are not currently anticipated obligations of the Funds.

 

The Administrator, Transfer Agent and Custodian

 

U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services (“Fund Services”), an indirect subsidiary of U.S. Bancorp, serves as the Fund’s fund accountant, administrator and transfer agent pursuant to certain fund accounting servicing, fund administration servicing and transfer agent servicing agreements. U.S. Bank National Association, a subsidiary of U.S. Bancorp and parent company of Fund Services, intends to serve as the Fund’s custodian pursuant to a custody agreement.

 

The Marketing Agent

 

Foreside Fund Services, LLC (the “Marketing Agent”) serves as the Marketing Agent of the Funds. Its principal duties are: (i) to work with the Transfer Agent to review and approve orders placed by Authorized Participants and transmitted to the Transfer Agent; (ii) maintain copies of confirmations of Creation Unit creation and redemption order acceptances; (iii) maintain telephonic, facsimile and/or access to direct computer communications links with the Transfer Agent; and (iv) review and approve, prior to use, all Trust marketing materials for compliance with applicable SEC and FINRA advertising rules.

 

The Marketing Agent retains all marketing materials separately for the Funds, at their offices located at Three Canal Plaza, Suite 100 Portland, Maine 04101.

 

As compensation for the services it provides, the Marketing Agent receives a fee from the Funds.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Offering Costs
9 Months Ended
Sep. 30, 2023
Offering Costs [Abstract]  
OFFERING COSTS

NOTE 5 – OFFERING COSTS

 

Offering costs will be amortized by the Funds over a twelve month period on a straight-line basis beginning once the fund commences operations. The Sponsor will not charge its Management Fee in the first year of operations of a Fund in an amount equal to the offering costs. Normal and expected expenses incurred in connection with the continuous offering of Shares of a Fund after the commencement of its trading operations will be paid by the Sponsor.

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Creation and Redemption of Creation Units
9 Months Ended
Sep. 30, 2023
CreationAndRedemptionOfCreationUnits [Abstract]  
CREATION AND REDEMPTION OF CREATION UNITS

NOTE 6 – CREATION AND REDEMPTION OF CREATION UNITS

 

Each Fund issues and redeems shares from time to time, but only in one or more Creation Units. A Creation Unit is a block of at least 10,000 Shares of a Fund. Creation Units may be created or redeemed only by Authorized Participants.

 

Except when aggregated in Creation Units, the Shares are not redeemable securities. Retail investors, therefore, generally will not be able to purchase or redeem Shares directly from or with a Fund. Rather, most retail investors will purchase or sell Shares in the secondary market with the assistance of a broker. Thus, some of the information contained in these Notes to Financial Statements—such as references to the Transaction Fees imposed on purchases and redemptions is not relevant to retail investors.

 

Transaction Fees on Creation and Redemption Transactions

 

The manner by which Creation Units are purchased or redeemed is governed by the terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook. By placing a purchase order, an Authorized Participant agrees to: (1) deposit cash with the Custodian; and (2) if permitted by the Sponsor in its sole discretion, enter into or arrange for an exchange of futures contract for related position or block trade with the relevant fund whereby the Authorized Participant would also transfer to such Fund a number and type of exchange-traded futures contracts at or near the closing settlement price for such contracts on the purchase order date.

 

Authorized Participants may pay a fee up to 0.20% of the value of each order they place with each order to create or redeem a Creation Unit in order to compensate the Administrator, the Custodian and the Transfer Agent of each Fund and its Shares, for services in processing the creation and redemption of Creation Units and to offset the costs of increasing or decreasing derivative positions, unless the transaction fee is waived or otherwise adjusted by the Sponsor. The Sponsor provides such Authorized Participant with prompt notice in advance of any such waiver or adjustment of the transaction fee. Authorized Participants may sell the Shares included in the Creation Units they purchase from the Funds to other investors in the secondary market.

 

Transaction fees for the three months ended September 30, 2023 and September 30, 2022 were as follows:

 

Fund  Three
Months
Ended
September 30,
2023
(Unaudited)
   Three
Months
Ended
September 30,
2022
(Unaudited)
 
-1x Short VIX Futures ETF  $30,396   $20,124 
2x Long VIX Futures ETF   50,484    78,086 
Total Trust  $80,880   $98,210 

 

Transaction fees for the nine months ended September 30, 2023 and September 30, 2022 were as follows:

 

Fund  Nine Months
Ended
September 30,
2023
(Unaudited)
   Period
Ended
September 30,
2022^
(Unaudited)
 
-1x Short VIX Futures ETF  $107,878   $83,994 
2x Long VIX Futures ETF   170,097    124,991 
Total Trust  $277,975   $208,985 

 

^The Fund commenced operations on March 28, 2022.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Highlights
9 Months Ended
Sep. 30, 2023
Financial Highlights [Abstract]  
FINANCIAL HIGHLIGHTS

NOTE 7 – FINANCIAL HIGHLIGHTS

 

Selected data is for a Share outstanding throughout the Three Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited):

 

   -1x Short VIX Futures ETF   2x Long VIX Futures ETF   -1x Short VIX Futures ETF   2x Long VIX Futures ETF 
   Quarter Ended   Quarter Ended   Quarter Ended   Quarter Ended 
   September 30,
2023
   September 30,
2023
   September 30,
2022
   September 30,
2022
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Net Asset Value, Beginning of Period  $28.13   $4.44   $10.40   $85.60 
Net investment loss (1)   (0.11)   (0.01)   (0.06)   (2.38)
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts (2)   0.01    (0.96)   (0.00)   (13.87)
Net Increase (Decrease) in Net Asset Value Resulting from Operations   (0.10)   (0.97)   (0.06)   (16.25)
Net Asset Value, End of Period  $28.03   $3.47   $10.34   $69.35 
Market Value Per Share, at September 30, 2023 and September 30, 2022  $27.88   $3.49   $10.52   $67.00 
Total Return at Net Asset Value (4)   -0.36%   -21.85%   -0.58%   -18.97%
Total Return at Market Value (4)   -0.68%   -21.75%   -0.87%   -18.21%
                     
Ratios to Average Net Assets: (5)                    
Expense ratio (6)   1.89%   2.21%   2.34%   2.35%
Net Investment Loss   -1.49%   -1.04%   -2.06%   -1.93%

 

(1)Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.
(2)Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.
(3)Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.
(4)Percentages are not annualized for the period ended September 30, 2023 and September 30, 2022
(5)Percentages are annualized.
(6)The expense ratio would be 1.89% and 2.21% respectively, for the three months ended September 30, 2023, and 2.23% and 2.27% for the three months ended September 30, 2022 if brokerage commissions and futures and futures account fees were excluded.

 

Selected data is for a Share outstanding throughout the Nine Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited):

 

   -1x Short VIX Futures ETF   2x Long VIX Futures ETF   -1x Short VIX Futures ETF   2x Long VIX Futures ETF 
   Nine Months
Ended
   Nine Months
Ended
   For the
Period Ended
   For the
Period Ended
 
   September 30,
2023
   September 30,
2023
   September 30,
2022^
   September 30,
2022^
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Net Asset Value, Beginning of Period  $14.63   $29.25   $15.00   $75.00 
Net investment loss (1)   (0.27)   (0.07)   (0.12)   (0.60)
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts (2)   13.67    (25.71)   (4.54)   (5.05)
Net Increase (Decrease) in Net Asset Value Resulting from Operations   13.40    (25.78)   (4.66)   (5.65)
Net Asset Value, End of Period  $28.03   $3.47   $10.34   $69.35 
Market Value Per Share, at September 30, 2023 and September 30, 2022  $27.88   $3.49   $10.52   $67.00 
Total Return at Net Asset Value (4)   91.59%   -88.14%   -31.07%   -7.53%
Total Return at Market Value (4)   90.18%   -88.01%   -29.87%   -10.67%
                     
Ratios to Average Net Assets: (5)                    
Expense ratio (6)   2.10%   2.15%   2.33%   2.34%
Net Investment Loss   -1.69%   -1.26%   -2.06%   -1.93%

 

^The Fund commenced operations on March 28, 2022.

 

(1)Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.
(2)Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.
(3)Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.
(4)Percentages are not annualized for the periods ended September 30, 2023 and September 30, 2022
(5)Percentages are annualized.
(6)The expense ratio would be 2.08% and 2.15% respectively, for the nine months ended September 30, 2023, and 2.23% and 2.27% for the period ended September 30, 2022, if brokerage commissions and futures and futures account fees were excluded.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Risk
9 Months Ended
Sep. 30, 2023
Risk [Abstract]  
RISK

NOTE 8 – RISK

 

Correlation and Compounding Risk

 

The Funds do not seek to achieve their stated investment objective over a period of time greater than a single day (as measured from NAV calculation time to NAV calculation time). The return of a Fund for a period longer than a single day is the result of its return for each day compounded over the period and usually will differ in amount and possibly even direction from the inverse (-1x) or two times (2x) the return of the Fund’s benchmark for the period. A Fund will lose money if its benchmark performance is flat over time, and it is possible for a Fund to lose money over time even if the performance of its benchmark increases in the case of UVIX (or decreases in the case of SVIX), as a result of daily rebalancing, the benchmark’s volatility, compounding, and other factors. Compounding is the cumulative effect of applying investment gains and losses and income to the principal amount invested over time. Gains or losses experienced over a given period will increase or reduce the principal amount invested from which the subsequent period’s returns are calculated. The effects of compounding will likely cause the performance of a Fund to differ from the Fund’s stated multiple times the return of its benchmark for the same period. The effect of compounding becomes more pronounced as benchmark volatility and holding period increase. The impact of compounding will impact each shareholder differently depending on the period of time an investment in a Fund is held and the volatility of the benchmark during the holding period of an investment in the Fund. Longer holding periods, higher benchmark volatility, inverse exposure and greater leverage each affect the impact of compounding on a Fund’s returns. Daily compounding of a Fund’s investment returns can dramatically and adversely affect its longer-term performance during periods of high volatility. Volatility may be at least as important to a Fund’s return for a period as the return of the Fund’s underlying benchmark.

 

Each Fund uses leverage and should produce daily returns that are more volatile than that of its benchmark. For example, the daily return of UVIX should be approximately two times as volatile on a daily basis as is the return of a fund with an objective of matching the same benchmark. The daily return of SVIX is designed to return the inverse (-1x) of the return that would be expected of a fund with an objective of matching the same benchmark. The Funds are not appropriate for all investors and present significant risks not applicable to other types of funds. The Funds use leverage and are riskier than similarly benchmarked exchange-traded funds that do not use leverage. An investor should only consider an investment in a Fund if he or she understands the consequences of seeking daily leveraged or daily inverse investment results. Shareholders who invest in the Funds should actively manage and monitor their investments, as frequently as daily.

 

While the Funds seek to meet their investment objectives, there is no guarantee they will do so. Factors that may affect a Fund’s ability to meet its investment objective include: (1) the Sponsor’s ability to purchase and sell Financial Instruments in a manner that correlates to a Fund’s objective; (2) an imperfect correlation between the performance of Financial Instruments held by a Fund and the performance of the applicable benchmark; (3) bid-ask spreads on such Financial Instruments; (4) fees, expenses, transaction costs, financing costs associated with the use of Financial Instruments and commission costs; (5) holding or trading instruments in a market that has become illiquid or disrupted; (6) a Fund’s Share prices being rounded to the nearest cent and/or valuation methodology; (7) changes to a benchmark Index that are not disseminated in advance; (8) the need to conform a Fund’s portfolio holdings to comply with investment restrictions or policies or regulatory or tax law requirements; (9) early and unanticipated closings of the markets on which the holdings of a Fund trade, resulting in the inability of the Fund to execute intended portfolio transactions; (10) accounting standards; and (11) differences caused by a Fund obtaining exposure to only a representative sample of the components of a benchmark, over weighting or under weighting certain components of a benchmark or obtaining exposure to assets that are not included in a benchmark.

 

A number of factors may affect a Fund’s ability to achieve a high degree of correlation with its benchmark, and there can be no guarantee that a Fund will achieve a high degree of correlation. Failure to achieve a high degree of correlation may prevent a Fund from achieving its investment objective. In order to achieve a high degree of correlation with their underlying benchmarks, the Funds seek to rebalance their portfolios daily to keep exposure consistent with their investment objectives. Being materially under- or over-exposed to the benchmark may prevent such Funds from achieving a high degree of correlation with such benchmark. Market disruptions or closure, large amounts of assets into or out of the Funds, regulatory restrictions, extreme market volatility, and other factors will adversely affect such Funds’ ability to adjust exposure to requisite levels. The target amount of portfolio exposure is impacted dynamically by the benchmarks’ movements during each day. Other things being equal, more significant movement in the value of its benchmark up or down will require more significant adjustments to a Fund’s portfolio. Because of this, it is unlikely that the Funds will be perfectly exposed (i.e., --1x, -2x, as applicable) to its benchmark at the end of each day, and the likelihood of being materially under- or over-exposed is higher on days when the benchmark levels are volatile near the close of the trading day.

 

Each Fund seeks to rebalance its portfolio on a daily basis. The time and manner in which a Fund rebalances its portfolio may vary from day to day depending upon market conditions and other circumstances at the discretion of the Sponsor. Unlike other funds that do not rebalance their portfolios as frequently, each Fund may be subject to increased trading costs associated with daily portfolio rebalancing in order to maintain appropriate exposure to the underlying benchmarks.

 

Counterparty Risk

 

Each Fund may use derivatives such as swap agreements and forward contracts (collectively referred to herein as “derivatives”) in the manner described herein as a means to achieve their respective investment objectives. The use of derivatives by a Fund exposes the Fund to counterparty risks.

 

Regulatory Treatment

 

Derivatives are generally traded in OTC markets and have only recently become subject to comprehensive regulation in the United States. Cash-settled forwards are generally regulated as “swaps”, whereas physically settled forwards are generally not subject to regulation (in the case of commodities other than currencies) or subject to the federal securities laws (in the case of securities). Title VII of the Dodd-Frank Act (“Title VII”) created a regulatory regime for derivatives, with the CFTC responsible for the regulation of swaps and the SEC responsible for the regulation of “security-based swaps.” The SEC requirements have largely yet to be made effective, but the CFTC requirements are largely in place. The CFTC requirements have included rules for some of the types of transactions in which the Funds will engage, including mandatory clearing and exchange trading, reporting, and margin for OTC swaps. Title VII also created new categories of regulated market participants, such as “swap dealers,” “security-based swap dealers,” “major swap participants,” and “major security-based swap participants” who are, or will be, subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The regulatory requirements under Title VII continue to be developed and there may be further modifications that could materially and adversely impact the Funds, the markets in which a Fund trades and the counterparties with which the Fund engages in transactions.

 

As noted, the CFTC rules may not apply to all of the swap agreements and forward contracts entered into by the Funds. Investors, therefore, may not receive the protection of CFTC regulation or the statutory scheme of the Commodity Exchange Act (the “CEA”) in connection with each Fund’s swap agreements or forward contracts. The lack of regulation in these markets could expose investors to significant losses under certain circumstances, including in the event of trading abuses or financial failure by participants.

 

Counterparty Credit Risk

 

The Funds will be subject to the credit risk of the counterparties to the derivatives. In the case of cleared derivatives, the Funds will have credit risk to the clearing corporation in a similar manner as the Funds would for futures contracts. In the case of OTC derivatives, the Funds will be subject to the credit risk of the counterparty to the transaction – typically a single bank or financial institution. As a result, a Fund is subject to increased credit risk with respect to the amount it expects to receive from counterparties to OTC derivatives entered into as part of that Fund’s principal investment strategy. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, a Fund could suffer significant losses on these contracts and the value of an investor’s investment in a Fund may decline.

 

The Funds have sought to mitigate these risks by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily, subject to certain minimum thresholds. However, there are no limitations on the percentage of assets each Fund may invest in swap agreements or forward contracts with a particular counterparty. To the extent any such collateral is insufficient or there are delays in accessing the collateral, the Funds will be exposed to counterparty risk as described above, including possible delays in recovering amounts as a result of bankruptcy proceedings. The Funds typically enter into transactions only with major global financial institutions.

 

OTC derivatives of the type that may be utilized by the Funds are generally less liquid than futures contracts because they are not traded on an exchange, do not have uniform terms and conditions, and are generally entered into based upon the creditworthiness of the parties and the availability of credit support, such as collateral, and in general, are not transferable without the consent of the counterparty. These agreements contain various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net positions owed to the party under the agreement. For example, if the level of the Fund’s benchmark has a dramatic intraday move that would cause a material decline in the Fund’s NAV, the terms of the swap may permit the counterparty to immediately close out the transaction with the Fund. In that event, it may not be possible for the Fund to enter into another swap or to invest in other Financial Instruments necessary to achieve the desired exposure consistent with the Fund’s objective. This, in turn, may prevent the Fund from achieving its investment objective, particularly if the level of the Fund’s benchmark reverses all or part of its intraday move by the end of the day.

 

In addition, cleared derivatives benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. To the extent the Fund enters into cleared swap transactions, the Fund will deposit collateral with a FCM in cleared swaps customer accounts, which are required by CFTC regulations to be separate from its proprietary collateral posted for cleared swaps transactions. Cleared swap customer collateral is subject to regulations that closely parallel the regulations governing customer segregated funds for futures transactions but provide certain additional protections to cleared swaps collateral in the event of a clearing broker or clearing broker customer default. For example, in the event of a default of both the clearing broker and a customer of the clearing broker, a clearing house is only permitted to access the cleared swaps collateral in the legally separate (but operationally comingled) account of the defaulting cleared swap customer of the clearing broker, as opposed to the treatment of customer segregated funds, under which the clearing house may access all of the commingled customer segregated funds of a defaulting clearing broker. Derivatives entered into directly between two counterparties do not necessarily benefit from such protections, particularly if entered into with an entity that is not registered as a “swap dealer” with the CFTC. This exposes the Funds to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem, thus causing the Funds to suffer a loss.

 

The Sponsor regularly reviews the performance of its counterparties for, among other things, creditworthiness and execution quality. In addition, the Sponsor periodically considers the addition of new counterparties and the counterparties used by a Fund may change at any time. Each day, the Funds disclose their portfolio holdings as of the prior Business Day. Each Fund’s portfolio holdings identifies its counterparties, as applicable. This portfolio holdings information may be accessed through the web on the Sponsor’s website at www.volatilityshares.com.

 

Each counterparty and/or any of its affiliates may be an Authorized Participant or shareholder of a Fund, subject to applicable law.

 

The counterparty risk for cleared derivatives transactions is generally lower than for OTC derivatives. Once a transaction is cleared, the clearing organization is substituted and is a Fund’s counterparty on the derivative. The clearing organization guarantees the performance of the other side of the derivative. Nevertheless, some risk remains, as there is no assurance that the clearing organization, or its members, will satisfy its obligations to a Fund.

 

Leverage Risk

 

The Funds may utilize leverage in seeking to achieve their respective investment objectives and will lose more money in market environments adverse to their respective daily investment objectives than funds that do not employ leverage. The use of leveraged and/or inverse leveraged positions increases the risk of total loss of an investor’s investment, even over periods as short as a single day.

 

For example, because UVIX includes a two times (2x) multiplier, a single-day movement in the relevant benchmark approaching 50% at any point in the day could result in the total loss or almost total loss of an investor’s investment if that movement is contrary to the investment objective of the Fund in which an investor has invested, even if such Fund’s benchmark subsequently moves in an opposite direction, eliminating all or a portion of the movement. This would be the case with downward single-day or intraday movements in the underlying benchmark of a Fund or upward single-day or intraday movements in the benchmark of a Fund, even if the underlying benchmark maintains a level greater than zero at all times.

 

Liquidity Risk

 

Financial Instruments cannot always be liquidated at the desired price. It is difficult to execute a trade at a specific price when there is a relatively small volume of buy and sell orders in a market. A market disruption can also make it difficult to liquidate a position or find a swap or forward contract counterparty at a reasonable cost. Market illiquidity may cause losses for the Funds. The large size of the positions which the Funds may acquire increases the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred while trying to do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically invest in Financial Instruments related to one benchmark, which in many cases is highly concentrated.

 

“Contango” and “Backwardation” Risk

 

The Funds typically hold futures contracts. As the futures contracts near expiration, they are generally replaced by contracts that have a later expiration. Thus, for example, a contract purchased and held in November 2019 may specify a January 2020 expiration. As that contract nears expiration, it may be replaced by selling the January 2020 contract and purchasing the contract expiring in March 2020. This process is referred to as “rolling.” Rolling may have a positive or negative impact on performance. For example, historically, the prices of certain types of futures contracts have frequently been higher for contracts with shorter-term expirations than for contracts with longer-term expirations, which is referred to as “backwardation.” In these circumstances, absent other factors, the sale of the January 2020 contract would take place at a price that is higher than the price at which the March 2020 contract is purchased, thereby creating a gain in connection with rolling. While certain types of futures contracts have historically exhibited consistent periods of backwardation, backwardation will likely not exist in these markets at all times.

 

Since the introduction of VIX futures contracts, there have frequently been periods where VIX futures prices reflect higher expected volatility levels further out in time. This can result in a loss from “rolling” the VIX futures to maintain the constant weighted average maturity of the applicable Fund benchmark. Losses from exchanging a lower priced VIX future for a higher priced longer-term future in the rolling process could adversely affect the value of a Fund and, accordingly, decrease the return of a Fund.

 

Natural Disaster/Epidemic Risk

 

Natural or environmental disasters, such as earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease, including pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and markets and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster and health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays, shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding results on the operating performance of the Funds and their investments. A climate of uncertainty and panic, including the contagion of infectious viruses or diseases, may adversely affect global, regional, and local economies and reduce the availability of potential investment opportunities, and increases the difficulty of performing due diligence and modeling market conditions, potentially reducing the accuracy of financial projections. Under these circumstances, the Funds may have difficulty achieving their investment objectives which may adversely impact performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual companies (including, but not limited to, the Funds’ Sponsor and third party service providers), sectors, industries, markets, securities and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the value of the Funds’ investments. These factors can cause substantial market volatility, exchange trading suspensions and closures and can impact the ability of the Funds to complete redemptions and otherwise affect Fund performance and Fund trading in the secondary market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long such events will last and whether they will continue or recur cannot be predicted. Impacts from these events could have significant impact on a Fund’s performance, resulting in losses to your investment.

 

Risk that Current Assumptions and Expectations Could Become Outdated As a Result of Global Economic Shocks

 

The onset of the novel coronavirus (COVID-19) has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow and contain the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies as economic activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at least equal to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market in the fastest such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US, oil experienced shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as of the date hereof may cause the underlying assumptions and expectations of the Funds to become outdated quickly or inaccurate, resulting in significant losses.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

 

Management has evaluated the possibility of subsequent events existing in the Trust’s and the Funds’ financial statements through the date the financial statements were issued. On September 22, 2023, the Trust announced a 1-for-10 reverse share split (a “Reverse Split”) of the shares of beneficial interest of 2x Long VIX Futures ETF (ticker symbol: UVIX). The Reverse Split was effective prior to market open on October 11, 2023, when the fund began trading at its post-split price. The Reverse Split increased the price per share of the fund with a proportionate decrease in the number of shares outstanding. Therefore, the Reverse Split did not change the aggregate net asset value of a shareholder’s investment at the time of the Reverse Split.

 

For UVIX shareholders who held a quantity of shares that was not an exact multiple of the Reverse Split ratio (i.e., not a multiple of 10), the Reverse Split resulted in the creation of a fractional share. Post-Reverse Split fractional shares were made available to be redeemed for cash and sent to the shareholder’s broker of record. This redemption may have caused some shareholders to realize gains or losses, which could have been a taxable event for those shareholders.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2023
Significant Accounting Policies [Abstract]  
Emerging growth company

Emerging growth company

The Trust is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year.

For as long as the Trust remains an “emerging growth company,” it may take advantage of certain exemptions from the various reporting requirements that are applicable to public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an “emerging growth company.”

 

Use of Estimates & Indemnifications

Use of Estimates & Indemnifications

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

In the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications. The Trust’s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.

Basis of Presentation

Basis of Presentation

Pursuant to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for the purchase of Shares in that Fund.

Statements of Cash Flows

The cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated September 30, 2023 and December 31, 2022 and represents cash, but does not include short-term investments.

Final Net Asset Value for Fiscal Period

Final Net Asset Value for Fiscal Period

The cut-off times and the times of the calculation of the Funds’ final net asset value for creation and redemption of fund Shares for the three months ended September 30, 2023 were typically as follows. All times are Eastern Standard Time:

     Create/Redeem    NAV
Calculation
   NAV
Fund    Cut-off*(EST)    Time (EST)    Calculation Date
-1x Short VIX Futures ETF and    2:00 p.m.   4:00 p.m.    September 30, 2023
2x Long VIX Futures ETF    2:00 p.m.    4:00 p.m.    September 30, 2023
*Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended September 30, 2023.

Market value per Share is determined at the close of Cboe BZX and may be later than when the Funds’ NAV per Share is calculated.

For financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds’ final creation/redemption NAV for the three months ended September 30, 2023.

Investment Valuation

Investment Valuation

Short-term investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations are typically categorized as Level I in the fair value hierarchy.

Derivatives (e.g., futures contracts, options, swap agreements) are generally valued using independent sources and/or agreements with counterparties or other procedures as determined by the Sponsor. Futures contracts are generally valued at the last settled price on the applicable exchange on which that future trades. For financial reporting purposes, all futures contracts are generally valued at the last settled price. Futures contracts valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically categorized as Level II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as the basis for determining the market value of such position. Such fair value prices would generally be determined based on available inputs about the current value of the underlying financial instrument or commodity and would be based on principles that the Sponsor deems fair and equitable so long as such principles are consistent with industry standards. The Sponsor may fair value an asset of a Fund pursuant to the policies the Sponsor has adopted. Depending on the source and relevant significance of valuation inputs, these instruments may be classified as Level II or Level III in the fair value hierarchy.

 

Fair value pricing may require subjective determinations about the value of an investment. While the Funds’ policies are intended to result in a calculation of its respective Fund’s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial statements.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds’ own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:

Level I – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level II – Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated inputs).

Level III – Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.

In some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement in its entirety.

Fair value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances indicate that a transaction is not orderly.

The following table summarizes the valuation of investments at September 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:

   September 30, 2023 (Unaudited)   December 31, 2022 
Fund  Level 1 -
Money
Market
Fund
   Level 2 -
Futures
Contracts*
   Total
September 30,
2023
   Level 1 -
Money
Market
Fund
   Level 2 -
Futures
Contracts*
   Total
December 31,
2022
 
-1x Short VIX Futures ETF  $7,673,680   $(6,409,592)  $1,264,088   $-   $1,156,106   $1,156,106 
2x Long VIX Futures ETF  $24,356,501    11,140,667    35,497,168    8,250,285    (9,203,522)   (953,237)
Total Trust  $32,030,181   $4,731,075   $36,761,256   $8,250,285   $(8,047,416)  $202,869 
*Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.

Investment Transactions and Related Income

Investment Transactions and Related Income

Investment transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between periods are reflected in the Statements of Operations.

Interest income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.

 

Brokerage Commissions and Futures Account Fees

Brokerage Commissions and Futures Account Fees

Each Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (“NFA”) fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities for each Fund’s investment in U.S. Commodity Futures Trading Commission (“CFTC”) regulated investments. The effects of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). ). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more than 0.29% and 0.19%, for SVIX and UVIX, respectively, of each Fund’s average net assets annually.

Federal Income Tax

Federal Income Tax

Each Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund’s Shares is required to take into account its allocable share of its Fund’s income, gain, loss, deductions and other items for its Fund’s taxable year ending with or within the beneficial owner’s taxable year.

Management of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Significant Accounting Policies [Abstract]  
Schedule of Cut-Off Times and the Times of the Calculation of the Funds The cut-off times and the times of the calculation of the Funds’ final net asset value for creation and redemption of fund Shares for the three months ended September 30, 2023 were typically as follows. All times are Eastern Standard Time:
     Create/Redeem    NAV
Calculation
   NAV
Fund    Cut-off*(EST)    Time (EST)    Calculation Date
-1x Short VIX Futures ETF and    2:00 p.m.   4:00 p.m.    September 30, 2023
2x Long VIX Futures ETF    2:00 p.m.    4:00 p.m.    September 30, 2023
*Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended September 30, 2023.
Schedule of Valuation of Investments at Using the Fair Value Hierarchy The following table summarizes the valuation of investments at September 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:
   September 30, 2023 (Unaudited)   December 31, 2022 
Fund  Level 1 -
Money
Market
Fund
   Level 2 -
Futures
Contracts*
   Total
September 30,
2023
   Level 1 -
Money
Market
Fund
   Level 2 -
Futures
Contracts*
   Total
December 31,
2022
 
-1x Short VIX Futures ETF  $7,673,680   $(6,409,592)  $1,264,088   $-   $1,156,106   $1,156,106 
2x Long VIX Futures ETF  $24,356,501    11,140,667    35,497,168    8,250,285    (9,203,522)   (953,237)
Total Trust  $32,030,181   $4,731,075   $36,761,256   $8,250,285   $(8,047,416)  $202,869 
*Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Investments (Tables)
9 Months Ended
Sep. 30, 2023
Investments [Abstract]  
Schedule of Fair Value of Derivative Instruments the contract as each party to a trade looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.
Fair Values of Derivative Instruments as of September 30, 2023 (Unaudited)  
        Asset Derivatives     Liability Derivatives  
Derivatives Not
Accounted for as
Hedging Instruments
  Fund   Statements of
Financial
Condition Location
  Unrealized
Appreciation*
    Statements of
Financial
Condition Location
  Unrealized
Depreciation*
 
VIX Futures Contracts                            
    -1x Short VIX Futures ETF       $ -         $ (6,409,592)  
    2x Long VIX Futures ETF         11,140,667           -  
    Total Trust       $ 11,140,667         $ (6,409,592  
  * Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.
Fair Values of Derivative Instruments as of December 31, 2022  
        Asset Derivatives     Liability Derivatives  
Derivatives Not
Accounted for as
Hedging Instruments
  Fund   Statements of
Financial
Condition Location
  Unrealized
Appreciation*
    Statements of
Financial
Condition Location
  Unrealized
Depreciation*
 
VIX Futures Contracts                            
    -1x Short VIX Futures ETF       $ 1,156,106         $ -  
    2x Long VIX Futures ETF         -           (9,203,522 )
    Total Trust       $ 1,156,106         $   (9,203,522 )
Schedule of Effect of Derivative Instruments on the Statement of Operations
The Effect of Derivative Instruments on the Statement of Operations  
For the Three Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited)  
                                 
Derivatives Not
Accounted for as Hedging Instruments
  Location of Gain (Loss) on Derivatives Recognized in Income   Fund   Realized Gain
(Loss) on
Derivatives Recognized
in Income
September 30,
2023
    Change in
Unrealized
Appreciation
(Depreciation)
on Derivatives
Recognized
in Income
September 30,
2023*
    Realized Gain
(Loss) on
Derivatives
Recognized
in Income
September 30,
2022
    Change in
Unrealized
Appreciation
(Depreciation)
on Derivatives
Recognized
in Income
Sepetember 30,
2022*
 
VIX Futures Contracts   Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts                                    
        -1x Short VIX Futures ETF   $ 15,738,591     $ (12,928,171 )   $ 8,077,788   $ (6,278,300 )
        2x Long VIX Futures ETF     (42,049,000 )     30,931,703       (22,686,413 )     20,574,735
        Total Trust   $ (26,310,409 )   $ 18,003,532     $ (14,608,625 )   $ 14,296,435  
The Effect of Derivative Instruments on the Statement of Operations  
For the Nine Months Ended September 30, 2023 (Unaudited) and September 30, 2022^ (Unaudited)  
                                 
Derivatives Not
Accounted for as Hedging Instruments
  Location of Gain (Loss) on Derivatives Recognized in Income   Fund   Realized Gain
(Loss) on
Derivatives
Recognized
in Income
September 30,
2023
    Change in
Unrealized
Appreciation
(Depreciation)
on Derivatives
Recognized in
Income
September 30,
2023*
    Realized Gain
(Loss) on
Derivatives
Recognized
in Income
September 30,
2022
    Change in
Unrealized
Appreciation
(Depreciation)
on Derivatives
Recognized
in Income
September 30,
2022*
 
VIX Futures Contracts   Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts                                    
        -1x Short VIX Futures ETF   $ 58,190,096      $ (7,565,698 )   $ 3,500,659     $ (5,577,769 )
        2x Long VIX Futures ETF     (228,151,397 )     20,344,189       (15,158,418 )     20,593,993  
        Total Trust   $ (169,961,301 )   $ 12,778,491     $ (11,657,759 )   $ 15,016,224  
Schedule of Pledged by Funds Fair Values of Derivative Instruments For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund’s derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related collateral received or pledged by the Funds as of September 30, 2023 and December 31, 2022.
Fair Values of Derivative Instruments as of September 30, 2023 (Unaudited) 
         
   Assets   Liabilities 
Fund  Gross
Amounts of
Recognized
Assets
presented
in the
Statements
of Financial
Condition
   Gross
Amounts
Offset
in the
Statements
of Financial
Condition
   Net Amounts
of Assets
presented
in the
Statements
of Financial
Condition
   Gross
Amounts of
Recognized
Liabilities
presented
in the
Statements
of Financial
Condition
   Gross
Amounts
Offset
in the
Statements
of Financial
Condition
   Net Amounts
of Liabilities
presented
in the
Statements
of Financial
Condition
 
-1x Short VIX Futures ETF  $-   $          -   $-   $1,327,607   $          -   $1,327,607 
2x Long VIX Futures ETF   1,945,302    -    1,945,302    -    -    - 
Fair Values of Derivative Instruments as of December 31, 2022 
         
   Assets   Liabilities 
Fund  Gross
Amounts of
Recognized
Assets
presented
in the
Statements
of Financial
Condition
   Gross
Amounts
Offset
in the
Statements
of Financial
Condition
   Net Amounts
of Assets
presented
in the
Statements
of Financial
Condition
   Gross
Amounts of
Recognized
Liabilities
presented
in the
Statements
of Financial
Condition
   Gross
Amounts
Offset
in the
Statements
of Financial
Condition
   Net Amounts
of Liabilities
presented
in the
Statements
of Financial
Condition
 
-1x Short VIX Futures ETF  $-   $          -   $-   $187,030   $             -   $187,030 
2x Long VIX Futures ETF   830,840    -    830,840    -    -    - 
Schedule of Gross Amounts Not Offset in the Statements of Financial Condition These amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement, as further described above under the caption “Accounting for Derivative Instruments”.
Gross Amounts Not Offset in the Statements of Financial Condition as of September 30, 2023 (Unaudited) 
                 
Fund  Amounts of
Recognized
Assets /
(Liabilities)
presented
in the
Statements
of Financial
Condition
   Financial
Instruments
for the Benefit
of (the Funds) / the
Counterparties
   Cash
Collateral for
the Benefit of
(the Funds) / the
Counterparties
   Net Amount 
-1x Short VIX Futures ETF  $(1,327,607)  $          -   $         -   $(1,327,607)
2x Long VIX Futures ETF   1,945,302    -    -    1,945,302 
Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022 
                 
Fund  Amounts of
Recognized
Assets /
(Liabilities)
presented
in the
Statements
of Financial
Condition
   Financial
Instruments
for the Benefit
of (the Funds) / the
Counterparties
   Cash
Collateral for
the Benefit of
(the Funds) / the
Counterparties
   Net Amount 
-1x Short VIX Futures ETF  $(187,030)  $          -   $         -   $(187,030)
2x Long VIX Futures ETF   830,840    -    -    830,840 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Creation and Redemption of Creation Units (Tables)
9 Months Ended
Sep. 30, 2023
CreationAndRedemptionOfCreationUnits [Abstract]  
Schedule of Transaction Fees Transaction fees for the three months ended September 30, 2023 and September 30, 2022 were as follows:
Fund  Three
Months
Ended
September 30,
2023
(Unaudited)
   Three
Months
Ended
September 30,
2022
(Unaudited)
 
-1x Short VIX Futures ETF  $30,396   $20,124 
2x Long VIX Futures ETF   50,484    78,086 
Total Trust  $80,880   $98,210 

 

Fund  Nine Months
Ended
September 30,
2023
(Unaudited)
   Period
Ended
September 30,
2022^
(Unaudited)
 
-1x Short VIX Futures ETF  $107,878   $83,994 
2x Long VIX Futures ETF   170,097    124,991 
Total Trust  $277,975   $208,985 
^The Fund commenced operations on March 28, 2022.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Highlights (Tables)
9 Months Ended
Sep. 30, 2023
Financial Highlights [Abstract]  
Schedule of Share Outstanding Selected data is for a Share outstanding throughout the Three Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited):
   -1x Short VIX Futures ETF   2x Long VIX Futures ETF   -1x Short VIX Futures ETF   2x Long VIX Futures ETF 
   Quarter Ended   Quarter Ended   Quarter Ended   Quarter Ended 
   September 30,
2023
   September 30,
2023
   September 30,
2022
   September 30,
2022
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Net Asset Value, Beginning of Period  $28.13   $4.44   $10.40   $85.60 
Net investment loss (1)   (0.11)   (0.01)   (0.06)   (2.38)
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts (2)   0.01    (0.96)   (0.00)   (13.87)
Net Increase (Decrease) in Net Asset Value Resulting from Operations   (0.10)   (0.97)   (0.06)   (16.25)
Net Asset Value, End of Period  $28.03   $3.47   $10.34   $69.35 
Market Value Per Share, at September 30, 2023 and September 30, 2022  $27.88   $3.49   $10.52   $67.00 
Total Return at Net Asset Value (4)   -0.36%   -21.85%   -0.58%   -18.97%
Total Return at Market Value (4)   -0.68%   -21.75%   -0.87%   -18.21%
                     
Ratios to Average Net Assets: (5)                    
Expense ratio (6)   1.89%   2.21%   2.34%   2.35%
Net Investment Loss   -1.49%   -1.04%   -2.06%   -1.93%
(1)Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.
(2)Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.
(3)Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.
(4)Percentages are not annualized for the period ended September 30, 2023 and September 30, 2022
(5)Percentages are annualized.
(6)The expense ratio would be 1.89% and 2.21% respectively, for the three months ended September 30, 2023, and 2.23% and 2.27% for the three months ended September 30, 2022 if brokerage commissions and futures and futures account fees were excluded.

 

   -1x Short VIX Futures ETF   2x Long VIX Futures ETF   -1x Short VIX Futures ETF   2x Long VIX Futures ETF 
   Nine Months
Ended
   Nine Months
Ended
   For the
Period Ended
   For the
Period Ended
 
   September 30,
2023
   September 30,
2023
   September 30,
2022^
   September 30,
2022^
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Net Asset Value, Beginning of Period  $14.63   $29.25   $15.00   $75.00 
Net investment loss (1)   (0.27)   (0.07)   (0.12)   (0.60)
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts (2)   13.67    (25.71)   (4.54)   (5.05)
Net Increase (Decrease) in Net Asset Value Resulting from Operations   13.40    (25.78)   (4.66)   (5.65)
Net Asset Value, End of Period  $28.03   $3.47   $10.34   $69.35 
Market Value Per Share, at September 30, 2023 and September 30, 2022  $27.88   $3.49   $10.52   $67.00 
Total Return at Net Asset Value (4)   91.59%   -88.14%   -31.07%   -7.53%
Total Return at Market Value (4)   90.18%   -88.01%   -29.87%   -10.67%
                     
Ratios to Average Net Assets: (5)                    
Expense ratio (6)   2.10%   2.15%   2.33%   2.34%
Net Investment Loss   -1.69%   -1.26%   -2.06%   -1.93%
^The Fund commenced operations on March 28, 2022.
(1)Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.
(2)Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.
(3)Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.
(4)Percentages are not annualized for the periods ended September 30, 2023 and September 30, 2022
(5)Percentages are annualized.
(6)The expense ratio would be 2.08% and 2.15% respectively, for the nine months ended September 30, 2023, and 2.23% and 2.27% for the period ended September 30, 2022, if brokerage commissions and futures and futures account fees were excluded.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies (Details) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Significant Accounting Policies [Line Items]    
Annual gross revenue $ 1,070  
Non-convertible debt securities 1,000  
Non-affiliates exceeded $ 700  
Fund's average net assets percentage 100.00% 100.00%
SVIX [Member]    
Significant Accounting Policies [Line Items]    
Fund's average net assets percentage 0.29%  
UVIX [Member]    
Significant Accounting Policies [Line Items]    
Fund's average net assets percentage 0.19%  
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds
3 Months Ended
Sep. 30, 2023
-1x Short VIX Futures ETF [Member]  
Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds [Line Items]  
Create/Redeem Cut-off (EST) 2:00 p.m.
NAV Calculation Time (EST) 4:00 p.m.
NAV Calculation Date Sep. 30, 2023
2x Long VIX Futures ETF [Member]  
Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds [Line Items]  
Create/Redeem Cut-off (EST) 2:00 p.m.
NAV Calculation Time (EST) 4:00 p.m.
NAV Calculation Date Sep. 30, 2023
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]    
Total Trust $ 36,761,256 $ 202,869
-1x Short VIX Futures ETF [Member]    
Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]    
Total Trust 1,264,088 1,156,106
2x Long VIX Futures ETF [Member]    
Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]    
Total Trust 35,497,168 (953,237)
Level 1 [Member] | Money Market Fund [Member]    
Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]    
Total Trust 32,030,181 8,250,285
Level 1 [Member] | Money Market Fund [Member] | -1x Short VIX Futures ETF [Member]    
Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]    
Total Trust 7,673,680
Level 1 [Member] | Money Market Fund [Member] | 2x Long VIX Futures ETF [Member]    
Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]    
Total Trust 24,356,501 8,250,285
Level 2 [Member] | Futures Contracts [Member]    
Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]    
Total Trust [1] 4,731,075 (8,047,416)
Level 2 [Member] | Futures Contracts [Member] | -1x Short VIX Futures ETF [Member]    
Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]    
Total Trust [1] (6,409,592) 1,156,106
Level 2 [Member] | Futures Contracts [Member] | 2x Long VIX Futures ETF [Member]    
Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]    
Total Trust [1] $ 11,140,667 $ (9,203,522)
[1] Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Investments (Details) - Schedule of Fair Value of Derivative Instruments
Sep. 30, 2023
Dec. 31, 2022
Asset Derivatives [Member] | Statements of Financial Condition Location [Member]    
Schedule of Fair Value of Derivative Instruments [Line Items]    
Total Trust [1] $11,140,667  
Asset Derivatives [Member] | Unrealized Appreciation [Member]    
Schedule of Fair Value of Derivative Instruments [Line Items]    
Total Trust [1] $(6,409,592  
Asset Derivatives [Member] | -1x Short VIX Futures ETF [Member] | Statements of Financial Condition Location [Member]    
Schedule of Fair Value of Derivative Instruments [Line Items]    
Total Trust [1]  
Asset Derivatives [Member] | -1x Short VIX Futures ETF [Member] | Unrealized Appreciation [Member]    
Schedule of Fair Value of Derivative Instruments [Line Items]    
Total Trust [1] $(6,409,592)  
Asset Derivatives [Member] | 2x Long VIX Futures ETF [Member] | Statements of Financial Condition Location [Member]    
Schedule of Fair Value of Derivative Instruments [Line Items]    
Total Trust [1] 11,140,667  
Asset Derivatives [Member] | 2x Long VIX Futures ETF [Member] | Unrealized Appreciation [Member]    
Schedule of Fair Value of Derivative Instruments [Line Items]    
Total Trust [1]  
Liability Derivatives [Member] | Statements of Financial Condition Location [Member]    
Schedule of Fair Value of Derivative Instruments [Line Items]    
Total Trust [1]   $1,156,106
Liability Derivatives [Member] | Unrealized Depreciation [Member]    
Schedule of Fair Value of Derivative Instruments [Line Items]    
Total Trust [1]   $(9,203,522)
Liability Derivatives [Member] | -1x Short VIX Futures ETF [Member] | Statements of Financial Condition Location [Member]    
Schedule of Fair Value of Derivative Instruments [Line Items]    
Total Trust [1]   $1,156,106
Liability Derivatives [Member] | -1x Short VIX Futures ETF [Member] | Unrealized Depreciation [Member]    
Schedule of Fair Value of Derivative Instruments [Line Items]    
Total Trust [1]  
Liability Derivatives [Member] | 2x Long VIX Futures ETF [Member] | Statements of Financial Condition Location [Member]    
Schedule of Fair Value of Derivative Instruments [Line Items]    
Total Trust [1]  
Liability Derivatives [Member] | 2x Long VIX Futures ETF [Member] | Unrealized Depreciation [Member]    
Schedule of Fair Value of Derivative Instruments [Line Items]    
Total Trust [1]   (9,203,522)
[1] Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Investments (Details) - Schedule of Effect of Derivative Instruments on the Statement of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
VIX Futures Contracts Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts        
Realized Gain (Loss) on Derivatives Recognized in Income $ (26,310,409) $ (14,608,625) $ (169,961,301) $ (11,657,759)
Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income 18,003,532 14,296,435 12,778,491 15,016,224
1 x Short VIX Futures ETF [Member]        
VIX Futures Contracts Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts        
Realized Gain (Loss) on Derivatives Recognized in Income 15,738,591 8,077,788 58,190,096 3,500,659
Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income (12,928,171) (6,278,300) (7,565,698) (5,577,769)
2x Long VIX Futures ETF [Member]        
VIX Futures Contracts Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts        
Realized Gain (Loss) on Derivatives Recognized in Income (42,049,000) (22,686,413) (228,151,397) (15,158,418)
Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income $ 30,931,703 $ 20,574,735 $ 20,344,189 $ 20,593,993
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Investments (Details) - Schedule of Pledged by Funds Fair Values of Derivative Instruments - USD ($)
Sep. 30, 2023
Dec. 31, 2022
-1x Short VIX Futures ETF [Member] | Other Assets [Member]    
Investments (Details) - Schedule of Pledged by Funds Fair Values of Derivative Instruments [Line Items]    
Gross Amounts of Recognized Assets presented in the Statements of Financial Condition
Gross Amounts Offset in the Statements of Financial Condition
Net Amounts of Assets presented in the Statements of Financial Condition  
-1x Short VIX Futures ETF [Member] | Other Liabilities [Member]    
Investments (Details) - Schedule of Pledged by Funds Fair Values of Derivative Instruments [Line Items]    
Gross Amounts of Recognized Liabilities presented in the Statements of Financial Condition 1,327,607 187,030
Gross Amounts Offset in the Statements of Financial Condition
Net Amounts of Liabilities presented in the Statements of Financial Condition 1,327,607 187,030
2x Long VIX Futures ETF [Member] | Other Assets [Member]    
Investments (Details) - Schedule of Pledged by Funds Fair Values of Derivative Instruments [Line Items]    
Gross Amounts of Recognized Assets presented in the Statements of Financial Condition 1,945,302 830,840
Gross Amounts Offset in the Statements of Financial Condition
Net Amounts of Assets presented in the Statements of Financial Condition 1,945,302 830,840
2x Long VIX Futures ETF [Member] | Other Liabilities [Member]    
Investments (Details) - Schedule of Pledged by Funds Fair Values of Derivative Instruments [Line Items]    
Gross Amounts of Recognized Liabilities presented in the Statements of Financial Condition  
Gross Amounts Offset in the Statements of Financial Condition
Net Amounts of Liabilities presented in the Statements of Financial Condition
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Investments (Details) - Schedule of Gross Amounts Not Offset in the Statements of Financial Condition - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
-1x Short VIX Futures ETF [Member]    
Investments (Details) - Schedule of Gross Amounts Not Offset in the Statements of Financial Condition [Line Items]    
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition $ (1,327,607) $ (187,030)
Financial Instruments for the Benefit of (the Funds) / the Counterparties  
Cash Collateral for the Benefit of (the Funds) / the Counterparties  
Net Amount (1,327,607) (187,030)
2x Long VIX Futures ETF [Member]    
Investments (Details) - Schedule of Gross Amounts Not Offset in the Statements of Financial Condition [Line Items]    
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition 1,945,302 830,840
Financial Instruments for the Benefit of (the Funds) / the Counterparties  
Cash Collateral for the Benefit of (the Funds) / the Counterparties  
Net Amount $ 1,945,302 $ 830,840
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Agreements (Details)
Sep. 30, 2023
Agreements [Line Items]  
Sub-advisory fee rate 0.20%
SVIX [Member]  
Agreements [Line Items]  
Average daily net assets rate 1.35%
UVIX [Member]  
Agreements [Line Items]  
Average daily net assets rate 1.65%
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Creation and Redemption of Creation Units (Details)
9 Months Ended
Sep. 30, 2023
shares
CreationAndRedemptionOfCreationUnits [Abstract]  
Shares of fund 10,000
Authorized participants percentage 0.20%
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees [Line Items]        
Total Trust $ 80,880 $ 98,210 $ 277,975 $ 208,985
1 x Short VIX Futures ETF [Member]        
Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees [Line Items]        
Total Trust 30,396 20,124 107,878 83,994
2x Long VIX Futures ETF [Member]        
Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees [Line Items]        
Total Trust $ 50,484 $ 78,086 $ 170,097 $ 124,991
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Highlights (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Minimum [Member]        
Financial Highlights [Line Items]        
Expense ratio percentage 1.89%   2.08%  
Brokerage commissions rate   2.23%   2.23%
Maximum [Member]        
Financial Highlights [Line Items]        
Expense ratio percentage 2.21%   2.15%  
Brokerage commissions rate   2.27%   2.27%
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Highlights (Details) - Schedule of Share Outstanding - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
[1]
-1x Short VIX Futures ETF [Member]        
Financial Highlights (Details) - Schedule of Share Outstanding [Line Items]        
Net Asset Value, Beginning of Period $ 28.13 $ 10.4 $ 14.63 $ 15
Total Return at Net Asset Value (0.36%) [2] (0.58%) [2] 91.59% [3] (31.07%) [3]
Total Return at Market Value (0.68%) [2] (0.87%) [2] 90.18% [3] (29.87%) [3]
Ratios to Average Net Assets: (5)        
Expense ratio 1.89% [4],[5] 2.34% [4],[5] 2.10% [6],[7] 2.33% [6],[7]
Net Investment Loss (1.49%) [4] (2.06%) [4] (1.69%) [6] (2.06%) [6]
Net investment loss $ (0.11) [8] $ (0.06) [8] $ (0.27) [9] $ (0.12) [9]
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts 0.01 [10] 0 [10] 13.67 [11] (4.54) [11]
Net Increase (Decrease) in Net Asset Value Resulting from Operations (0.1) (0.06) 13.4 (4.66)
Net Asset Value, End of Period 28.03 10.34 [1] 28.03 10.34
Market Value Per Share, at September 30, 2023 and September 30, 2022 27.88 10.52 27.88 10.52
2x Long VIX Futures ETF [Member]        
Financial Highlights (Details) - Schedule of Share Outstanding [Line Items]        
Net Asset Value, Beginning of Period $ 4.44 $ 85.6 $ 29.25 $ 75
Total Return at Net Asset Value (21.85%) [2] (18.97%) [2] (88.14%) [3] (7.53%) [3]
Total Return at Market Value (21.75%) [2] (18.21%) [2] (88.01%) [3] (10.67%) [3]
Ratios to Average Net Assets: (5)        
Expense ratio 2.21% [4],[5] 2.35% [4],[5] 2.15% [6],[7] 2.34% [6],[7]
Net Investment Loss (1.04%) [4] (1.93%) [4] (1.26%) [6] (1.93%) [6]
Net investment loss $ (0.01) [8] $ (2.38) [8] $ (0.07) [9] $ (0.6) [9]
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts (0.96) [10] (13.87) [10] (25.71) [11] (5.05) [11]
Net Increase (Decrease) in Net Asset Value Resulting from Operations (0.97) (16.25) (25.78) (5.65)
Net Asset Value, End of Period 3.47 69.35 [1] 3.47 69.35
Market Value Per Share, at September 30, 2023 and September 30, 2022 $ 3.49 $ 67 $ 3.49 $ 67
[1] The Fund commenced operations on March 28, 2022.
[2] Percentages are not annualized for the period ended September 30, 2023 and September 30, 2022
[3] Percentages are not annualized for the periods ended September 30, 2023 and September 30, 2022
[4] Percentages are annualized.
[5] The expense ratio would be 1.89% and 2.21% respectively, for the three months ended September 30, 2023, and 2.23% and 2.27% for the three months ended September 30, 2022 if brokerage commissions and futures and futures account fees were excluded.
[6] Percentages are annualized.
[7] The expense ratio would be 2.08% and 2.15% respectively, for the nine months ended September 30, 2023, and 2.23% and 2.27% for the period ended September 30, 2022, if brokerage commissions and futures and futures account fees were excluded.
[8] Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.
[9] Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.
[10] Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.
[11] Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Risk (Details)
9 Months Ended
Sep. 30, 2023
Risk [Abstract]  
Relevant benchmark percentage 50.00%
XML 45 f10q0923_vstrust_htm.xml IDEA: XBRL DOCUMENT 0001793497 2023-01-01 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2023-01-01 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2023-01-01 2023-09-30 0001793497 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2023-07-01 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2023-07-01 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-07-01 2022-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-07-01 2022-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2023-01-01 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2023-01-01 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-01-01 2022-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-01-01 2022-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2023-06-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2023-06-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-06-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-06-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2021-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2021-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:FirstAmericanGovernmentObligationsFundMember 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2023-01-01 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2023-01-01 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2023-01-01 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2022-12-31 0001793497 2022-01-01 2022-12-31 0001793497 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2022-01-01 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2022-01-01 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:FirstAmericanGovernmentObligationsFundMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2023-01-01 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2023-01-01 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:FirstAmericanGovernmentObligationsFundMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFuturesOneMember 2022-12-31 0001793497 cik0001793497:SVIXMember 2023-09-30 0001793497 cik0001793497:UVIXMember 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001793497 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001793497 cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001793497 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember cik0001793497:AssetDerivativesMember cik0001793497:StatementsOfFinancialConditionLocationMember 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember cik0001793497:AssetDerivativesMember cik0001793497:UnrealizedAppreciationMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:AssetDerivativesMember cik0001793497:StatementsOfFinancialConditionLocationMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:AssetDerivativesMember cik0001793497:UnrealizedAppreciationMember 2023-09-30 0001793497 cik0001793497:AssetDerivativesMember cik0001793497:StatementsOfFinancialConditionLocationMember 2023-09-30 0001793497 cik0001793497:AssetDerivativesMember cik0001793497:UnrealizedAppreciationMember 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember cik0001793497:LiabilityDerivativesMember cik0001793497:StatementsOfFinancialConditionLocationMember 2022-12-31 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember cik0001793497:LiabilityDerivativesMember cik0001793497:UnrealizedDepreciationMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:LiabilityDerivativesMember cik0001793497:StatementsOfFinancialConditionLocationMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:LiabilityDerivativesMember cik0001793497:UnrealizedDepreciationMember 2022-12-31 0001793497 cik0001793497:LiabilityDerivativesMember cik0001793497:StatementsOfFinancialConditionLocationMember 2022-12-31 0001793497 cik0001793497:LiabilityDerivativesMember cik0001793497:UnrealizedDepreciationMember 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2023-07-01 2023-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2022-07-01 2022-09-30 0001793497 2023-07-01 2023-09-30 0001793497 2022-07-01 2022-09-30 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2022-01-01 2022-09-30 0001793497 2022-01-01 2022-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember us-gaap:OtherAssetsMember 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember us-gaap:OtherLiabilitiesMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:OtherAssetsMember 2023-09-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:OtherLiabilitiesMember 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember us-gaap:OtherAssetsMember 2022-12-31 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember us-gaap:OtherLiabilitiesMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:OtherAssetsMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:OtherLiabilitiesMember 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:SVIXMember 2023-09-30 0001793497 cik0001793497:UVIXMember 2023-09-30 0001793497 srt:MinimumMember 2023-07-01 2023-09-30 0001793497 srt:MaximumMember 2023-07-01 2023-09-30 0001793497 srt:MinimumMember 2022-07-01 2022-09-30 0001793497 srt:MaximumMember 2022-07-01 2022-09-30 0001793497 srt:MinimumMember 2023-01-01 2023-09-30 0001793497 srt:MaximumMember 2023-01-01 2023-09-30 0001793497 srt:MinimumMember 2022-01-01 2022-09-30 0001793497 srt:MaximumMember 2022-01-01 2022-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2023-06-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2022-06-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2023-07-01 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2022-07-01 2022-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2022-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2022-12-31 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2021-12-31 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2023-01-01 2023-09-30 0001793497 cik0001793497:MinusOnexShortVIXFuturesETFMember 2022-01-01 2022-09-30 shares iso4217:USD iso4217:USD shares pure 10-Q true 2023-09-30 2023 false 001-34200 VS Trust DE 84-6704517 2000 PGA Boulevard Suite 4440 Palm Beach Gardens FL 33408 (866) 261-0273 -1x Short VIX Futures ETF SVIX CboeBZX 2x Long VIX Futures ETF UVIX CboeBZX Yes Yes Non-accelerated Filer true true false false 29360000 504600 7673680 24356501 8250285 40015 112405 12909 50483 24989 42198 10295 15666 6935800 1931028 104412396 55293437 48144554 114821272 1945302 830840 2081 571 579 112151080 88687724 48672929 125900153 1327607 187030 -6 1903018 111877 125640 54374 176838 17968 25664 15869 19957 203733 279945 125274 203411 33799 53324 8761 11181 1694984 484579 2294326 411387 110456096 88203145 46378603 125488766 -43701765 -374688877 -29386125 -203182472 -66754331 286485732 -16992478 77693706 110456096 88203145 46378603 125488766 110456096 88203145 46378603 125488766 3940000 25420000 3170000 21450000 28.03 3.47 14.63 5.85 27.88 3.49 14.66 5.82 7673680 24356501 8250285 86183 257541 43411 126917 7 86183 257541 43411 126924 293542 365111 146457 464768 27917 28148 15332 25723 81552 81188 80462 81792 7688 13740 27963 34070 4038 16295 410699 488187 274252 622648 324516 230646 230841 495724 -15738591 42049000 -8077788 22686413 12928171 -30931703 6278300 -20574735 2810420 -11117297 1799488 -2111678 2485904 -11347943 1568647 -2607402 207714 691812 62395 143699 61 160 207714 691812 62455 143859 688455 1284769 310019 575991 74725 90847 39233 49590 240644 242137 96221 97514 57822 58561 68358 74437 8613 320 24038 24438 1070259 1676634 537868 821971 862545 984822 475413 678112 -58190096 228151397 -3500659 15158418 7565698 -20344189 5577769 -20593993 50624398 -207807208 -2077111 5435575 49761853 -208792030 -2552524 4757463 -324516 -230646 -230841 -495724 15738591 -42049000 8077788 -22686413 -12928171 30931703 -6278300 20574735 2485904 -11347943 1568647 -2607402 -68508308 -91271140 -37128501 -148158278 32840529 77058854 29971993 112204673 35667779 14212286 7156508 35953605 38153683 2864343 8725155 33346203 72302413 85338802 46889371 60436455 110456096 88203145 55614526 93782658 -862545 -984822 -475413 -678112 58190096 -228151397 3500659 -15158418 -7565698 20344189 -5577769 20593993 49761853 -208792030 -2552524 4757463 -187008767 -369331697 -169115707 -252892858 172693127 197825288 110948657 163867663 14315640 171506409 58167050 89025195 64077493 -37285621 55614526 93782658 46378603 125488766 110456096 88203145 55614526 93782658 2485904 -11347943 1568647 -2607402 113633779 133007714 73580457 189402007 105960099 118168760 65379064 175315240 35708583 -28009343 -3665556 16108875 -1242108 1945302 1274983 26812 47053 13363 57469 -253 1521 1333 9391 -16431 4743330 -1023713 -2874781 575655 264682 6 1327607 -3406049 191690 -41257 13210 17753 -107134 3262 7567 16555 27319 34701 33913 55336 56798 10872 14275 14922 21029 -39277433 -6426140 -2145481 -38401864 72117962 85350046 32683591 150498756 32840529 78923906 34077640 112204673 39277433 6426140 -1394049 38294083 -3539530 -107781 3539530 107781 49761853 -208792030 -2552524 4757463 340725312 442361238 160823700 250370760 333051632 426255022 144330975 219134233 56267842 -59527835 36207427 56663638 1114462 2708079 27106 61922 22965 69844 -571 1502 -14694 -26532 3727069 6 575655 264682 1140577 774721 -57503 51198 -44372 -177469 2099 5707 38976 49916 78459 76534 70547 71973 25038 42143 50564 58460 -12917222 -166501637 -53722139 -89025193 187008767 364326925 164670796 252892856 174596145 197825288 110948657 163867663 12412622 166501637 53722139 89025193 -504600 504600 0.0501 7673680 7673680 7673680 0.0695 7673680 0.9305 102782416 1 110456096 -2472 -460721 -3709 -5948871 -6409592 1.1 504600 0.989 45874003 1 46378603 -1150 1058570 -804 97536 1156106 0.05 24356501 24356501 24356501 0.2761 24356501 0.7239 63846644 1 88203145 3945 674595 5918 10466072 11140667 8250285 8250285 0.0657 8250285 117238481 1 125488766 6221 -8416975 4355 -786547 -9203522 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 1 – ORGANIZATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">VS Trust (the “Trust”) is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series (each, a “Fund” and collectively, the “Funds”). As of September 30, 2023, the following two series of the Trust have commenced investment operations: -1x Short VIX Futures ETF (“SVIX”) and 2x Long VIX Futures ETF (“UVIX”). Each of the Funds listed above issues common units of beneficial interest (“Shares”), which represent units of fractional undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (“Cboe BZX”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds’ inception of operation was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other than matters relating to its organization and the registration of each series under the Securities Act of 1933.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN"><span style="font-family: Times New Roman, Times, Serif">Each Fund’s investment exposure to VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each Fund to regulation under the Commodity Exchange Act of 1934 (“CEA”) and Commodity Futures Trading Commission (“CFTC”) rules. The Sponsor is registered as a Commodity Pool Operator (“CPO”) and the Fund will be operated in accordance with applicable CFTC rules. Registration as a CPO imposes additional compliance obligations on the Sponsor and the Funds related to additional laws, regulations and enforcement policies, which could increase compliance costs and may affect the operations and financial performance of the Funds.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN"><span style="font-family: Times New Roman, Times, Serif">Volatility Shares LLC (the “Sponsor”) is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust’s commodity pool operator. The Funds are commodity pools, as defined under the Commodity Exchange Act (the “CEA”), and the applicable regulations of the CFTC and are operated by the Sponsor, which is registered as a commodity pool operator with the CFTC. The Trust is not an investment company registered under the Investment Company Act of 1940.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Each Fund is an investment company, as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946 “Financial Services — Investment Companies.” As such, the Funds follow the investment company accounting and reporting guidance. The following is a summary of significant accounting policies followed by each Fund, as applicable, in preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America (“GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The accompanying unaudited financial statements were prepared in accordance with GAAP for interim financial information and with the instructions for Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). In the opinion of management, all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Emerging growth company</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN"><span style="font-family: Times New Roman, Times, Serif">The Trust is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN"><span style="font-family: Times New Roman, Times, Serif">For as long as the Trust remains an “emerging growth company,” it may take advantage of certain exemptions from the various reporting requirements that are applicable to public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an “emerging growth company.”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Use of Estimates &amp; Indemnifications</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">In the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications. The Trust’s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Basis of Presentation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Pursuant to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for the purchase of Shares in that Fund.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated September 30, 2023 and December 31, 2022 and represents cash, but does not include short-term investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Final Net Asset Value for Fiscal Period</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The cut-off times and the times of the calculation of the Funds’ final net asset value for creation and redemption of fund Shares for the three months ended September 30, 2023 were typically as follows. All times are Eastern Standard Time:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="width: 57%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Create/Redeem</b></span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV<br/> Calculation</b></span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cut-off*(EST)</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Time (EST)</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Calculation <span style="font-size: 10pt">Date</span></b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF and</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2:00 p.m.</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4:00 p.m. </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30, 2023</span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2:00 p.m.</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4:00 p.m.</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30, 2023</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td><span style="font-family: Times New Roman, Times, Serif">Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended September 30, 2023.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Market value per Share is determined at the close of Cboe BZX and may be later than when the Funds’ NAV per Share is calculated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">For financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds’ final creation/redemption NAV for the three months ended September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Investment Valuation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Short-term investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations are typically categorized as Level I in the fair value hierarchy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Derivatives (e.g., futures contracts, options, swap agreements) are generally valued using independent sources and/or agreements with counterparties or other procedures as determined by the Sponsor. Futures contracts are generally valued at the last settled price on the applicable exchange on which that future trades. For financial reporting purposes, all futures contracts are generally valued at the last settled price. Futures contracts valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically categorized as Level II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as the basis for determining the market value of such position. Such fair value prices would generally be determined based on available inputs about the current value of the underlying financial instrument or commodity and would be based on principles that the Sponsor deems fair and equitable so long as such principles are consistent with industry standards. The Sponsor may fair value an asset of a Fund pursuant to the policies the Sponsor has adopted. Depending on the source and relevant significance of valuation inputs, these instruments may be classified as Level II or Level III in the fair value hierarchy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Fair value pricing may require subjective determinations about the value of an investment. While the Funds’ policies are intended to result in a calculation of its respective Fund’s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Fair Value of Financial Instruments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds’ own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Level I – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Level II – Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated inputs).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Level III – Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">In some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement in its entirety.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Fair value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances indicate that a transaction is not orderly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The following table summarizes the valuation of investments at September 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">September 30, 2023 (Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level 1 - <br/> Money <br/> Market <br/> Fund</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level 2 - <br/> Futures <br/> Contracts*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Total <br/> September 30, <br/> 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level 1 - <br/> Money <br/> Market <br/> Fund</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level 2 - <br/> Futures <br/> Contracts*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Total <br/> December 31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,673,680</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,409,592</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,264,088</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-41; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,156,106</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,156,106</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,356,501</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,140,667</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,497,168</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,250,285</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,203,522</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(953,237</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total Trust</span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,030,181</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,731,075</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,761,256</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,250,285</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,047,416</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">202,869</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td><span style="font-family: Times New Roman, Times, Serif">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Investment Transactions and Related Income</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Investment transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between periods are reflected in the Statements of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Interest income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Brokerage Commissions and Futures Account Fees</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Each Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (“NFA”) fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities for each Fund’s investment in U.S. Commodity Futures Trading Commission (“CFTC”) regulated investments. The effects of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). ). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more than 0.29% and 0.19%, for SVIX and UVIX, respectively, of each Fund’s average net assets annually.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Federal Income Tax</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Each Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund’s Shares is required to take into account its allocable share of its Fund’s income, gain, loss, deductions and other items for its Fund’s taxable year ending with or within the beneficial owner’s taxable year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Management of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Emerging growth company</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN"><span style="font-family: Times New Roman, Times, Serif">The Trust is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN"><span style="font-family: Times New Roman, Times, Serif">For as long as the Trust remains an “emerging growth company,” it may take advantage of certain exemptions from the various reporting requirements that are applicable to public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an “emerging growth company.”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5IN"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 1070000000.00 1000000000 700000000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Use of Estimates &amp; Indemnifications</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">In the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications. The Trust’s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Basis of Presentation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Pursuant to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for the purchase of Shares in that Fund.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated September 30, 2023 and December 31, 2022 and represents cash, but does not include short-term investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Final Net Asset Value for Fiscal Period</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The cut-off times and the times of the calculation of the Funds’ final net asset value for creation and redemption of fund Shares for the three months ended September 30, 2023 were typically as follows. All times are Eastern Standard Time:</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="width: 57%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Create/Redeem</b></span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV<br/> Calculation</b></span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cut-off*(EST)</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Time (EST)</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Calculation <span style="font-size: 10pt">Date</span></b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF and</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2:00 p.m.</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4:00 p.m. </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30, 2023</span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2:00 p.m.</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4:00 p.m.</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30, 2023</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td><span style="font-family: Times New Roman, Times, Serif">Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended September 30, 2023.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Market value per Share is determined at the close of Cboe BZX and may be later than when the Funds’ NAV per Share is calculated.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">For financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds’ final creation/redemption NAV for the three months ended September 30, 2023.</span></p> <span style="font-family: Times New Roman, Times, Serif">The cut-off times and the times of the calculation of the Funds’ final net asset value for creation and redemption of fund Shares for the three months ended September 30, 2023 were typically as follows. All times are Eastern Standard Time:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="width: 57%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Create/Redeem</b></span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV<br/> Calculation</b></span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cut-off*(EST)</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Time (EST)</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Calculation <span style="font-size: 10pt">Date</span></b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF and</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2:00 p.m.</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4:00 p.m. </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30, 2023</span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2:00 p.m.</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4:00 p.m.</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30, 2023</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td><span style="font-family: Times New Roman, Times, Serif">Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended September 30, 2023.</span></td></tr></table> 2:00 p.m. 4:00 p.m. 2023-09-30 2:00 p.m. 4:00 p.m. 2023-09-30 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Investment Valuation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Short-term investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations are typically categorized as Level I in the fair value hierarchy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Derivatives (e.g., futures contracts, options, swap agreements) are generally valued using independent sources and/or agreements with counterparties or other procedures as determined by the Sponsor. Futures contracts are generally valued at the last settled price on the applicable exchange on which that future trades. For financial reporting purposes, all futures contracts are generally valued at the last settled price. Futures contracts valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically categorized as Level II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as the basis for determining the market value of such position. Such fair value prices would generally be determined based on available inputs about the current value of the underlying financial instrument or commodity and would be based on principles that the Sponsor deems fair and equitable so long as such principles are consistent with industry standards. The Sponsor may fair value an asset of a Fund pursuant to the policies the Sponsor has adopted. Depending on the source and relevant significance of valuation inputs, these instruments may be classified as Level II or Level III in the fair value hierarchy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Fair value pricing may require subjective determinations about the value of an investment. While the Funds’ policies are intended to result in a calculation of its respective Fund’s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Fair Value of Financial Instruments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds’ own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Level I – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Level II – Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated inputs).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Level III – Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">In some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement in its entirety.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Fair value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances indicate that a transaction is not orderly.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The following table summarizes the valuation of investments at September 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">September 30, 2023 (Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level 1 - <br/> Money <br/> Market <br/> Fund</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level 2 - <br/> Futures <br/> Contracts*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Total <br/> September 30, <br/> 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level 1 - <br/> Money <br/> Market <br/> Fund</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level 2 - <br/> Futures <br/> Contracts*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Total <br/> December 31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,673,680</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,409,592</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,264,088</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-41; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,156,106</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,156,106</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,356,501</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,140,667</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,497,168</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,250,285</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,203,522</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(953,237</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total Trust</span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,030,181</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,731,075</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,761,256</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,250,285</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,047,416</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">202,869</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td><span style="font-family: Times New Roman, Times, Serif">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.</span></p> <span style="font-family: Times New Roman, Times, Serif">The following table summarizes the valuation of investments at September 30, 2023 (unaudited) and December 31, 2022 using the fair value hierarchy:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">September 30, 2023 (Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level 1 - <br/> Money <br/> Market <br/> Fund</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level 2 - <br/> Futures <br/> Contracts*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Total <br/> September 30, <br/> 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level 1 - <br/> Money <br/> Market <br/> Fund</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level 2 - <br/> Futures <br/> Contracts*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Total <br/> December 31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,673,680</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,409,592</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,264,088</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-41; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,156,106</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,156,106</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,356,501</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,140,667</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,497,168</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,250,285</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,203,522</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(953,237</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total Trust</span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,030,181</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,731,075</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,761,256</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,250,285</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,047,416</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">202,869</span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td><span style="font-family: Times New Roman, Times, Serif">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</span></td></tr></table> 7673680 -6409592 1264088 1156106 1156106 24356501 11140667 35497168 8250285 -9203522 -953237 32030181 4731075 36761256 8250285 -8047416 202869 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Investment Transactions and Related Income</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Investment transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between periods are reflected in the Statements of Operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Interest income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Brokerage Commissions and Futures Account Fees</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Each Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (“NFA”) fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities for each Fund’s investment in U.S. Commodity Futures Trading Commission (“CFTC”) regulated investments. The effects of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). ). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more than 0.29% and 0.19%, for SVIX and UVIX, respectively, of each Fund’s average net assets annually.</span></p> 0.0029 0.0019 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Federal Income Tax</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Each Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund’s Shares is required to take into account its allocable share of its Fund’s income, gain, loss, deductions and other items for its Fund’s taxable year ending with or within the beneficial owner’s taxable year.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Management of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 3 – INVESTMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Short-Term Investments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds may purchase U.S. Treasury Bills, agency securities, and other high-credit quality short-term fixed income or similar securities with original maturities of one year or less. A portion of these investments may be posted as collateral in connection with swap agreements, futures, and/or forward contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Accounting for Derivative Instruments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">In seeking to achieve each Fund’s investment objective, the Sponsor uses a mathematical approach to investing. Using this approach, the Sponsor determines the type, quantity and mix of investment positions, including derivative positions, which the Sponsor believes in combination, should produce returns consistent with a Fund’s objective.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">All open derivative positions at period end are reflected on each respective Fund’s Schedule of Investments. Certain Funds utilized a varying level of derivative instruments in conjunction with investment securities in seeking to meet their investment objectives during the period. While the volume of open positions may vary on a daily basis as each Fund transacts derivatives contracts in order to achieve the appropriate exposure to meet its investment objective, the volume of these open positions relative to the net assets of each respective Fund at the date of this report is generally representative of open positions throughout the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Following is a description of the derivative instruments used by the Funds during the reporting period, including the primary underlying risk exposures related to each instrument type.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Futures Contracts</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds may enter into futures contracts to gain exposure to changes in the value of, or as a substitute for investing directly in (or shorting), an underlying benchmark. A futures contract obligates the seller to deliver (and the purchaser to accept) the future delivery of a specified quantity and type of asset at a specified time and place. The contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the underlying commodity, if applicable, or by making an offsetting sale or purchase of an identical futures contract on the same or linked exchange before the designated date of delivery, or by cash settlement at expiration of contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Upon entering into a futures contract, each Fund is required to deposit and maintain as collateral at least such initial margin as required by the exchange on which the transaction is affected. The initial margin is segregated as cash and/or securities balances with brokers for futures contracts, as disclosed in the Statements of Financial Condition, and is restricted as to its use. The Funds that enter into futures contracts maintain collateral at the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund generally agrees to receive from or pay to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract. Such receipts or payments are known as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize a gain or loss upon closing of a futures transaction.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Futures contracts involve, to varying degrees, elements of market risk (specifically exchange rate sensitivity, commodity price risk or equity market volatility risk) and exposure to loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure each Fund has in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation between movements in the price of the futures contracts and the market value of the underlying Index or commodity and the possibility of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the Funds since futures contracts are exchange-traded and the credit risk resides with the Funds’ clearing broker or clearinghouse itself. Many futures exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund will be required to make daily cash payments of variation margin. The risk the Fund will be unable to close out a futures position will be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Option Contracts</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">An option is a contract that gives the buyer the right, but not the obligation, to buy or sell a specified quantity of a commodity or other instrument at a specific (or strike) price within a specified period of time, regardless of the market price of that instrument. There are two types of options: calls and puts. A call option conveys to the option buyer the right to purchase a particular futures contract at a stated price at any time during the life of the option. A put option conveys to the option buyer the right to sell a particular futures contract at a stated price at any time during the life of the option. Options written by a Fund may be wholly or partially covered (meaning that the Fund holds an offsetting position) or uncovered. In the case of the purchase of an option, the risk of loss of an investor’s entire investment (i.e., the premium paid plus transaction charges) reflects the nature of an option as a wasting asset that may become worthless when the option expires. Where an option is written or granted (i.e., sold) uncovered, the seller may be liable to pay substantial additional margin, and the risk of loss is unlimited, as the seller will be obligated to deliver, or take delivery of, an asset at a predetermined price which may, upon exercise of the option, be significantly different from the market value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">When a Fund writes a call or put, an amount equal to the premium received is recorded and subsequently marked to market to reflect the current value of the option written. Premiums received from writing options which expire are treated as realized gains. Premiums received from writing options which are exercised or closed are added to the proceeds or offset against amounts paid on the underlying futures, swap or security transaction to determine the realized gain (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">When a Fund purchases an option, the Fund pays a premium which is included as an asset on the Statement of Financial Condition and subsequently marked to market to reflect the current value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk associated with purchasing put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised or closed are added to the amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized gain (loss) when the underlying transaction is executed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Certain options transactions may subject the writer (seller) to unlimited risk of loss in the event of an increase in the price of the contract to be purchased or delivered. The value of a Fund’s options transactions, if any, will be affected by, among other things, changes in the value of a Fund’s underlying benchmark relative to the strike price, changes in interest rates, changes in the actual and implied volatility of the Fund’s underlying benchmark, and the remaining time until the options expire, or any combination thereof. The value of the options should not be expected to increase or decrease at the same rate as the level of the Fund’s underlying benchmark, which may contribute to tracking error. Options may be less liquid than certain other securities. A Fund’s ability to trade options will be dependent on the willingness of counterparties to trade such options with the Fund. In a less liquid market for options, a Fund may have difficulty closing out certain option positions at desired times and prices. A Fund may experience substantial downside from specific option positions and certain option positions may expire worthless. Over-the-counter options generally are not assignable except by agreement between the parties concerned, and no party or purchaser has any obligation to permit such assignments. The over-the-counter market for options is relatively illiquid, particularly for relatively small transactions. The use of options transactions exposes a Fund to liquidity risk and counterparty credit risk, and in certain circumstances may expose the Fund to unlimited risk of loss. The Funds may buy and sell options on futures contracts, which may present even greater volatility and risk of loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Swap Agreements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds may enter into swap agreements for purposes of pursuing their investment objectives or as a substitute for investing directly in (or shorting) an underlying Index or to create an economic hedge against a position. Swap agreements are two-party contracts that have traditionally been entered into primarily with institutional investors in over-the-counter (“OTC”) markets for a specified period, ranging from a day to more than one year. However, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) provides for significant reforms of the OTC derivative markets, including a requirement to execute certain swap transactions on a CFTC-regulated market and/or to clear such transactions through a CFTC-regulated central clearing organization. In a standard swap transaction, two parties agree to exchange the returns earned or realized on a particular predetermined investment, instrument or Index in exchange for a fixed or floating rate of return in respect of a predetermined notional amount. Transaction or commission costs are reflected in the benchmark level at which the transaction is entered into. The gross returns to be exchanged are calculated with respect to a notional amount and the benchmark returns to which the swap is linked. Swap agreements do not involve the delivery of underlying instruments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Generally, swap agreements entered into by the Funds calculate and settle the obligations of the parties to the agreement on a “net basis” with a single payment. Consequently, each Fund’s current obligations (or rights) under a swap agreement will generally be equal only to the net amount to be paid or received under the agreement based on the relative values of such obligations (or rights) (the “net amount”). In a typical swap agreement entered into by UVIX, the would be entitled to settlement payments in the event the level of the benchmark increases and would be required to make payments to the swap counterparties in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount the Funds may pay. In a typical swap agreement entered into by SVIX, the Fund would be required to make payments to the swap counterparties in the event the level of the benchmark increases and would be entitled to settlement payments in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount the Funds may pay.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The net amount of the excess, if any, of each Fund’s obligations over its entitlements with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the counterparty in a segregated account by the Funds’ Custodian. The net amount of the excess, if any, of each Fund’s entitlements over its obligations with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the Fund in a segregated account by a third party custodian. Until a swap agreement is settled in cash, the gain or loss on the notional amount less any transaction costs or trading spreads payable by each Fund on the notional amount are recorded as “unrealized appreciation or depreciation on swap agreements” and, when cash is exchanged, the gain or loss realized is recorded as “realized gains or losses on swap agreements.” Swap agreements are generally valued at the last settled price of the benchmark referenced asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Swap agreements contain various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net positions owed to the party under the agreement. This could cause a Fund to have to enter into a new transaction with the same counterparty, enter into a transaction with a different counterparty or seek to achieve its investment objective through any number of different investments or investment techniques.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Swap agreements involve, to varying degrees, elements of market risk and exposure to loss in excess of the unrealized gain/loss reflected. The notional amounts reflect the extent of the total investment exposure each Fund has under the swap agreement, which may exceed the NAV of each Fund. Additional risks associated with the use of swap agreements are imperfect correlations between movements in the notional amount and the price of the underlying reference Index and the inability of counterparties to perform. Each Fund bears the risk of loss of the amount expected to be received under a swap agreement in the event of the default or bankruptcy of a swap agreement counterparty. A Fund will typically enter into swap agreements only with major global financial institutions. The creditworthiness of each of the firms that is a party to a swap agreement is monitored by the Sponsor. The Sponsor may use various techniques to minimize credit risk including early termination and payment, using different counterparties, limiting the net amount due from any individual counterparty and generally requiring collateral to be posted by the counterparty in an amount approximately equal to that owed to the Funds. Outstanding swap agreements contractually terminate within one month but may be terminated without penalty by either party at any time. Upon termination, the Fund is obligated to pay or receive the “unrealized appreciation or depreciation” amount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds, as applicable, collateralize swap agreements by segregating or designating cash and/or certain securities as indicated on the Statements of Financial Condition or Schedules of Investments. As noted above, collateral posted in connection with OTC derivative transactions is held for the benefit of the counterparty in a segregated tri-party account at the Custodian to protect the counterparty against non-payment by the Funds. The collateral held in this account is restricted as to its use. In the event of a default by the counterparty, the Funds will seek withdrawal of this collateral from the segregated account and may incur certain costs in exercising its right with respect to the collateral. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, the Funds may experience significant delays in obtaining any recovery in a bankruptcy or other reorganizational proceeding. The Funds may obtain only limited recovery or may obtain no recovery in such circumstances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds remain subject to credit risk with respect to the amount they expect to receive from counterparties. However, the Funds have sought to mitigate these risks in connection with OTC swaps by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily, in an amount approximately equal to what the counterparty owes the Fund, subject to certain minimum thresholds. In the event of a bankruptcy of a counterparty, such Fund will have direct access to the collateral received from the counterparty, generally as of the day prior to the bankruptcy, because there is a one day time lag between the Fund’s request for collateral and the delivery of such collateral. To the extent any such collateral is insufficient, the Funds will be exposed to counterparty risk as described above, including the possible delays in recovering amounts as a result of bankruptcy proceedings.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The counterparty/credit risk for cleared derivative transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted for each counterparty to a cleared derivative contract and, in effect, guarantees the parties’ performance under the contract as each party to a trade looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="14" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Values of Derivative Instruments as of September 30, 2023 (Unaudited)</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset Derivatives</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability Derivatives</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/> Accounted for as <br/> Hedging Instruments</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/> Financial <br/> Condition Location</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Appreciation*</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/> Financial <br/> Condition Location</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Depreciation*</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr> <td style="white-space: nowrap; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; width: 11%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: hidden-fact-42; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: hidden-fact-43; font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,409,592) </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,140,667</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-44">-</span> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust </b></span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="white-space: nowrap; border-bottom: black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-45; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11,140,667</b></span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="white-space: nowrap; border-bottom: black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-46; font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,409,592</span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="14" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Values of Derivative Instruments as of December 31, 2022</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset Derivatives</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability Derivatives</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/> Accounted for as <br/> Hedging Instruments</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/> Financial <br/> Condition Location</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Appreciation*</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/> Financial <br/> Condition Location</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Depreciation*</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr> <td style="white-space: nowrap; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; width: 11%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: hidden-fact-47; font-family: Times New Roman, Times, Serif; font-size: 10pt">1,156,106 </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: hidden-fact-48; font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-49">-</span> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,203,522</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust </b></span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="white-space: nowrap; border-bottom: black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-50; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,156,106 </b></span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="white-space: nowrap; border-bottom: black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-51; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>  (9,203,522</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0%"></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="20" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>The Effect of Derivative Instruments on the Statement of Operations</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td colspan="20" style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the Three Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited)</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/> Accounted for as Hedging Instruments</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Location of Gain (Loss) on Derivatives Recognized in Income</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Realized Gain <br/> (Loss) on <br/> Derivatives Recognized <br/> in Income <br/> September 30, <br/> 2023</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in <br/> Unrealized <br/> Appreciation <br/> (Depreciation) <br/> on Derivatives <br/> Recognized <br/> in Income <br/> September 30, <br/> 2023*</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Realized Gain<br/> (Loss) on <br/> Derivatives <br/> Recognized <br/> in Income <br/> September 30, <br/> 2022</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in <br/> Unrealized <br/> Appreciation <br/> (Depreciation) <br/> on Derivatives <br/> Recognized <br/> in Income <br/> Sepetember 30, <br/> 2022*</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 11%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,738,591</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,928,171</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,077,788</span></td> <td style="width: 1%"></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,278,300</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(42,049,000</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,931,703</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(22,686,413</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,574,735</span></td> <td style="padding-bottom: 1.5pt"></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(26,310,409</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18,003,532</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>(14,608,625</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,296,435</span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="20" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>The Effect of Derivative Instruments on the Statement of Operations</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td colspan="20" style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the Nine Months Ended September 30, 2023 (Unaudited) and September 30, 2022^ (Unaudited)</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/> Accounted for as Hedging Instruments</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Location of Gain (Loss) on Derivatives Recognized in Income</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Realized Gain <br/> (Loss) on <br/> Derivatives <br/> Recognized <br/> in Income<br/> September 30, <br/> 2023</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in <br/> Unrealized <br/> Appreciation <br/> (Depreciation) <br/> on Derivatives <br/> Recognized in <br/> Income <br/> September 30, <br/> 2023*</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Realized Gain<br/> (Loss) on <br/> Derivatives <br/> Recognized <br/> in Income <br/> September 30, <br/> 2022</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in <br/> Unrealized <br/> Appreciation <br/> (Depreciation) <br/> on Derivatives <br/> Recognized<br/> in Income <br/> September 30, <br/> 2022*</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 11%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">58,190,096 </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,565,698</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,500,659</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,577,769</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(228,151,397</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,344,189</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,158,418</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,593,993</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(169,961,301</span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12,778,491</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(11,657,759</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15,016,224</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Offsetting Assets and Liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Each Fund is subject to master netting agreements or similar arrangements that allow for amounts owed between each Fund and the counterparty to be netted upon an early termination. The party that has the larger payable pays the excess of the larger amount over the smaller amount to the other party. The master netting agreements or similar arrangements do not apply to amounts owed to/from different counterparties. As described above, the Funds utilize derivative instruments to achieve their investment objective during the year. The amounts shown in the Statements of Financial Condition do not take into consideration the effects of legally enforceable master netting agreements or similar arrangements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund’s derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related collateral received or pledged by the Funds as of September 30, 2023 and December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="24" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Fair Values of Derivative Instruments as of September 30, 2023 (Unaudited)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts of<br/> Recognized<br/> Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Amounts<br/> of Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts of<br/> Recognized<br/> Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Amounts<br/> of Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-52; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-53; font-family: Times New Roman, Times, Serif">          -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-54; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,327,607</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-55; font-family: Times New Roman, Times, Serif">          -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,327,607</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,945,302</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-56; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,945,302</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-57; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-58; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="24" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Fair Values of Derivative Instruments as of December 31, 2022</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts of<br/> Recognized<br/> Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Amounts<br/> of Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts of<br/> Recognized<br/> Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Amounts<br/> of Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-59; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-60; font-family: Times New Roman, Times, Serif">          -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">187,030</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-61; font-family: Times New Roman, Times, Serif">             -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">187,030</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">830,840</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-62; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">830,840</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Asset (Liability) amounts shown in the table below represent amounts owed to (by) the Funds for the derivative-related investments at September 30, 2023 and December 31, 2022. These amounts may be collateralized by cash or financial instruments, segregated for the benefit of the Funds or the counterparties, depending on whether the related contracts are in an appreciated or depreciated position at period end. Amounts shown in the column labeled “Net Amount” represent the uncollateralized portions of these amounts at period end. These amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement, as further described above under the caption “Accounting for Derivative Instruments”.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; background-color: white"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="16" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Gross Amounts Not Offset in the Statements of Financial Condition as of September 30, 2023 (Unaudited)</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Financial<br/> Instruments<br/> for the Benefit<br/> of (the Funds) / the<br/> Counterparties</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Cash<br/> Collateral for<br/> the Benefit of<br/> (the Funds) / the<br/> Counterparties</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Amount</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,327,607</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-66; font-family: Times New Roman, Times, Serif">          -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-67; font-family: Times New Roman, Times, Serif">         -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,327,607</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,945,302</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-69; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,945,302</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="16" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Financial<br/> Instruments<br/> for the Benefit<br/> of (the Funds) / the<br/> Counterparties</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Cash<br/> Collateral for<br/> the Benefit of<br/> (the Funds) / the<br/> Counterparties</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Amount</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(187,030</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">          -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">         -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(187,030</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">830,840</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">830,840</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> the contract as each party to a trade looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="14" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Values of Derivative Instruments as of September 30, 2023 (Unaudited)</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset Derivatives</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability Derivatives</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/> Accounted for as <br/> Hedging Instruments</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/> Financial <br/> Condition Location</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Appreciation*</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/> Financial <br/> Condition Location</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Depreciation*</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr> <td style="white-space: nowrap; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; width: 11%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: hidden-fact-42; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: hidden-fact-43; font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,409,592) </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,140,667</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-44">-</span> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust </b></span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="white-space: nowrap; border-bottom: black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-45; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11,140,667</b></span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="white-space: nowrap; border-bottom: black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-46; font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,409,592</span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="14" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Values of Derivative Instruments as of December 31, 2022</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset Derivatives</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="4" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability Derivatives</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/> Accounted for as <br/> Hedging Instruments</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/> Financial <br/> Condition Location</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Appreciation*</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of <br/> Financial <br/> Condition Location</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized <br/> Depreciation*</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr> <td style="white-space: nowrap; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; width: 11%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: hidden-fact-47; font-family: Times New Roman, Times, Serif; font-size: 10pt">1,156,106 </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: hidden-fact-48; font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-49">-</span> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,203,522</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust </b></span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="white-space: nowrap; border-bottom: black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-50; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,156,106 </b></span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="white-space: nowrap; border-bottom: black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-51; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>  (9,203,522</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> 11,140,667 (9,203,522) <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="20" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>The Effect of Derivative Instruments on the Statement of Operations</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td colspan="20" style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the Three Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited)</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/> Accounted for as Hedging Instruments</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Location of Gain (Loss) on Derivatives Recognized in Income</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Realized Gain <br/> (Loss) on <br/> Derivatives Recognized <br/> in Income <br/> September 30, <br/> 2023</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in <br/> Unrealized <br/> Appreciation <br/> (Depreciation) <br/> on Derivatives <br/> Recognized <br/> in Income <br/> September 30, <br/> 2023*</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Realized Gain<br/> (Loss) on <br/> Derivatives <br/> Recognized <br/> in Income <br/> September 30, <br/> 2022</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in <br/> Unrealized <br/> Appreciation <br/> (Depreciation) <br/> on Derivatives <br/> Recognized <br/> in Income <br/> Sepetember 30, <br/> 2022*</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 11%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,738,591</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,928,171</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,077,788</span></td> <td style="width: 1%"></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,278,300</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(42,049,000</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,931,703</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(22,686,413</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,574,735</span></td> <td style="padding-bottom: 1.5pt"></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(26,310,409</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18,003,532</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>(14,608,625</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,296,435</span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="20" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>The Effect of Derivative Instruments on the Statement of Operations</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td colspan="20" style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the Nine Months Ended September 30, 2023 (Unaudited) and September 30, 2022^ (Unaudited)</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives Not <br/> Accounted for as Hedging Instruments</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Location of Gain (Loss) on Derivatives Recognized in Income</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Realized Gain <br/> (Loss) on <br/> Derivatives <br/> Recognized <br/> in Income<br/> September 30, <br/> 2023</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in <br/> Unrealized <br/> Appreciation <br/> (Depreciation) <br/> on Derivatives <br/> Recognized in <br/> Income <br/> September 30, <br/> 2023*</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Realized Gain<br/> (Loss) on <br/> Derivatives <br/> Recognized <br/> in Income <br/> September 30, <br/> 2022</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in <br/> Unrealized <br/> Appreciation <br/> (Depreciation) <br/> on Derivatives <br/> Recognized<br/> in Income <br/> September 30, <br/> 2022*</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 11%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="white-space: nowrap; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">58,190,096 </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,565,698</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,500,659</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,577,769</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(228,151,397</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,344,189</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,158,418</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,593,993</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Trust</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(169,961,301</span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12,778,491</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(11,657,759</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15,016,224</b></span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 15738591 -12928171 8077788 -6278300 -42049000 30931703 -22686413 20574735 -26310409 18003532 -14608625 14296435 58190096 -7565698 3500659 -5577769 -228151397 20344189 -15158418 20593993 -169961301 12778491 -11657759 15016224 <span style="font-family: Times New Roman, Times, Serif">For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund’s derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related collateral received or pledged by the Funds as of September 30, 2023 and December 31, 2022.</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="24" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Fair Values of Derivative Instruments as of September 30, 2023 (Unaudited)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts of<br/> Recognized<br/> Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Amounts<br/> of Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts of<br/> Recognized<br/> Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Amounts<br/> of Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-52; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-53; font-family: Times New Roman, Times, Serif">          -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-54; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,327,607</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-55; font-family: Times New Roman, Times, Serif">          -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,327,607</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,945,302</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-56; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,945,302</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-57; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-58; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="24" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Fair Values of Derivative Instruments as of December 31, 2022</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts of<br/> Recognized<br/> Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Amounts<br/> of Assets<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts of<br/> Recognized<br/> Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gross<br/> Amounts<br/> Offset<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Amounts<br/> of Liabilities<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-59; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-60; font-family: Times New Roman, Times, Serif">          -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">187,030</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-61; font-family: Times New Roman, Times, Serif">             -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">187,030</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">830,840</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-62; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">830,840</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 1327607 1327607 1945302 1945302 187030 187030 830840 830840 These amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement, as further described above under the caption “Accounting for Derivative Instruments”.<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="16" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Gross Amounts Not Offset in the Statements of Financial Condition as of September 30, 2023 (Unaudited)</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Financial<br/> Instruments<br/> for the Benefit<br/> of (the Funds) / the<br/> Counterparties</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Cash<br/> Collateral for<br/> the Benefit of<br/> (the Funds) / the<br/> Counterparties</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Amount</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,327,607</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-66; font-family: Times New Roman, Times, Serif">          -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-67; font-family: Times New Roman, Times, Serif">         -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,327,607</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,945,302</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-69; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,945,302</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="16" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements<br/> of Financial<br/> Condition</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Financial<br/> Instruments<br/> for the Benefit<br/> of (the Funds) / the<br/> Counterparties</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Cash<br/> Collateral for<br/> the Benefit of<br/> (the Funds) / the<br/> Counterparties</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Amount</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(187,030</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">          -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">         -</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(187,030</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">830,840</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">830,840</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> -1327607 -1327607 1945302 1945302 -187030 -187030 830840 830840 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 4 – AGREEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">SVIX pays the Sponsor a management fee (the “Management Fee”), monthly in arrears, in an amount equal to <b>1.35</b>% per annum of its average daily net assets. UVIX pays the Sponsor a Management Fee, monthly in arrears, in an amount equal to <b>1.65</b>% per annum of its average daily net assets. “Average daily net assets” is calculated by dividing the month-end net assets of each Fund by the number of calendar days in such month.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">No other Management Fee is paid by the Funds. The Management Fee is paid in consideration of the Sponsor’s trading advisory services and the other services provided to the Fund that the Sponsor pays directly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Pursuant to the Sponsor Agreement between Sponsor and the Trust, on behalf of the Funds, the Sponsor oversees and pays Penserra Capital Management, LLC. (“Commodity Sub-Adviser”) for its services as Commodity Sub-Adviser. The Commodity Sub-Adviser is paid by the Sponsor an annual sub-advisory fee of 0.20% based on each Fund’s average daily net assets (total assets of the Fund, minus the sum of its accrued liabilities). The Funds do not directly pay the Commodity Sub-Adviser.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Non-Recurring Fees and Expenses</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Each Fund pays all its non-recurring and unusual fees and expenses, if any, as determined by the Sponsor. Non-recurring and unusual fees and expenses are fees and expenses that are unexpected or unusual in nature, such as legal claims and liabilities, litigation costs or indemnification or other material expenses which are not currently anticipated obligations of the Funds.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>The Administrator, Transfer Agent and Custodian</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services (“Fund Services”), an indirect subsidiary of U.S. Bancorp, serves as the Fund’s fund accountant, administrator and transfer agent pursuant to certain fund accounting servicing, fund administration servicing and transfer agent servicing agreements. U.S. Bank National Association, a subsidiary of U.S. Bancorp and parent company of Fund Services, intends to serve as the Fund’s custodian pursuant to a custody agreement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>The Marketing Agent</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Foreside Fund Services, LLC (the “Marketing Agent”) serves as the Marketing Agent of the Funds. Its principal duties are: (i) to work with the Transfer Agent to review and approve orders placed by Authorized Participants and transmitted to the Transfer Agent; (ii) maintain copies of confirmations of Creation Unit creation and redemption order acceptances; (iii) maintain telephonic, facsimile and/or access to direct computer communications links with the Transfer Agent; and (iv) review and approve, prior to use, all Trust marketing materials for compliance with applicable SEC and FINRA advertising rules.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The Marketing Agent retains all marketing materials separately for the Funds, at their offices located at Three Canal Plaza, Suite 100 Portland, Maine 04101.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">As compensation for the services it provides, the Marketing Agent receives a fee from the Funds.</span></p> 0.0135 0.0165 0.002 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 5 – OFFERING COSTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Offering costs will be amortized by the Funds over a twelve month period on a straight-line basis beginning once the fund commences operations. The Sponsor will not charge its Management Fee in the first year of operations of a Fund in an amount equal to the offering costs. Normal and expected expenses incurred in connection with the continuous offering of Shares of a Fund after the commencement of its trading operations will be paid by the Sponsor.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 6 – CREATION AND REDEMPTION OF CREATION UNITS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Each Fund issues and redeems shares from time to time, but only in one or more Creation Units. A Creation Unit is a block of at least 10,000 Shares of a Fund. Creation Units may be created or redeemed only by Authorized Participants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Except when aggregated in Creation Units, the Shares are not redeemable securities. Retail investors, therefore, generally will not be able to purchase or redeem Shares directly from or with a Fund. Rather, most retail investors will purchase or sell Shares in the secondary market with the assistance of a broker. Thus, some of the information contained in these Notes to Financial Statements—such as references to the Transaction Fees imposed on purchases and redemptions is not relevant to retail investors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Transaction Fees on Creation and Redemption Transactions</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The manner by which Creation Units are purchased or redeemed is governed by the terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook. By placing a purchase order, an Authorized Participant agrees to: (1) deposit cash with the Custodian; and (2) if permitted by the Sponsor in its sole discretion, enter into or arrange for an exchange of futures contract for related position or block trade with the relevant fund whereby the Authorized Participant would also transfer to such Fund a number and type of exchange-traded futures contracts at or near the closing settlement price for such contracts on the purchase order date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Authorized Participants may pay a fee up to 0.20% of the value of each order they place with each order to create or redeem a Creation Unit in order to compensate the Administrator, the Custodian and the Transfer Agent of each Fund and its Shares, for services in processing the creation and redemption of Creation Units and to offset the costs of increasing or decreasing derivative positions, unless the transaction fee is waived or otherwise adjusted by the Sponsor. The Sponsor provides such Authorized Participant with prompt notice in advance of any such waiver or adjustment of the transaction fee. Authorized Participants may sell the Shares included in the Creation Units they purchase from the Funds to other investors in the secondary market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Transaction fees for the three months ended September 30, 2023 and September 30, 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three<br/> Months <br/> Ended <br/> September 30, <br/> 2023 <br/> (Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three <br/> Months <br/> Ended <br/> September 30, <br/> 2022 <br/> (Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,396</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,124</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,484</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">78,086</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total Trust</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">80,880</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">98,210</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Transaction fees for the nine months ended September 30, 2023 and September 30, 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine Months <br/> Ended <br/> September 30, <br/> 2023 <br/> (Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Period <br/> Ended <br/> September 30, <br/> 2022^ <br/> (Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">107,878</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83,994</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">170,097</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">124,991</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total Trust</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">277,975</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">208,985</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">^</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Fund commenced operations on March 28, 2022.</span></td> </tr></table> 10000 0.002 <span style="font-family: Times New Roman, Times, Serif">Transaction fees for the three months ended September 30, 2023 and September 30, 2022 were as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three<br/> Months <br/> Ended <br/> September 30, <br/> 2023 <br/> (Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three <br/> Months <br/> Ended <br/> September 30, <br/> 2022 <br/> (Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,396</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,124</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,484</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">78,086</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total Trust</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">80,880</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">98,210</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Fund</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine Months <br/> Ended <br/> September 30, <br/> 2023 <br/> (Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Period <br/> Ended <br/> September 30, <br/> 2022^ <br/> (Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">107,878</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83,994</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">170,097</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">124,991</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total Trust</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">277,975</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">208,985</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">^</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Fund commenced operations on March 28, 2022.</span></td> </tr></table> 30396 20124 50484 78086 80880 98210 107878 83994 170097 124991 277975 208985 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 7 – FINANCIAL HIGHLIGHTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Selected data is for a Share outstanding throughout the Three Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quarter Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quarter Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quarter Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quarter Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30, <br/> 2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30, <br/> 2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30, <br/> 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30, <br/> 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Asset Value, Beginning of Period</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28.13</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.44</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.40</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85.60</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.11</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.01</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.06</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2.38</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.96</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.00</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13.87</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Increase (Decrease) in Net Asset Value Resulting from Operations</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.10</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.97</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.06</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(16.25</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Asset Value, End of Period</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28.03</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.47</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.34</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">69.35</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Market Value Per Share, at September 30, 2023 and September 30, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27.88</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.49</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.52</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67.00</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-0.36</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-21.85</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-0.58</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-18.97</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-0.68</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-21.75</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-0.87</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-18.21</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.89</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.21</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.34</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.35</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Investment Loss</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.49</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.04</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-2.06</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.93</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(1)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(2)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(3)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(4)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Percentages are not annualized for the period ended September 30, 2023 and September 30, 2022</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(5)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Percentages are annualized.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(6)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">The expense ratio would be 1.89% and 2.21% respectively, for the three months ended September 30, 2023, and 2.23% and 2.27% for the three months ended September 30, 2022 if brokerage commissions and futures and futures account fees were excluded.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Selected data is for a Share outstanding throughout the Nine Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; background-color: white"> </span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine Months<br/> Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine Months<br/> Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the<br/> Period Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the<br/> Period Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30,<br/> 2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30,<br/> 2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, <br/> 2022<sup>^</sup></b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, <br/> 2022<sup>^</sup></b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Asset Value, Beginning of Period</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14.63</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29.25</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15.00</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75.00</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.27</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.07</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.12</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.60</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13.67</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25.71</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4.54</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5.05</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Increase (Decrease) in Net Asset Value Resulting from Operations</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13.40</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25.78</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4.66</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5.65</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Asset Value, End of Period</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28.03</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.47</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.34</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">69.35</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Market Value Per Share, at September 30, 2023 and September 30, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27.88</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.49</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.52</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67.00</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">91.59</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-88.14</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-31.07</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right">-7.53</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">90.18</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-88.01</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right">-29.87</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right">-10.67</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.34</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Investment Loss</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.69</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.26</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-2.06</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.93</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">^</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Fund commenced operations on March 28, 2022.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Percentages are not annualized for the periods ended September 30, 2023 and September 30, 2022</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(5)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Percentages are annualized.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(6)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The expense ratio would be 2.08% and 2.15% respectively, for the nine months ended September 30, 2023, and 2.23% and 2.27% for the period ended September 30, 2022, if brokerage commissions and futures and futures account fees were excluded.</span></td> </tr></table> <span style="font-family: Times New Roman, Times, Serif; background-color: white">Selected data is for a Share outstanding throughout the Three Months Ended September 30, 2023 (Unaudited) and September 30, 2022 (Unaudited):</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quarter Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quarter Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quarter Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quarter Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30, <br/> 2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30, <br/> 2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30, <br/> 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30, <br/> 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Asset Value, Beginning of Period</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28.13</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.44</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.40</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85.60</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.11</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.01</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.06</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2.38</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.96</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.00</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13.87</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Increase (Decrease) in Net Asset Value Resulting from Operations</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.10</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.97</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.06</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(16.25</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Asset Value, End of Period</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28.03</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.47</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.34</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">69.35</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Market Value Per Share, at September 30, 2023 and September 30, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27.88</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.49</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.52</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67.00</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-0.36</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-21.85</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-0.58</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-18.97</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-0.68</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-21.75</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-0.87</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-18.21</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.89</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.21</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.34</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.35</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Investment Loss</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.49</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.04</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-2.06</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.93</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(1)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(2)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(3)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(4)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Percentages are not annualized for the period ended September 30, 2023 and September 30, 2022</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(5)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Percentages are annualized.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(6)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">The expense ratio would be 1.89% and 2.21% respectively, for the three months ended September 30, 2023, and 2.23% and 2.27% for the three months ended September 30, 2022 if brokerage commissions and futures and futures account fees were excluded.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">-1x Short VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2x Long VIX Futures ETF</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine Months<br/> Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine Months<br/> Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the<br/> Period Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the<br/> Period Ended</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30,<br/> 2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30,<br/> 2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, <br/> 2022<sup>^</sup></b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, <br/> 2022<sup>^</sup></b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Asset Value, Beginning of Period</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14.63</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29.25</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15.00</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75.00</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.27</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.07</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.12</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.60</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13.67</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25.71</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4.54</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5.05</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Increase (Decrease) in Net Asset Value Resulting from Operations</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13.40</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25.78</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4.66</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5.65</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Asset Value, End of Period</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28.03</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.47</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.34</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">69.35</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Market Value Per Share, at September 30, 2023 and September 30, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27.88</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.49</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.52</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67.00</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">91.59</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-88.14</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-31.07</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right">-7.53</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">90.18</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-88.01</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right">-29.87</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right">-10.67</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.34</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net Investment Loss</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.69</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.26</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-2.06</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.93</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">^</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Fund commenced operations on March 28, 2022.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Percentages are not annualized for the periods ended September 30, 2023 and September 30, 2022</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(5)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Percentages are annualized.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(6)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The expense ratio would be 2.08% and 2.15% respectively, for the nine months ended September 30, 2023, and 2.23% and 2.27% for the period ended September 30, 2022, if brokerage commissions and futures and futures account fees were excluded.</span></td> </tr></table> 28.13 4.44 10.4 85.6 -0.11 -0.01 -0.06 -2.38 0.01 -0.96 0 -13.87 -0.1 -0.97 -0.06 -16.25 28.03 3.47 10.34 69.35 27.88 3.49 10.52 67 -0.0036 -0.2185 -0.0058 -0.1897 -0.0068 -0.2175 -0.0087 -0.1821 0.0189 0.0221 0.0234 0.0235 -0.0149 -0.0104 -0.0206 -0.0193 0.0189 0.0221 0.0223 0.0227 14.63 29.25 15 75 -0.27 -0.07 -0.12 -0.6 13.67 -25.71 -4.54 -5.05 13.4 -25.78 -4.66 -5.65 28.03 3.47 10.34 69.35 27.88 3.49 10.52 67 0.9159 -0.8814 -0.3107 -0.0753 0.9018 -0.8801 -0.2987 -0.1067 0.021 0.0215 0.0233 0.0234 -0.0169 -0.0126 -0.0206 -0.0193 0.0208 0.0215 0.0223 0.0227 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 8 – RISK</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Correlation and Compounding Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds do not seek to achieve their stated investment objective over a period of time greater than a single day (as measured from NAV calculation time to NAV calculation time). The return of a Fund for a period longer than a single day is the result of its return for each day compounded over the period and usually will differ in amount and possibly even direction from the inverse (-1x) or two times (2x) the return of the Fund’s benchmark for the period. A Fund will lose money if its benchmark performance is flat over time, and it is possible for a Fund to lose money over time even if the performance of its benchmark increases in the case of UVIX (or decreases in the case of SVIX), as a result of daily rebalancing, the benchmark’s volatility, compounding, and other factors. Compounding is the cumulative effect of applying investment gains and losses and income to the principal amount invested over time. Gains or losses experienced over a given period will increase or reduce the principal amount invested from which the subsequent period’s returns are calculated. The effects of compounding will likely cause the performance of a Fund to differ from the Fund’s stated multiple times the return of its benchmark for the same period. The effect of compounding becomes more pronounced as benchmark volatility and holding period increase. The impact of compounding will impact each shareholder differently depending on the period of time an investment in a Fund is held and the volatility of the benchmark during the holding period of an investment in the Fund. Longer holding periods, higher benchmark volatility, inverse exposure and greater leverage each affect the impact of compounding on a Fund’s returns. Daily compounding of a Fund’s investment returns can dramatically and adversely affect its longer-term performance during periods of high volatility. Volatility may be at least as important to a Fund’s return for a period as the return of the Fund’s underlying benchmark.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Each Fund uses leverage and should produce daily returns that are more volatile than that of its benchmark. For example, the daily return of UVIX should be approximately two times as volatile on a daily basis as is the return of a fund with an objective of matching the same benchmark. The daily return of SVIX is designed to return the inverse (-1x) of the return that would be expected of a fund with an objective of matching the same benchmark. <b><i>The Funds are not appropriate for all investors and present significant risks not applicable to other types of funds. </i></b>The Funds use leverage and are riskier than similarly benchmarked exchange-traded funds that do not use leverage. An investor should only consider an investment in a Fund if he or she understands the consequences of seeking daily leveraged or daily inverse investment results. Shareholders who invest in the Funds should actively manage and monitor their investments, as frequently as daily.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">While the Funds seek to meet their investment objectives, there is no guarantee they will do so. Factors that may affect a Fund’s ability to meet its investment objective include: (1) the Sponsor’s ability to purchase and sell Financial Instruments in a manner that correlates to a Fund’s objective; (2) an imperfect correlation between the performance of Financial Instruments held by a Fund and the performance of the applicable benchmark; (3) bid-ask spreads on such Financial Instruments; (4) fees, expenses, transaction costs, financing costs associated with the use of Financial Instruments and commission costs; (5) holding or trading instruments in a market that has become illiquid or disrupted; (6) a Fund’s Share prices being rounded to the nearest cent and/or valuation methodology; (7) changes to a benchmark Index that are not disseminated in advance; (8) the need to conform a Fund’s portfolio holdings to comply with investment restrictions or policies or regulatory or tax law requirements; (9) early and unanticipated closings of the markets on which the holdings of a Fund trade, resulting in the inability of the Fund to execute intended portfolio transactions; (10) accounting standards; and (11) differences caused by a Fund obtaining exposure to only a representative sample of the components of a benchmark, over weighting or under weighting certain components of a benchmark or obtaining exposure to assets that are not included in a benchmark.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">A number of factors may affect a Fund’s ability to achieve a high degree of correlation with its benchmark, and there can be no guarantee that a Fund will achieve a high degree of correlation. Failure to achieve a high degree of correlation may prevent a Fund from achieving its investment objective. In order to achieve a high degree of correlation with their underlying benchmarks, the Funds seek to rebalance their portfolios daily to keep exposure consistent with their investment objectives. Being materially under- or over-exposed to the benchmark may prevent such Funds from achieving a high degree of correlation with such benchmark. Market disruptions or closure, large amounts of assets into or out of the Funds, regulatory restrictions, extreme market volatility, and other factors will adversely affect such Funds’ ability to adjust exposure to requisite levels. The target amount of portfolio exposure is impacted dynamically by the benchmarks’ movements during each day. Other things being equal, more significant movement in the value of its benchmark up or down will require more significant adjustments to a Fund’s portfolio. Because of this, it is unlikely that the Funds will be perfectly exposed (i.e., --1x, -2x, as applicable) to its benchmark at the end of each day, and the likelihood of being materially under- or over-exposed is higher on days when the benchmark levels are volatile near the close of the trading day.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Each Fund seeks to rebalance its portfolio on a daily basis. The time and manner in which a Fund rebalances its portfolio may vary from day to day depending upon market conditions and other circumstances at the discretion of the Sponsor. Unlike other funds that do not rebalance their portfolios as frequently, each Fund may be subject to increased trading costs associated with daily portfolio rebalancing in order to maintain appropriate exposure to the underlying benchmarks.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Counterparty Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Each Fund may use derivatives such as swap agreements and forward contracts (collectively referred to herein as “derivatives”) in the manner described herein as a means to achieve their respective investment objectives. The use of derivatives by a Fund exposes the Fund to counterparty risks.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Regulatory Treatment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Derivatives are generally traded in OTC markets and have only recently become subject to comprehensive regulation in the United States. Cash-settled forwards are generally regulated as “swaps”, whereas physically settled forwards are generally not subject to regulation (in the case of commodities other than currencies) or subject to the federal securities laws (in the case of securities). Title VII of the Dodd-Frank Act (“Title VII”) created a regulatory regime for derivatives, with the CFTC responsible for the regulation of swaps and the SEC responsible for the regulation of “security-based swaps.” The SEC requirements have largely yet to be made effective, but the CFTC requirements are largely in place. The CFTC requirements have included rules for some of the types of transactions in which the Funds will engage, including mandatory clearing and exchange trading, reporting, and margin for OTC swaps. Title VII also created new categories of regulated market participants, such as “swap dealers,” “security-based swap dealers,” “major swap participants,” and “major security-based swap participants” who are, or will be, subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The regulatory requirements under Title VII continue to be developed and there may be further modifications that could materially and adversely impact the Funds, the markets in which a Fund trades and the counterparties with which the Fund engages in transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">As noted, the CFTC rules may not apply to all of the swap agreements and forward contracts entered into by the Funds. Investors, therefore, may not receive the protection of CFTC regulation or the statutory scheme of the Commodity Exchange Act (the “CEA”) in connection with each Fund’s swap agreements or forward contracts. The lack of regulation in these markets could expose investors to significant losses under certain circumstances, including in the event of trading abuses or financial failure by participants.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Counterparty Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds will be subject to the credit risk of the counterparties to the derivatives. In the case of cleared derivatives, the Funds will have credit risk to the clearing corporation in a similar manner as the Funds would for futures contracts. In the case of OTC derivatives, the Funds will be subject to the credit risk of the counterparty to the transaction – typically a single bank or financial institution. As a result, a Fund is subject to increased credit risk with respect to the amount it expects to receive from counterparties to OTC derivatives entered into as part of that Fund’s principal investment strategy. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, a Fund could suffer significant losses on these contracts and the value of an investor’s investment in a Fund may decline.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds have sought to mitigate these risks by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily, subject to certain minimum thresholds. However, there are no limitations on the percentage of assets each Fund may invest in swap agreements or forward contracts with a particular counterparty. To the extent any such collateral is insufficient or there are delays in accessing the collateral, the Funds will be exposed to counterparty risk as described above, including possible delays in recovering amounts as a result of bankruptcy proceedings. The Funds typically enter into transactions only with major global financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">OTC derivatives of the type that may be utilized by the Funds are generally less liquid than futures contracts because they are not traded on an exchange, do not have uniform terms and conditions, and are generally entered into based upon the creditworthiness of the parties and the availability of credit support, such as collateral, and in general, are not transferable without the consent of the counterparty. These agreements contain various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net positions owed to the party under the agreement. For example, if the level of the Fund’s benchmark has a dramatic intraday move that would cause a material decline in the Fund’s NAV, the terms of the swap may permit the counterparty to immediately close out the transaction with the Fund. In that event, it may not be possible for the Fund to enter into another swap or to invest in other Financial Instruments necessary to achieve the desired exposure consistent with the Fund’s objective. This, in turn, may prevent the Fund from achieving its investment objective, particularly if the level of the Fund’s benchmark reverses all or part of its intraday move by the end of the day.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">In addition, cleared derivatives benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. To the extent the Fund enters into cleared swap transactions, the Fund will deposit collateral with a FCM in cleared swaps customer accounts, which are required by CFTC regulations to be separate from its proprietary collateral posted for cleared swaps transactions. Cleared swap customer collateral is subject to regulations that closely parallel the regulations governing customer segregated funds for futures transactions but provide certain additional protections to cleared swaps collateral in the event of a clearing broker or clearing broker customer default. For example, in the event of a default of both the clearing broker and a customer of the clearing broker, a clearing house is only permitted to access the cleared swaps collateral in the legally separate (but operationally comingled) account of the defaulting cleared swap customer of the clearing broker, as opposed to the treatment of customer segregated funds, under which the clearing house may access all of the commingled customer segregated funds of a defaulting clearing broker. Derivatives entered into directly between two counterparties do not necessarily benefit from such protections, particularly if entered into with an entity that is not registered as a “swap dealer” with the CFTC. This exposes the Funds to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem, thus causing the Funds to suffer a loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Sponsor regularly reviews the performance of its counterparties for, among other things, creditworthiness and execution quality. In addition, the Sponsor periodically considers the addition of new counterparties and the counterparties used by a Fund may change at any time. Each day, the Funds disclose their portfolio holdings as of the prior Business Day. Each Fund’s portfolio holdings identifies its counterparties, as applicable. This portfolio holdings information may be accessed through the web on the Sponsor’s website at www.volatilityshares.com.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Each counterparty and/or any of its affiliates may be an Authorized Participant or shareholder of a Fund, subject to applicable law.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The counterparty risk for cleared derivatives transactions is generally lower than for OTC derivatives. Once a transaction is cleared, the clearing organization is substituted and is a Fund’s counterparty on the derivative. The clearing organization guarantees the performance of the other side of the derivative. Nevertheless, some risk remains, as there is no assurance that the clearing organization, or its members, will satisfy its obligations to a Fund.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Leverage Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds may utilize leverage in seeking to achieve their respective investment objectives and will lose more money in market environments adverse to their respective daily investment objectives than funds that do not employ leverage. The use of leveraged and/or inverse leveraged positions increases the risk of total loss of an investor’s investment, even over periods as short as a single day.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">For example, because UVIX includes a two times (2x) multiplier, a single-day movement in the relevant benchmark approaching 50% at any point in the day could result in the total loss or almost total loss of an investor’s investment if that movement is contrary to the investment objective of the Fund in which an investor has invested, even if such Fund’s benchmark subsequently moves in an opposite direction, eliminating all or a portion of the movement. This would be the case with downward single-day or intraday movements in the underlying benchmark of a Fund or upward single-day or intraday movements in the benchmark of a Fund, even if the underlying benchmark maintains a level greater than zero at all times.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Liquidity Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Financial Instruments cannot always be liquidated at the desired price. It is difficult to execute a trade at a specific price when there is a relatively small volume of buy and sell orders in a market. A market disruption can also make it difficult to liquidate a position or find a swap or forward contract counterparty at a reasonable cost. Market illiquidity may cause losses for the Funds. The large size of the positions which the Funds may acquire increases the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred while trying to do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically invest in Financial Instruments related to one benchmark, which in many cases is highly concentrated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>“Contango” and “Backwardation” Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The Funds typically hold futures contracts. As the futures contracts near expiration, they are generally replaced by contracts that have a later expiration. Thus, for example, a contract purchased and held in November 2019 may specify a January 2020 expiration. As that contract nears expiration, it may be replaced by selling the January 2020 contract and purchasing the contract expiring in March 2020. This process is referred to as “rolling.” Rolling may have a positive or negative impact on performance. For example, historically, the prices of certain types of futures contracts have frequently been higher for contracts with shorter-term expirations than for contracts with longer-term expirations, which is referred to as “backwardation.” In these circumstances, absent other factors, the sale of the January 2020 contract would take place at a price that is higher than the price at which the March 2020 contract is purchased, thereby creating a gain in connection with rolling. While certain types of futures contracts have historically exhibited consistent periods of backwardation, backwardation will likely not exist in these markets at all times.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Since the introduction of VIX futures contracts, there have frequently been periods where VIX futures prices reflect higher expected volatility levels further out in time. This can result in a loss from “rolling” the VIX futures to maintain the constant weighted average maturity of the applicable Fund benchmark. Losses from exchanging a lower priced VIX future for a higher priced longer-term future in the rolling process could adversely affect the value of a Fund and, accordingly, decrease the return of a Fund.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Natural Disaster/Epidemic Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Natural or environmental disasters, such as earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease, including pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and markets and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster and health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays, shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding results on the operating performance of the Funds and their investments. A climate of uncertainty and panic, including the contagion of infectious viruses or diseases, may adversely affect global, regional, and local economies and reduce the availability of potential investment opportunities, and increases the difficulty of performing due diligence and modeling market conditions, potentially reducing the accuracy of financial projections. Under these circumstances, the Funds may have difficulty achieving their investment objectives which may adversely impact performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual companies (including, but not limited to, the Funds’ Sponsor and third party service providers), sectors, industries, markets, securities and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the value of the Funds’ investments. These factors can cause substantial market volatility, exchange trading suspensions and closures and can impact the ability of the Funds to complete redemptions and otherwise affect Fund performance and Fund trading in the secondary market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long such events will last and whether they will continue or recur cannot be predicted. Impacts from these events could have significant impact on a Fund’s performance, resulting in losses to your investment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Risk that Current Assumptions and Expectations Could Become Outdated As a Result of Global Economic Shocks</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The onset of the novel coronavirus (COVID-19) has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow and contain the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies as economic activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at least equal to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market in the fastest such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US, oil experienced shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as of the date hereof may cause the underlying assumptions and expectations of the Funds to become outdated quickly or inaccurate, resulting in significant losses.</span></p> 0.50 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 9 – SUBSEQUENT EVENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Management has evaluated the possibility of subsequent events existing in the Trust’s and the Funds’ financial statements through the date the financial statements were issued. On September 22, 2023, the Trust announced a 1-for-10 reverse share split (a “Reverse Split”) of the shares of beneficial interest of 2x Long VIX Futures ETF (ticker symbol: UVIX). The Reverse Split was effective prior to market open on October 11, 2023, when the fund began trading at its post-split price. The Reverse Split increased the price per share of the fund with a proportionate decrease in the number of shares outstanding. Therefore, the Reverse Split did not change the aggregate net asset value of a shareholder’s investment at the time of the Reverse Split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">For UVIX shareholders who held a quantity of shares that was not an exact multiple of the Reverse Split ratio (i.e., not a multiple of 10), the Reverse Split resulted in the creation of a fractional share. Post-Reverse Split fractional shares were made available to be redeemed for cash and sent to the shareholder’s broker of record. This redemption may have caused some shareholders to realize gains or losses, which could have been a taxable event for those shareholders.</span></p> 0.0657 $(6,409,592) $11,140,667 $(6,409,592 $1,156,106 $1,156,106 $(9,203,522) false --12-31 Q3 0001793497 Investments in securities, at cost No Par Value Represents annualized seven-day yield at September 30, 2023. $48,144,554 of cash os pledged as collateral for futures contracts $104,412,396 of cash is pledged as collateral for futures contracts. $55,293,437 of cash is pledged as collateral for futures contracts. $114,821,272 of cash is pledged as collateral for futures contracts. Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures. Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures. Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period. Percentages are not annualized for the periods ended September 30, 2023 and September 30, 2022 Percentages are annualized. The expense ratio would be 2.08% and 2.15% respectively, for the nine months ended September 30, 2023, and 2.23% and 2.27% for the period ended September 30, 2022, if brokerage commissions and futures and futures account fees were excluded. Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements. Percentages are not annualized for the period ended September 30, 2023 and September 30, 2022 Percentages are annualized. The expense ratio would be 1.89% and 2.21% respectively, for the three months ended September 30, 2023, and 2.23% and 2.27% for the three months ended September 30, 2022 if brokerage commissions and futures and futures account fees were excluded. Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period. Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements. The Fund commenced operations on March 28, 2022. EXCEL 46 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( !)];U<'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " 2?6]7F[\^&>X K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M2L0P$(=?17)OITG50^CFHGA2$%Q0O(5D=C?8_"$9:??M;>MN%]$'\)B97[[Y M!J8S29J8\3G'A)DJLD2:CIIA/>&M6?/K,_0*S!K!'CX$*\)H#4_/$ M=!S[#BZ &4:8??DNH%V)2_5/[-(!=DJ.Q:VI81CJH5URTPX7Y9U*Q<* MZ6!P^E6-U*(]]GUA]]%V$?K=NX? M&Y\%50>_[D)] 5!+ P04 " 2?6]7F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M !)];U>('^AAT04 @; 8 >&PO=V]R:W-H965T&UL MM9E=D]HV%(;O\RLT=*:3S"S!EKW IBPS0):4Z28A"TF;W E;8$]LB\KRPO[[ M'MG&(AES[*;I7BS^TNM'7^\YLD8'(;^F >>*'.,H26\[@5+[5[U>Z@4\9NE+ ML><)W-D*&3,%IW+72_>2,S\O%$<]:EG]7LS"I#,>Y=>68K(.E7%G5S6::KX66W)/3Q$%HK':5W%"T&W7E!/GU?IGGG\M@/S(^7R MD7?&O_YB]ZW?$%RWPG4Q]7'9-0]\%Z9*,N!^QV)>1XGK?%H]6TL85@C2=85T MC4I5+;A^VM>2X,5MJ_L!H>A7%'U49I9)J2'F8>JQB'SF3.JA1V VU$+A:MVN M3;N.C7 -*JY!FPZ;B3B&@;52POMZ15;YZ"7O,Y4JEOAALJM#+(2ON/T+?@;]1YKD(85TA!%FD!O^7F/S2-6^V:\_)9%*4>:YJ;BN&G5-$ BH!T%1@HA?"&*$U!#2=FZPY#(4 M/CH'&Z0JQ\\M'Z,S9F^CYFSHSFUB#A?K.Q47:Z(RGF[C9OP]5=ETE[EPN0\H ME;%U&S?F3W%;+B'7[$@6/G1KN V](JU'6A&7'+K=_L!R MKVTLOZ#&[VFK)'[B^Y %IE>G@V+9\3ZI;SM<$GK8>K9\,R%3D47\D4ETR65B M &T5 ^I)UP=12XI+KK(01HOKNNB0-$&!M@H*%>%,G\%87(M#[:JU06[)HOC9 ME#,O(&^@$7F"Y6W4! C:*D!4E-6464KQ&"9>?9?CFO-[#,V$"MHJ5%1H2P%K MDHA\"?>7YS&NZ#BN-<383+B@N,7GG3F1G%U&P06>#_O]%]A7 A,D'-S7[T6> MF04BP=RX083V[:Y%!UA^YICXX+2*#XL$XFCQ44LGVNRT;*G%PQ7Q58ICPH2# M&WG7/D(N!/&3?%K\1>:9RO1J]VX]KV5"M7[PCBX MU4.6XN>+T:=X(Z):0%Q@!;V"D9CHX.!6O@X5Y"9B2VSZ?/."K+B721B2M4BX M4LL1\RVGB1$.;NHG,,B'O8 E.W[QHUF#T&PC^/0+VG@F)#BX?=,CN1?0C6VF M"*KTHP/.1 AG^-.G"!HA?I38Q T'M_T64P07^(A/$=>$#1=W_'\Q11J46HV7 M;RE-*'%QXV\_01J$D G2.]N,Q3[%-75:IMG4FQNF,>+/:*W M3'\ 2$G$MU#4>CD 3:8*;4\&0[+\4S.D_(X7\J%_F::%_-$Z;?%X[!<%C*9U(WFV9 $@1C. MDW0Q.#^M/[LKSD_SE!K^CA3U0?#\]-E M\BA'4GU;WA7ZW7#C99+.Y:),\P4JY/1L\!&?7 E>-:@MOJ?RN=QZC2HI#WG^ MHWIS/3D;!%5$,I-C5;E(]+\G>2FSK/*DX_AOXW2PN6;5_99.U.QL$ W01$Z35::^YL__EHV@.L!QGI7U7_3I;J?.1RI14H^C*E$^11_+4NI7R6*"OJ3) M0YJE*I4E.OJV2%:35,G)._0!?1M=H:.?WYT.E;Y^Y64X;JYUN;X6<5U++H\1 M#=XC$A *-+_R-[^28]TV/.?Q]P"]H-,L+A;Y?_P=] M7JE5H;5^NO\,*?.ZJB;G2;E,QO)LH&=?*8LG.3C_Y2W*V(Y%M)#+OP%XFY0P2Z&T%QX0@;6L_HO93K:M/ MYSQ@(@A.AT] U'P3-?=&?;UXDJ5:3\5T@4HY7A7U]'N/$H6>DFPE@6 N_$Y_ MQW] /;%NQ+<4A"*D(C(2UDJ]SO?JL9VN$)NN$!U=H:1VJ#18QC)]2AXR2/JE ML%2P(,"\I<&VPB0.8GBPPDV$H3?"NT(NDW2"Y(L&<"G72V:N9K) 2;V&0O&& M5B2$Q5'VP@&).1QOM(DW\L;[==.12.<*J)PEU5I7YMD$"M3KZ]"5X W. M?/=0O%$<>Q5?R65>IJJ:.Q=%_D,/3"6\6>4AT3'0[XQA0F/1&B';DD68,#W=L"*UH.C7<5;Z0?V*KZMYTR'3*^+ M0V1B:^1XB!V#9M(([,\C[G.59$WJ!(9/[#L+$\QQ8*VW@"F+1$ABXEBOL,$^ M]G/_+OFSZE\XPE[1WY>W7:$&_MA/?VL.+=?*0>','AI*0A&$[8$!#*,PH [F M8P-][ ?TU4HBE:-Z&H 1O@'!GJ'I&>C8$!W[D=[AONX _Q&QVB9+\H<%@) '.L;QKJM;#O.:.CBB*$]]N/^XT1O%=-2 M%4FUJ]8)Y'B7<_-YZW8Z(TC-NY(6 6A<)!,&(@3/P07A-L:\CZ]$]NOU\ L;;*W7[\K8KVU"7^*E[IW=#'S1LQ\DRU3<3J-=FJ%[K AR* M]I8-L"0QC82>IH[A,;PE?MZN;_5)-3/3AY6JUW*9% L]:TMTI-?)U7R5)4I. MJL/#=)PJ\)R+V!MH(4*]=%/;). B#0-1N MC;1_-AA(KWO/9*5F>9'^3T[>P;/#R^ T=/ MWG:[P?"8^'G<,521=:#D'"K;M&.H#&N)G[6C];CS,$&>)PQW#W!-2 FOI!O1D.]+TZ5GN/;J=36;R" M^ZN98E15E_6M_+X K11!!N+V'1<=#.10 S MS(Z%8S"I(3KU$_W7I/CQ*F\[_IM<243>'2($VT+"XZB= 0)FE1 '\JE!/O4C MWW\J.LY+!09-K&D"'W#ZKW[XAHAN'<-[@7Q.7M"77-]Q>]0>_)X./IG_.Q(% M:A(%RMY:?WC#^;Q'9D_>=F6:/(/Z\PQ7#<+?[( M;@^.=J69O(-VG!)$[74!L.*AXV2*&7PS M/[Z[#OV;YCL=$XDH#$G[N 2PU/OL5M7]YVA1K< M,C]N#SGT][LZ6'C/'&:&P\Q/S*[2 ;.!V-Y.^J_PAN -4]G>Y^CN>H#?QR&_ MV/CKCG9U&BBS#BCO52]@ %X)%ZS--<@N%!%U8*[#[\K8K>^O';GY@[U$OX/;1.0V9B"*[ MC@J85@,9$>9*G;G!+/=CMI^* ;=A_(%$@D4\I.VD&K(-0[W3"0/7[6:XR_W< M]9]$4.L.+'KG,N8: N_%#OKVC07*@EH\U]P$K+<"S8PE!?^*G_MI)!XW1[EC@. M&@%+[T&CJ'*!W4\,)D7G[[>[Y>@Y@VYR=)<4Z[I_AUB,BYO@F;-]4%-@]&G?\?4$L# M!!0 ( !)];U>(N;H$I@@ ,@Q 8 >&PO=V]R:W-H965T&ULM5MK<]NZ$?TK'+73<6:N([Q!NK9G;)&Y]4QB>RSGME\9";(XD4B5 MI!_MKR](R:((+!';%\V'6*0.#K2+Y>+LDCQ]+LJ?U5*I.GA9K_+J;+2LZ\W) M>%S-EFJ=5I^+CU/BP?QM6F5.F\';1>C0E"8KQ.LWQT?MJ>NRW/ M3XO'>I7EZK8,JL?U.BW_3]QE#\NZ.3$^/]VD#VJJZN^;VU(? MC?\&M*:/M[:WCHO3.CT_+8OG MH&S0FJWYT'J_':W]E>5-H$SK4G^;Z7'U^;1.:Z47OJZ"8A'<;%29-@M8!4?? M\_1QGM5J_BDX#KY/X^#HKY].Q[6>LQDYGNWX+[?\9("?!M^*O%Y609+/U1P8 M'[O'1X[Q8VWKWF#R:O E<1).U>9S0-%O 4&$ K]G\O;A!#+GS\V>?'CVGC/H M?O5IR\<&^/!+,%T691W\G[+] Z.YF:?'92;=*9.AOIA%6I M\DF-SO_V%RS0WR$G^R2+?9(EGLAZR\'VR\%:=CJP'%?YK%BK$\C[S*?W?9+% M/LD23V0][_.]][GS8KC*:Z59ZR!KEP%:A2V!: F:+?CI/!0XU!?RTZ%[;12C M#.,^*K91!$F)61^6V#!!:,3WJ)ZI8F^J<)IZ4R]5&5P-VND<#2]# 6:)Y[X M SS#,;8EXX<>Q; [Y=Z=TNG.^Z).5PYW2FM&*&QL%!0V-@H,&QLF".,#81/N M[0R=^2EYT?JT4A68H4*?&R3+/%$UO-_M/=_Y(RS;VFNQ7NCUH*%4A6T M"I$='A'EC!BQ9L,P$XQ+(]ALF C#PS#:^L2&48P0CN!HPZC3ILAI[\5<*]ZL MJAM-^J1^TU7%K'C,ZRQ_"-)\OI7'\RS-![VQX^^Y0T;8,',"P#"GU'!:#, D MD\3T!@"C$:%TP!L'2AT[O7%;%@M5-16:3C:#%F,[UV#.S?6'8(@)RV(;1A@2 MS,PV "X2A RD54PZDXG3Y*_9K*E)=^M=JH==,!2.)2?V(NF@->VW43HP!#7M MMV%#IC?J7/LEN>79?%3[]/9JS!1V_P+FOT!W0INV3NBWC:$ M:&@ZQD;I+8V:?K%1I$?6]TLGD[%3!^[VV]?="'0'LZW 2$21&0VQ!=;?V$ZW8O=PG?7,@#7P%:@F$L:\@B;D0C(8RUI MI9FT8P#(0QPA% DS%&TDY0@)/B1).@6,W1*X"<79,LT?E$[+P6.^#\MTHST\ MR[:;T]%<=4HQ)1$(LK3@% MH(+(D")D!BJ E%QP$85FH )(SG7PBX%()9UX)F[QW$N:C7PZ"-9^#M61_+JO M5"URL>L$SHIW"47TR0XBI/MIT_Z7-!\=3&=)O?3X"Z9?O]Z?W7] M>_#E[N9;<'.;W%W<7]U<3T%/02I:)T+$3$_90,Q%*)A9EP% %DF!0VY*, !Y M3'0]P D;\%0GSHE;G).7X&NAI?D;>L=NIO=F.J]LL5>VQ!=;?TVZBH'0CW:0 MB=<&OE>VV"M;XHNMOP9==4+)C]+ LZMO<52?$79W\JJ'L'OZ.\I3818;EC _,Y0@F>T(-'?!75]$0=P/^ M5QUC8C>IX0"Q<4V $&;Z!&AZ@P$"\+%&M \8W%4*1'Z\=4R<5<:[4Y-/MM@K M6^*+K;\*7?5"G$+[+0WD'4.O=!(I?^)6_W^ZBTR IGJ(F=E3A&!<$K.G", B%)H2+P%@+-*:$?8&[$"HTD[24[>D_T 7F0)* MG$IFEC8 C#(DS7H0@/&0"VS:;\,D8P=NZMO?"77J%NKO:".[F=ZQ3U.[)8X% MB;CI&1M&S0(R 4!$^V6@I4H/'GYQM]=_W4:F0#,\#'%HWD "<((08::(&,!A M(86@Y@T5 !@2',F!9$@[<4K=XO2-;61J"\6F.RR8V4:&@#I/24N!0, H9/;- M% @HI$X_9,#V3J12[K6-3'T*R8E7MM@K6^*+K;\PG1JF;C7LZ,]16Y >,X)8 MA,RNVP2"ZHLP%,R\,17#T!!S3"-K5P*P&LA#AH*J5L5^^PF4Z\BVBM; M[)4M\<767[1.1%.WB'9%*R">442Q1.;#/@"2("Z9I-86"2$IT]%G*FB8,Z)1 M-' 'CG8:FKHU]/^[F4RA-KS^)XEY/4X@*-%0O4>8GH.02(9($F1VE $L9Y3K M"@1V'>L$-_M%']Y_0WDWH^A[BS(9,3/.("@12$M94Z6#2!1J.8^HJ<@ +),Z M>H49:..#)]/7JGQH7PEH8D$78-O'E/=G]Z\=7+0/VQOG+_')! /G8WR2;%\J MZ.BW[SA\2\N'+*^"E5KHJ=!GJ=>VW+XVL#VHBTW[7/R/HJZ+=?MQJ=*Y*AN M_GY1%/7K03/!_N6-\_\!4$L#!!0 ( !)];U&PO=V]R:W-H965T&ULO5IM;]LV$/XKA#<,#;#4?'_)D@". MK:(%MBZ(TVU?59N)A=F2)\E)MU^_DZQ:-DDK;JOM2R+)SSW4/22/=Q0OG[/\ MSV)A;8D^K99I<358E.7Z8C@L9@N[BHO7V=JF\,M#EJ_B$F[SQV&QSFT\KXU6 MRR'%6 Y7<9(.KB_K9[?Y]66V*9=):F]S5&Q6JSC_^\8NL^>K 1E\?G"7/"[* MZL'P^G(=/]JI+3^L;W.X&^Y8YLG*ID62I2BW#U>#$;F(&*X,:L1OB7TN]JY1 MYXZ^&=+!KLS+GV?_RI$6+/ 'C"!K0QH*X!/V+ &@-V:@N\,>"GMB :@]KUX=;W M6KA)7,;7EWGVC/(*#6S51:U^;0UZ)6DU4*9E#K\F8%=>3\NXM-#Q)T'@1 MIX^V0$F*WL,8'16%+0OTZD,:;^9):>=GZ!Q]F$[0J^_/+HU'GUUZP=BL-TX8#4?/\)W3CZAZ2++2_3;NS_0FTVYR6$@1/=O M0AW=256%MHMB'<_LU0!B5V'S)SNX_N$[(O%/(97[))OT21;U1';0'WS7'[QF M9T?ZX]?;Z&YT_^[7]]-0!_ ^.Z!/LDF?9%%/9 <=('8=(#HG1!4 D_3)%F4= M'9=9481Z8DLB:Y)J47ZZ/F>4"R(OAT_[(@=PE&'-R2%N$L!I2047A[@H@.-* M<,)VN .OY59Z?(5C36S4*%*=S]- $B1F$Y1P6 M_* ^V^;$WGL2H9@6QG%\[ ,U5DII[0CDXX0F!F/C*![Y0"8@>Q(FK)#:*:1> M5&A6KY/5,KE)=VK%:QB%LR2N\Y]7<]O>G55KZU>IISP?S@DU5!/ERA= 2JHT MP]C1+P!40@II'*&C % (Z!%Y1$"]$U"?,+%FH%MA*YVV5V>5FBG\%&^3#I & M4KTD?40/>;9"D!CGM99!F;3WJI3#$,/<$,E*BK1$$3VM(AG M1P-7T^[A(B4E1%E/-A^I('@)=WA- D#"&4 Y=B7SD;"42H4%/B)86TR0[FKB M/JLT>%&RH"3,ET03P:1FKB0^4BLJB!"N)#X0U%"*NR,N"B"%D(0+*H](TN;S MI#NA?Q_=H]%T&MT'0SCI-:/OE6W2*UO4%]MA-[19/>E.ZV_L8Y*F55X!.=FM MS9,L'-"$/]T@7Z?["7:CM8_D4FO#W!1M$D0RI27VAF&G#U^K45L#D.XB((+T MM%N=0%9/,!?2R\+' :@WHQIY3B:-3B$]]+W-[DEW>D\_H9\S&!TG[()T,WWQ MG.V3;=(K6]07VV&?M 4#T=^P%T(ZRXTO[H8^V2:]LD5]L1UV0UN3D,X,^]0= MD8;E,,%C6'(O- 2 W A%N1L9 D"CN:XV/@_C0@ HE2:$AL,";;-_VIW]][XO M0OV$_9Q3S UV*_9Q"$II5;>ZB]$D#(7TB3#C9LPA+ "%YD0?D:LM&6AWR?"_ M;I)0/_5G&&H$Y:ZKXP"28J&X8F[*&$0R#M(85\8@IV'[Y*8NF*%D%"E&I#,+3H"6*Z@"^0QM=J:@[(>]TQH MK]\P>F6;],H6]<5VV"UMW4,[$_J7]DT:Z_WQ8*"Z)\0M5\,P6S0U+B:N)#H0K65!Z=26T%0+LK@.[-$]IK!= KVZ17MJ@OML-N M:"L VET!G+AY0OTT7 O&M'8SAW$ *3%GDGM[> $DH8)K#5'*'8?_Q8<"UI8* MK+M4>''WI+'?_W:K-0WHS:RG,R9W0*Y];SX=ZIHI7-'^OC7%4N MODG+[<&2W=/=D;%1?5#*>7Y#+L8D\'Q"+J+M@;"6?GL^[9V[P"P.\/659^OJD:V!V\N_X74$L# M!!0 ( !)];U=YB*Z'Y0L &=* 8 >&PO=V]R:W-H965T&ULQ5Q=;]LZ$OTK@G>Q:(&FYC>E;A(@L92] =HT:-K>?55L.M;6EKR2 MDK3_?BG;L2QR1,3#(74X&LXAQSI]+LH?U4RI.OBYF.?5V6!6U\L/ MPV$UGJE%6KTOEBK7WTR+&YZ?+]$'=J?K;\K;4 M?PVW5B;90N555N1!J:9G@PO\(>&B:;!"?,_4<[7S.6ANY;XH?C1_7$_.!J@9 MD9JK<=V82/5_3VJDYO/&DA['?S=&!]L^FX:[GU^L7ZUN7M_,?5JI43'_,YO4 ML[-!. @F:IH^SNLOQ?,?:G-#O+$W+N;5ZM_@>8-%@V#\6-7%8M-8CV"1Y>O_ MTY\;(G8::#MP [)I0,P&K*GM=(37U=!,0U&:34+KK3S M5,&;;WGZ.,EJ-7D;G 3?[N+@S=_?G@YKW6?3V+]SHJR#[]?_#JX>Z\=2::J_7D$3[335!+0/U3(= MJ[.!CEB5*I_4X/P??\,"_1-BV:>QV*>QQ).QSGRP[7RPE77:,Q^CB[L_@JN/ MG_\,KKY\_A1\ODV^7'R]OOE7<#'Z>OW]^NMU<@?-#/,Y,SZ-Q3Z-)9Z,=6:& M;V>&.Y^4&[UF9_E8K\65"MY,U/K36WTMR/57:54I'4)UOWJ!RO*'8%H6BT O MYV7:K(<5-&OK#L6JPV8]?SHG+.018J?#I]T)L7&8BU PV<7%-HY%4N"0TRXP ML8$GA'/"2=MSAR.QY4@XO?=B\A^]8*T7D[K09(R+?)S-U8HA35ZQT-3-BZIZ MVWS=7!PWZ\VR+)XR'=R#^U_!F\=*?\CRMR_<:2I7N4169PID4?CT?9_&8I_& M$D_&.O,JM_,JG;Y_^UB.9XW?ZPPARY_49HZAV5@;XKNNA3$5E$H9&6X-0"7E M(6+<=&P 21F2A%-,#->&^A6+W$QNM\)S;&:EE4F68CK8/[LOBARD"+FV"ZR31T@*A+ M_7R#OA0!T\XE"GEH!+21C:1"<,Z%P1-@D0LB9,A,GJ"^!4&2$0GSA%&;<*-C MF/J>EMEJK= N53YDC0H;J^PIO9\K,.M&]DP21C *#6[O QDY#EM=(]U?O(Q[9[$!&:T6@$X3#5X=#P2]">Q,CPWP3$D4CT/+N8 MM'208^@HZIE^8%LNP,=T8WIW4,1,.48 J&'"(L*&<8E-%ISWKVU(MTVP2J)]+E5=SX^:S:I)EN;@S'# Z9!.R[ 5*6PDEUROYF:H<([U8%+W]MKE MK)5$V)F9[^&LWY.]RIICK$'/1>QU6(F'875GI14TV*UH>F;%RL&6Z:_>',"6 M&I@2*9 T'1H 1EA$R'1H (<9XE*:@=D&2LDDP3V^VBH<[)8X/:S15 7NL+2T8)J:6&P&P$RREF3#$ $X_D,C-'Q7[O878>;\6>M)T M%PC&(D),>FP8T4]6:-)CPSCBHF>/D+1:@[BUQHV??3\"* H:$1T)354Q@J $ M,\Y";%(#R10284E,%A,(RG7D(9A&/12U$H/00XX!KJYO+FY&^X\!B-<3&J_6 M8J_6$E_6NO/3"A3B%BC&7N L;?:RJF(^>;?:U2ZFP;BHZLZWR\T>*K@EN.FN M$XD(QC*R5@0 J=>-D')3-,8 $H<2Z; AS(0"@@HF)-(#Z''E5C,0MV88-41H M0C8TE&JBU**'!4 C4!+J%(B8.Z,@E"$I!3/3*@B*I5X-A(X )A$0%J.(A8+W M+0NM$B!N); G[DVS/,W'KXA[PO: GK!G(T]T<&*(129'-A(3G;T).^K9R#U! MK\W)B3LGOTF^!MFMOA8T\1#DPFGQX( 'G3-P&G%J^12 MY(@)A$RZ/ VP2VF;T!-W0G^IDXP\;WQ*/X&WJLP*^,%S6CE@VX0 !Q$P@4!V M#_+W^R/K4M<* .(6 $FS>^'Y\6HN]6DM\6>O. M3ZNGZ'X]Y;DRA4(R"&M%'C$SR8"@1"#)D"D[0:1.1R."S/4A ;!,WVE"K5%3W,BB;2(P&8% M%H@-=29-D+G=&T-8Q@@5F%A;+!"VV8K1RDOTE*O05GE1M_+R5K!";56$<8A% MN#O(#5$ 5'**.;%T&0!E6G!PCBS1 4 )CG0\(K0O'K2JC+I5V5]0MT)MC41" MA")J!T](H0F,PE":>[P E$><2"W]3;8 HUP(0<6._W79:C4:=6LT/[4K%*K2 MBIB6">9V!X@DDD5F"5 ,(C%FS-Q"22 DD2A$LD?"TE9O4;?>^KVJ$@HLC::JAW "6_O!"8B+0M:STTM;#46/J@E[554)!2JP=!@Q3P3<(SAX M+00[-;TR.:93ESYBK3YB1]6.'55[PNSC#QU\I=@_IX()PH%$RO M3HY;O<..*@W;7WWBMGO C@ #RKQ8L\%G[:,,(<<4>"X;8ZT0 M84>5C;VNK(1!1S*48%-Y #B,I-8(YK,/V.,81Z8T@^S)3I+59:,5'.RH@C!O ME27,3O\E-X_\1@"*2(K-%!* <6E*W@1 L2C"/6>'K%4;[*@JK8,J2YB=[5,: M656' $R39GI%#,"D3E[,TED(AB/9(U99JR_8405:OU%9PJ ?A!!3?8X F'X$ MS6/9&( Q@DW9FP P'K*^'0_6Z@WFUAN>*DL8H ($(P*;>Q@C"$E#AG!H_40' M@F(A.,*"6L\3@ TC1#B.>ER(MPJ"HT-V\U];6L*]GK9XM19[M9;XLM:=GU9] M<+?Z\%U:PNVL M#[P5%=PM*@ZH+>& B)!Z%#0R?V0S@J 8$Z(9D^:N$XB-9-C6-0<[VCIM7Z+RO;J M]JU(%ZMW 1G7+_&'$0:NQ_A#LG[G46M^_0JF3ZLMARJ8JZGN"KV7VI/*]5N- MUG_4Q7+UVI[[HJZ+Q>KC3*43538 _?VT*.J7/YH.MN^6.O\?4$L#!!0 ( M !)];U<_5ZAVCP8 ,LB 8 >&PO=V]R:W-H965T&UL MM5IK3^,X%/TK5I=9,1*E?N;1A4K0QP[2,(QH85="\R&T;AM-FG03MS"K_?'K MI"%I&L=]4+Y X]Q[?,_UC7UBY^(E"']&4\X%>)UY?G19FPHQ;S8:T7#*9TYT M'LRY+^^,@W#F"'D93AK1/.3.*'&:>0T,H=&8.:Y?:UTD;=_#UD6P$)[K\^\A MB!:SF1/^NN9>\')90[6WAGMW,A5Q0Z-U,70Z"G_'%S>BR!N.(N,>'(H9PY+\E;W// MBY%D'/^DH+6LS]AQ_?<;>B\A+\D\.Q%O!]Y?[DA,+VM6#8SXV%EXXCYX^<)3 M0BS&&P9>E/P%+ZDMK('A(A+!+'66$4T3L>: 2(4#3AWPI@.K<""I M ]FU!YHZT$T'H\*!I0YLUQZ,U"$9S,8J64FF.XYP6A=A\ +"V%JBQ3^2X4J\ M98)=/ZZLO@CE75?ZB59?ENIHX7$0C,&-O^21D&4C(G#ZX#N+D2OXZ#.H@X=^ M!YR>?+YH"-EE[-@8IO#M%3RN@+?!;>"+:02Z_HB/%/Y=O3_"&H"&Y)H1QF^$ MVUB+V.?SO<.'TIWE+AC33@DRS])\&@%WN!N1!CCM\/Q2 M64U:X-W#7N6 EI*%$#,0-+)<%>BQC![3TJLC\ KZTR 4X/'F;]!;B(4,!G0' M/?!TRV?///RAHJ8%W9?:D< *_(V,OW',DEV!L;51, V3&!;Q6*78$L6EABHR-Z,N6E%DFA9 4 M#7OZ0)[0#PT=.Z-C[S NW[H#<-7O=P=]N10A"#^I&-IEA@A29D![DV'9DAK$ MM(PUAH5@$"%\?PX'UA=;T M)7F!--XV$X1Y_ MJ:/BCX9I :$%6.,<_[XO;,_^ ^TK^^ZA?NZE4'? MX][,CX16S$^N9Y!>T/0<-P2/CK?@2JJD7.:8FJ4:5YC)M;MJ\')A@CY,F:3( MA9!D/9EX4WDI#!%D%C.KHL]U!WJW\-B[](ZJ2HZ%5LQ/KDN07IAL*;VR$*D3 M$]J;PZEQQKE>P7J_L M)'MQ69E4O',J+/6!YJ(#;Q$=%;(6EU=Y@UC4,"@MQM;9TL$35A5Q5X&/D(EE M%]8&^=ZV#HA.#^-&P,"2(LLV!*ULBS.(9QJB8.W"N![!> M#VR;._9=L?3=[?ML'0NMF)Q,>"E2(7(C(ILTN1E^WJEGPCE6M61?2Y%,!Z*?">Z(^T$9%R5,@)6SZ$#.,* MCKFDP'I)DNL-HE^M>VX8"7 UXZ$[='SP9[#DH1\?C("[9\^=) PC^5#YH_6G[<"- M87TL^SYWQT(K9B[7)T2O3W;/G&KG: OX$U4GL"Q?U#NS>OA#<[-VU+-E:^2@ MJCKDY4L?R-XE]1$BB>0BB6P12>\IJ38IGP*I7U\Z6\*H>$50X&M?>DBLP(HM MN:HA>E7SA'Z $VJ=(4K/&*/QF>TPWHX-(C#W^&@BIV0G L/ \QS!0\<#XR $ MX[1FAH$O0F\2:O[8)(!HB8Q9QOH2O?C;YRD(=#@'ASPH4T<47D.&3*10R39GX<0,)7_!!X9U$0'3OO617H]<1QOD,[[%L):U:Z*I3#A_TC=W4=]R MM$>00*@T!,-_*QA"DF@D]./O$M2JUM2&]>L7]-NM[H6 MB6#*EHGZPM>_04FHK?%"GLC\+UF7%H:HP=IG!7_V7,9B)H!]?88 MN*6!NVO0WF/@E0;>KH&_QZ!5&K3RR!14\CB,F&*#GN!K(O1L1-,7>3!S:Z0? M9SKO8R7P:8QV:C#&0HJ6"1 ^)7?9"J3"I"I)+AXSMHQB!=%[DT-F\Q&$:$YS<]?@CE)5F "+&RL,$T M,2K0@IH3M'*@<-,T8\O%=N5BV^CB!TJ>R7C.A2+?[OXDMTNUQ&B13U]OR?=[ M2"<@_FKRU AZ:.Q/!+;%WZ_X^T;^N+?@!_87\819FBZSZ*T<^0V%XOA!VZG] M=K-F=.%(@IV*8,=(<,BE(A>XKT8\29B0C2VL@/!KI#I^Q_.[S@X1XU)'$NE6 M1+KGZ1/=IJWM.>T=;L;5C^065-P"DEU-F\ M6QTC#_>9_,ZSV4&MQ QY**]3H6T'H"8NZ&G;28FW79UNQ]]M(8WS'+_M!_7? MGORY&_?=_]\L2HQZMW!;7MMOO^I[YM6.3<9&6-#S*(N;-W"_T^9";M(0'=<+ M=J/2-.^_IG(C/>AIM0=]6WP8IVR[N9$?U*P_;F.!)?#MU7NUF7PVXQG$,64:V+MK]= M-Q+#-4L,;+[D'75:ERWJ7GJ!K]MYJ.53+,DB@6@&$78\$NH7F *!/7#*!0:D M*(D0/Z4%"Y6\:G+/KATK8/W-\N,9;;3,5/%!6XU61T W^<''J_'@>H@L&YZX MSO6P.#6R-TL49T[W3,QBK.T$IK@X47R1'VQ,N%(\S2_GP"(0 M>@(^GW*N7F[T M5AVN!?4$L#!!0 ( !)];U=UV>?8E04 /L, 8 M>&PO=V]R:W-H965T&ULC5=M;]LV$/ZN7W%P@:(#/+_(;IOF MQ8#C)EN -@Z2-"LZ[ ,MG2VN%*F15!SOU^^.>K$\I-F^))+(NWN>N^>.].G6 MV.\N0_3PE"OMSGJ9]\7Q<.B2#'/A!J9 32MK8W/AZ=5NAJZP*-)@E*MA/!J] M&^9"ZM[L-'R[L;-34WHE-=Y8<&6>"[L[1V6V9[UQK_EP*S>9YP_#V6DA-GB' M_DMQ8^EMV'I)98[:2:/!XOJL-Q\?GT]Y?]CP(''K.L_ 3%;&?.>7J_2L-V) MJ##Q[$'0OT=+\,W(G+2CA<&/6;3'UVUCOJ08IK M42I_:[:_8LWG+?M+C'+A+VRKO?&T!TGIO,EK8T*02UW]%T]U'CH&1Z,?&,2U M01QP5X$"RH_"B]FI-5NPO)N\\4.@&JP)G-1(?% ":C/L2C M>/*"OTE+;Q+\3?X'/?A]OG+>D@[^>(YIY6CZO"/NC6-7B 3/>B1^A_81>[/7 MK\;O1B9\M;W^97U]]F]]?+:^?P_:R]?7R_B(:P^M71_%X? )= M9_!P%]U;DA&\\1F&+?'H)'P)S^.3GT Z$/ 1E=@*B^"\\*4W=@<^V''?8PJ4 MOF7BS0HMQ%,NS_@#")VR<5):B]JK'9@JV[1=:F_ 82&L\.03K407O4&19'T* M5L.X+'5:HPB^2,NA61]1[?K0P+CZ"I>E M+ZGN<'%_"6]J6'>TT&:1"<1/\,E0X!\9?.D8#*(+RD8#+# $)9TG0&)E"*!T MKB1[QDG)+[7T@<8*-:YE(H7B)".%\'M &56P350?MIFD$!:#8HE>ZV3-74 T MA8HHL'R4U+W/>I8Z$#-;C=9ELF!CHZG4/A,^H![ />&O(O,JUS@L *NI9D0$ MF.5B91#.OWV%BZB6AE7V3R&K5U'[\_(2@)59S[F#$TA8*M8O[EJP^&/45$5]/8]906 M1PE59,4",Q 2VATRG"Z.9'$C>=HTB$->:C42B!K='5+W2,\?YXGG?>,/D\D M6!M1TQ_$WG55BD^%<20NCL]26]=22V@6MD[::>PK3?64OY@<] MLC=K.N3>BI1#\@J)GJ)$K?'E_:*UMJ5"5\NMH)I1O:2K\TSXB1@/LKW_&^(& MRU!BVMJZO%D>X&E44>6,LE2) M.(M9\DQJ:"E$?+/@-1%$HF8J6(/D%K(-UV M:UVAN%F"S*E,Q$^D!">' 1_9J7DIA9?W1X-JRXL%P6U8:A#QQ--:]?O M%,8%*]0TKA,,*BD,025A-6,@,:7B89?0W#.-1E/^HG@F?/BT.#I^:9??XX557D^].ZL-, M')9>*&>JFH7#F-/>VK5-TPH]8J'7?(RM/%6S@*?483]0QL@9W>SHF$W_6_!= M;AVQ]UOP>]%$W7K51(..1#TN&^W!:M=51%/"9^1^"+UE6,FU\5_QK0X_\J$- M9[8[45@,/! [WO>\K_;[%O6^MM&GH\%SUY]AYT*:H]V$:S>7H]2^NINV7]N; M_;RZT.ZW5S\+:!YO)*5+X9I,1X/W;WM@JZMV]>)-$:ZW*^/ILAP>,_IU@I8W MT/K:&-^\<(#V]\[L'U!+ P04 " 2?6]7)X"CXVH6 "(/ & 'AL M+W=OF_FJ76C?J8564]LW.LFFJEP<'-EWJ56)'IM(EOIF;>I4T>*P7![:J=9+Q MI%5Q,!V/3PY625[NO'W-[S[5;U^;MBGR4G^JE6U7JZ1>O].%N7^S,]GQ+_[( M%\N&7AR\?5TE"WVCF\_5IQI/!]TJ6;[2IZ+6EB^-FO?L6\ M@Y=98O6%*?Z99\WRS<[9CLKT/&F+Y@]S_Q_:\7-,ZZ6FL/RONI>Q1X<[*FUM M8U9N,BA8Y:7\31Z<'(()9^,G)DS=A"G3+1LQE>^3)GG[NC;WJJ;16(T^,*L\ M&\3E)2GEIJGQ;8YYS=N;?%'F\SQ-RD:=IZEIRR8O%^J3*?(TU_;U08--:.A! MZA9\)PM.GUCPA?K=E,W2JLLRT]EP_@&(ZRB<>@K?39]=\$97(W4XCM5T/#U\ M9KW#CN-#7N_P_\:Q^N_SF6UJ6,O_;&->UC[:OC9YT$M;):E^LP,7L;J^TSMO M?_[;Y&3\ZAG*CSK*CYY;_>W-]:\?KJ^N+\X_W*KSBXN/GS_<7G_X57WZ^-OU MQ?7ES39RGU_PP\?;RVBJ?O[;V70R>:6^L[ZZ3-)E=-66FF?P1^W2_M/QJZOS MFW?\YG;Y2 MUSWU%TP]E#]R*ZESBS"5+F/5++4BEJV:FP(1C%_TC$>.<427CEY0BW!5F9J? M%FV>@00]4K>8*8O0>Q*A#X7*S)4-S#)8K/)F*3-%K!J*8*I8WDE584PR*W0< MY:6"X55)S3*B=?,&I^9?S\\_>84Q$1%M MP5*D3=HR:3-:8BO5ZEZ#3&%1]J3)-4M8Z*7E(:P:WS78>!4LDY>2Q#@;0$D\ M7O0)CV\Y3=B(YE+ 5Y/Q_C]X' VI6V);5+MH"UZ$V6.>1S:C&N56TYB7@0WEQ>]!*Y%;K#"9.P$"2_=F* MW=F8%&5SRXHQ9<$V5!)[!2@$)36;XJ,)F2:YE1J>8,GRB-M$S9.\[J7LV?(2 MK/"OR:*M^E@F=UK-M"Y!9::)FW .2+%(CV)\.P=/(A3SG#_ MLUU58*QNU,>V5N]:BR^MI>A3-VUE$9%8,-/Q9 HV&UA/0:(FX!-AWR[1')N!$H?$&'TE=H3SRD$[$Z:_ R'=)T9*]4N!?83_]K:50N=0% M1V;:.YG/\R+G\*V/$U,7\SPW['_O %':]4D7S6BQ!VR#D(.[9I";%@+I.M5)5%N7IL5 M;W8'QR6M=-DMJHG_VL4")I@\O<](, ]ODJE/LOTXB@C/THO1'<%E6B QD$G/ MVH:G%OF*:5K D931UK1*L>X#/:<6"C -M--()ABP '@K1$5LC>M-W?(380M9EO5YF$=#([Y;:^JJ%/5)E=+4S U"9GHC$(O MIX>[W!H$D3O3L*J@N-J TF=HMDMHCE:C4,'#0;YSG@6]+B."'^FRQ9)5LA8* M2#W>J0DTR#Z9@"*Q88ZGC^VQ8932XZG +B6TYASY2\-NP?%KTZ8V4D8'\CY; M'6&'2R31%;OKS\FJ(F"8Z579 4W+*68#53VEN4WTQ&C$Z<(&B9V$O2)>=;CSZOPYE:QBR2_@$V"R*>\I!927D(85UY0M#0$BVI4I"8@$E:V@P,,QX$%<'AH6< *"KL[C3K2.+ M_@,%]7U.IO/@8#)[),@G49(L$L0G&&,*,=1"#X(;@M",$C.6236G,$;7R8(2 MK+B(XP"S22D8YRY%5)F_WZ7L=56Z.<$3^[H0Q@ M!39C32&=8F2:V*6+!I D3-E#ZYO>A##_@H9= =1:"MS,ILSI(PHY!09MG=Z7 M]!< 3#E;. 6M#)D;A>AJINO(MXM8#.]1<]!;=3CAMU-?H8LERUZ"*C*C)5=Y MN8*-NME'#%D%13]B$!%11!\ ",])O.H+PT(N'06P?9+ZA\72-OO XPH!3'?A MTSTY96)&ZIS1O^*F@XLF[(T%BB<7O!T*I>W26O>Y&:[@DB/G*+(6IRQR.]Z5 M\#2P,W?H-'7H>JEU338ILIMUA?C&);[O/H#QT>#X_DXT4O@N@]9D?[DP=0#_&K M+]?_@C@:3F67MU<1L3I]"4!=C58C==1]>LQ)-'U0OQ%:WECB1Z?_ G[A5>UB M&3W2B17)$HJ6Y-HRA$(88G]T@)Y*-"D=J*,TLX "+OUOZ#T*!XH:! M.1IV 'DOEYQD@:>R)TGA,;!I;=^"V @#OA3;$A$B1[]3\T&@8Q+BOZGAOA4: M??'B&B9 QT@ MU0(-O4<&N>/VF(UV]6@QBA'1)8)U2!;8J')[V_ND OJ OEDV>TQ!CS:6)$<4?TR-,"IF.F^RV# Q&VP,#P(X(^+OIQS4)]0BXGK.D:>,)_OPAIU+7UB0)V M0/@J@'C-71\Y!GNLMD!F2>D@(G4'!')5KOSSH*,[\0G(I0ZL2C)3<:I]S]%! M3A:D.2 0 H_LIB[8:H@PW_^CMU> MX6W4&PE12DN[1HMRO6GJ7WE+\3[3V41G"X.#S)'ZYS*GMN4F--DX)FLDF38F MDL8%GT1MYF]R)5=N$BFT7M<>H PH40NL%$3ZO. *?P-92'QU)DM0D#X[GN.^ M_HQ<$P%U<2M]\280W3,!FH0.R&59.*F<7_I4FD&6T@L5TT]2.!+"3$^N:]:3 M\].642(EJC1QS(S1"Q_H# Z+( MFUG7'Y,5=9EJW]6:Z?XHS_GB]I-9-N\OWD#[@O>Z=R6N+ 7LNDZ?WO07$5U> M#^AD276>) Q",(;.1OYR,<'%3Y#8^W2CTV69?VN] *E_J1,RMJC?TK5P^H[X MH M-'?=9D5./8*M;"S&9-&M:C,->,]W<:UV^Y!,S#^VX:9-7B?0R?<,4$1>Q MPU1A3G SLJ1)G#E2@XAT[&%/"(5"G*UVS8R0((=L$*SDZ<@=J@_! S8Z0 M%HDSSQ.LMA L)W7R:&W@IG29[<.;LD2,'-81&GMJ>W&NQ;(&P7(A^ M&S#@VCYR-0 ,>(36-<\"*?L:RZ7;GHUUK'3..T@ Y5Y?1*U.>1KU&<_)P'>; MFO"&R,L-VF@_FZ]R:E9NE]TCB<>/EXAZ!?S(>EYU@R,[V23V<>)):3XCM6B; MU!+N"$OL\5,SJH)D24))# #9@1F>U;69F9J;?]3([+<)'7^VYI':)V9?PL!> MX*F[,G1_L)CWH,Z">A/Z''J:3T<\_BD[?,921L/E'/-=%_KI2.OSAWYHI">$ MO1\OU"G,!Q ^/+%FI;OB2:9=*CA;D&P[;I?=Z9 .I>C.*:+\"AY%P6\I\U& M;MT$M*/^RS0U@ZR6.V'WNBCX+^TTS!7NVHT#-TG8)9.#5-J+2R/IZ@<74*1^ MX3MK'5CH(0(AWK YTVQK+>]V][OVGFC.2XMBJ(FHLY*7T98N_^[G?E&_8.07 ME")(''FB]MVG*3[=FB8IHJ>_>;(#K7Y2I_')Z6%\)S$TY.C>'QVAL_[_#PY/HDGXY/P\[;.="1+3X_B0PPZ'D_4!../QO')R:DZ M/(Z/7IS&DY,S=19/C\?Q].Q8[;Z(I^/#^'A*.^^^.#Z,IX>G:B\2^N4(YR=U M.(W'D-7D;(*'H_@4DAF?'M,7)_'I"<@])M+Z5<'163P^.HV/)B?,$<08GYV\ MB'Y!^.!,!43;KKC2N>/.#!);+D:PF^G^:4^.(1YU6&Q_U../>-*ESMJ"0>MU M>-#RD0ZV?/V>)>NN@*)#6]D2UKC(V7:[55TH^;'#HYSN@*0ZY]!Y4"5K=^JG MZ.:[)U]\P6<\2A[-TF2F,(NU1$WR5K)520?#'N7FS3NQ#)Q_KPM<- M"<_QX%:2-5W#N+_)-&C,+@C]K;?<"4,PS! M4'3@PZ72=V<)LN"JGIO!T@>2_C]2K"06GYQ*JF>-R*EBV*-S)6A@ M0]_5--$BK4/?JP>B]B1$SY'@ZA!W:^&'"/B(L7W7&)D)XH7*\;6S2OTG^N]I\Q=-"1_UE5B'1!T5W75M=:8J0W3UQ.)/=;(/,_&+<7G.+ MQ?W]KO#V6-?IG6L2PX?$Y=)N6^7:#U?G_G)M)-,6V':_K=PB5=X$--"[ MX+ \3(:U*+KMWH^;MUJVVY0WQQ==O?>W=W.9BD('@2[M)\@X@OA7C:W,]W8M]]P"MR M6'L@G&Z$H*WM![$KGB5RXIQM'MT58+YN:\9'ZR!T14'QL02RI),L<$[7'QG@ M!.?N\_Q!9_O.<5PCBB 6-6)-76I?S'(]'MAJ:%[D8EL[_=&&&P)9%?-]#"R= M'[J3EZ:[,$L#-ORW@W-^:?K>2R%3NQ2\/-YI^JN>CU>*NI4V0!GW=S+4(WO# MYB]]);D1607.1EK8ZE_$'"&-QT+P*%.Z'MS%DUNKDF')"U,YSJ_E.)^-) 4H ME' "Z7=7<=5X-'WQ=^9S/)J\^'O,J]_0QO3N,S[$02B@6R[AU1;O&Q'0+3/0 M77BP[E8R8=(KD%$#W;C8=9L\#'^8(C>.^)H[WTE"493+38L$X+!([BEV4[>M M;>CJ8R.WEV1NPYRZB=2V*75MEWG%?+ MSV5WY>RQP>[]0>;@F+@TTEWT5[?@ M'7Q?ZEW U.AL'$7\FQ@]NO=)DRXJMO M[D<<'(HA12/1E6\P^$;U1G BJA YD[R,^:)9C.HJ:P-X(?$2F'OE&CN;:X E MWH6N+D?N.($#"@8'^&R3NZWSZ1*"OSH9#=IT2P:3=[FFG\90<W]3Q/X-@7UN/?(1%/4T"(QT485&BG V8FQ;^HL!HJ:("7.G M:):USET.,3PQA9EV[_.R.R?%+%2R"'4N4XA N>-'\94;!_?.0NC>X7 ;TKF4 MZGP!-Z(8C]P\HT $>^&;]UTSKZ%Z)+PH^C2G? UX4-HZR.912JD?L"@*W#M_ MLX&J!$)0**<,7??ER!V'MVTQCNY]"Q;9)JZ^L'1ZO(.ZA7_W*@^-J?BWIC/3-&;%'Y? &KJF ?A^;DSC'VB#[L?';_\7 M4$L#!!0 ( !)];U>/GO#RU!T )A 9 >&PO=V]R:W-H965T6_C1I;_OSX%X1D,[ 4MR_*=HP>SW30-(=Q.YD@,4N M0)$EJ](4J6&15BN??M]5!RG*[M&9P6]M"I/9M/I MY;K@],#=^%'\[!L\<+) MBZ_6V8.^T^W[]0\-_'7B1RG,2E?6U%72Z,77![>G7WQSCL_3 S\9O;'1[P17 M,J_K#_C'F^+K@RD2I$N=MSA"!O]ZU"]U6>) 0,8_9,P#/R6^&/]VH[^FM<-: MYIG5+^OR9U.TRZ\/K@^20B^RKFQ_K#=_T[*>"QPOKTM+_Y]L^-G9V4&2=[:M M5_(R4+ R%?\[^RA\B%ZXGNYY828OS(ANGHBH_#9KLQ=?-?4F:?!I& U_T%+I M;2#.5+@I=VT#=PV\U[YX4SUJVP*76_O520L#XN637%[^AE^>[7GY)OF^KMJE M35Y5A2[Z[Y\ (9Z:F:/FF]F3 ][I]20YFZ;);#H[>V*\,[^Z,QKO[-.K2_[S M=F[;!J3@O\86RN.Y_OH 1-_JYE$?O/C+GTXOIU\^0>6YI_+\ MJ=%?O'G[TZN[^^]?O;V_&R/MR9?'27O[[OZ5.DO^\J?KV>GIETDT07*WK)OV M^%XW*Q5SYWZIU>NN*BP(US99=TV^!%E/WD_N)LD]:+OMFFWRC2E+FR:@K%6^ M3:S.N\:T1N.EJDCJ=JF;9 EJ<)PWNC!M\H\N*TT+3]*<+ #36LWV1K6UVA-KZ=J MT<'TLL(3F!1@<),U!;Y(PH04Y'G=5:VI'A3<3;[5C7G,$&N2-Q5(7,>$O*F4 MU?H#/)6T-8#1TFAX0L./!/E.6W7UI8V(3^KY+YI *\6%)7?KNK(P06>!%QDR M!@&Z-3DL)5NOFQK'@K%Y!)AHDKRW--_26/]$JN*Q"HV[ B)E:8IVNX;)8-M@ M.;!ON*LK\Q$Y&Y$%O#3(,6 *[&/9%3A'$58=W=\L#=(433C7)2[<*F+^:@Y[ MC,^F*"-=621 9-'E&O >^%[A=@'^P][!O+1!69];GD6P#66IT%:-DI)D0#=< MKXM$PZ*R!F=8H&D J8#-IWV ?5[S:/U)[L 2%EVID0^1SDR2E[IIP>XEK#A= M:TKSJRY4ECR"?4.NE+#4$E^+:#*14+ $_M)5D0A&G Y*@4]&XK-"P#IY0%Y#-PGQ_C7@#CU!K<#&0D\LWECUA%D[9,.4/0BF6_I M$18QWM;1>6)EI&UO#'I9";RGFY*DL3'V@V>\5<0TF %X1AP*4Q,. .&,?>JE MW]F^E8 G-0H@#" P&0D!7'Q W8@W&FQ*]<#"3)N:E1UR-$4TSY WM@,;;=H. M]@2AU"-94I@&-@^V UX]K!M%%@5N'"$PQVN<@VE:PL(_H&484@5259H'6#2C M'?B&)4MI :CT"#\/$?&(>V( 189SO6Z/Z 8/Z5[8*MA!(!LDRRP,\+('GT(V[H 74P4VSL+3 MEL9&F N8$VT-38KR9([EA%+JL04(!XTX>XN\/;;C%T \&@^ -'Z(XL';"'LO1;% ML.:A(BEUBNK(=S3EF06S#;249+*1S2!RIB'6(2UN6K"&8(,4"2W237*;[5"7 M1D!'D/"/#F2O8"DAK6>S"+)-V-]W*6#V$IPE@.Z.- HP@GR8YH$?=<,I46N_ M:$1_;RP=P")$(&8L%F2H6$@&@\)]J\%A>"8,9T\_XT2YQHSR J%T \1SNLQ=)8>H=81B9(DGC"Y\D/W2-1;5TQN&) M'531"\Z*I5R3HH'@R%!-R:(]0XK,5NH&>$HW>KWN0;>FB[%"Y M>5\KCW^C5$W474=F"R9?(\]I8N8_NB\?JGI#(@4&V_"03LR\@Y.C&28X"#(- M;W05./3DJA!$T]BPU1:9]L,#%W>88R4EVA)++OCWDT M0U>P L)8N"#TUFR=&P($TG:">4NBMJ-G"D7%K,")0)"!ZPT[4["ZN6XW&GR= M5?VHO;\JOD6^5W!MXHRHXW0,_/S+'9-N4-[^P V;.>R3FI"P-[&+A M!D7@V@5O\')QO2.(AK&I1G""8 < M,H0T;0<-*; %;"L$L^2T,:<@-N00>)1A3@$Y= M+B;)]UFU]52X>9G5\QH"4A93) /LZ-$5_;,K+O&&?:6^]I9KC^ MAQ+\=QB:E#7;3I)WR)( :SPARNP;1LY[X>KRM:B;5A^^Y@4=:X,)3L MS$4$;DNBX!7=Q!J1PQ $@IM,T1&$%)F$9#7[SAD]XM'\S<*3!Z)?U:UHEKAT MZ.3Q^U$> )]"7QV-?Z1BCAK:5O3LS-I1K+("V&(=+GBX2+V\LS&9ZYX[!=ZD MDR RF-Z\[8584JB=,;L*?53E:<9(;(1N]S@! !F_N80PWALDIRVR8)8#84Y1 M$%*+Z>%4A,LIT_[P)BH0"Q!8#+P8J$!9*-2+@JA;<$O7WK<+FD="_D"Q-/D6 MY.]3J(>9Y900BS8'+H7H@$PI/.LB@_%PA&QT,(_P+&7K5!3SQ?%)CD%6@E[< M!WTDVXIK)I4.PTM&!9$'="U-T MMBC(RFH+6D<& :<*DM*V-)AO4;FJ*F#C/ M1PRR7R1H\T4!.K)U=$7N(^\>]=8Z196K \[A79_0["'2$/P4\Z ER\DTXQ5 M7HK6(B@IS<*;-)Z5,I&P0Y]+F>Q9H&K'%4[^*:I8_ "9&L3\"H5>=%[@<[.L M$5/(OVP$8')088Q2#EA)*JZ)7IEN!6LQ&%IW M/8\4$Q -F,TCYY.QIE49Q?0Q-9R.V&2 GGC 3,/LM=K43;LD8=\L=15O M,P6@B+\_D]<11C5A'X!+#T 9[JF0;X&K1X%U:9RCD+TJ#4(="72VC1$?(-C[ M@(R8J?=&>CPUZ/Z30<,9LEXBQ"&DRY(446J$[$5+B!WR!Y1\"=D-!U0'_*48/^J)OIQ#**2DQB\6'/,P6G"F)H_LQV[XAU?B0[*TRYPOV M,BFVQ^L@.KP^YDV=:UU03,C:#9$P3ACB&5(MR>%$[KROE& -1848?-O30)(H M$1')8T;+2@Y12(_Z>^O@P@[!@N^BVY7Y/>7E&BO94&:=E])ZD,K8D\G8$0+U M3"%(1H0@VBGBW"+DRCYWZY7SZ[PS-(STHH'1&.$Z(GM)ZB_*/U0&I.UYI*K/ M%*F^W.R(55_J=L0J@OF^'*E/RU$ YFC 07(-E@"./%HJJ>8HQZN>([C*O-M- M Q+@-,DA0^<1KM7CZ@!QF0)R^KU)R[&DJD?C:>^,H%\7C"6Q3K#7I0*]M VK M8B,KX)1N!3#L8-ZE%<$E2'&3<(>IA(M^W@.\($&F&J3KA[.-9=]W*C+L2_)* MT[@08- #AQVF=(Y-AS4"R8:#("NS6I?H=4;Y&V'9)\F)C*'&O"+) 3I/6+QK+PF#D64%J*/7/*V.NFJ9O@"SIO GT72:N

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end XML 47 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 48 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 110 176 1 true 26 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.vts.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Statements of Assets and Liabilities (Unaudited) Sheet http://www.vts.com/role/ConsolidatedBalanceSheet Statements of Assets and Liabilities (Unaudited) Statements 2 false false R3.htm 002 - Statement - Statements of Operations (Unaudited) Sheet http://www.vts.com/role/ConsolidatedIncomeStatement Statements of Operations (Unaudited) Statements 3 false false R4.htm 003 - Statement - Statement of Changes in Net Assets (Unaudited) Sheet http://www.vts.com/role/ConsolidatedIncomeStatement0 Statement of Changes in Net Assets (Unaudited) Statements 4 false false R5.htm 004 - Statement - Statements of Cash Flows (Unaudited) Sheet http://www.vts.com/role/ConsolidatedCashFlow Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Statement - Schedule of Investments (Unaudited) Sheet http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable Schedule of Investments (Unaudited) Statements 6 false false R7.htm 006 - Statement - Schedule of Investments (Unaudited) (Parentheticals) Sheet http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals Schedule of Investments (Unaudited) (Parentheticals) Statements 7 false false R8.htm 007 - Disclosure - Organization Sheet http://www.vts.com/role/Organization Organization Notes 8 false false R9.htm 008 - Disclosure - Significant Accounting Policies Sheet http://www.vts.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Investments Sheet http://www.vts.com/role/Investments Investments Notes 10 false false R11.htm 010 - Disclosure - Agreements Sheet http://www.vts.com/role/Agreements Agreements Notes 11 false false R12.htm 011 - Disclosure - Offering Costs Sheet http://www.vts.com/role/OfferingCosts Offering Costs Notes 12 false false R13.htm 012 - Disclosure - Creation and Redemption of Creation Units Sheet http://www.vts.com/role/CreationandRedemptionofCreationUnits Creation and Redemption of Creation Units Notes 13 false false R14.htm 013 - Disclosure - Financial Highlights Sheet http://www.vts.com/role/FinancialHighlights Financial Highlights Notes 14 false false R15.htm 014 - Disclosure - Risk Sheet http://www.vts.com/role/Risk Risk Notes 15 false false R16.htm 015 - Disclosure - Subsequent Events Sheet http://www.vts.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 016 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.vts.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.vts.com/role/SignificantAccountingPolicies 17 false false R18.htm 017 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.vts.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.vts.com/role/SignificantAccountingPolicies 18 false false R19.htm 018 - Disclosure - Investments (Tables) Sheet http://www.vts.com/role/InvestmentsTables Investments (Tables) Tables http://www.vts.com/role/Investments 19 false false R20.htm 019 - Disclosure - Creation and Redemption of Creation Units (Tables) Sheet http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables Creation and Redemption of Creation Units (Tables) Tables http://www.vts.com/role/CreationandRedemptionofCreationUnits 20 false false R21.htm 020 - Disclosure - Financial Highlights (Tables) Sheet http://www.vts.com/role/FinancialHighlightsTables Financial Highlights (Tables) Tables http://www.vts.com/role/FinancialHighlights 21 false false R22.htm 021 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.vts.com/role/SignificantAccountingPoliciesDetails Significant Accounting Policies (Details) Details http://www.vts.com/role/SignificantAccountingPoliciesTables 22 false false R23.htm 022 - Disclosure - Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds Sheet http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds Details http://www.vts.com/role/SignificantAccountingPoliciesTables 23 false false R24.htm 023 - Disclosure - Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy Sheet http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy Details http://www.vts.com/role/SignificantAccountingPoliciesTables 24 false false R25.htm 024 - Disclosure - Investments (Details) - Schedule of Fair Value of Derivative Instruments Sheet http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable Investments (Details) - Schedule of Fair Value of Derivative Instruments Details http://www.vts.com/role/InvestmentsTables 25 false false R26.htm 025 - Disclosure - Investments (Details) - Schedule of Effect of Derivative Instruments on the Statement of Operations Sheet http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable Investments (Details) - Schedule of Effect of Derivative Instruments on the Statement of Operations Details http://www.vts.com/role/InvestmentsTables 26 false false R27.htm 026 - Disclosure - Investments (Details) - Schedule of Pledged by Funds Fair Values of Derivative Instruments Sheet http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable Investments (Details) - Schedule of Pledged by Funds Fair Values of Derivative Instruments Details http://www.vts.com/role/InvestmentsTables 27 false false R28.htm 027 - Disclosure - Investments (Details) - Schedule of Gross Amounts Not Offset in the Statements of Financial Condition Sheet http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable Investments (Details) - Schedule of Gross Amounts Not Offset in the Statements of Financial Condition Details http://www.vts.com/role/InvestmentsTables 28 false false R29.htm 028 - Disclosure - Agreements (Details) Sheet http://www.vts.com/role/AgreementsDetails Agreements (Details) Details http://www.vts.com/role/Agreements 29 false false R30.htm 029 - Disclosure - Creation and Redemption of Creation Units (Details) Sheet http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails Creation and Redemption of Creation Units (Details) Details http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables 30 false false R31.htm 030 - Disclosure - Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees Sheet http://www.vts.com/role/ScheduleofTransactionFeesTable Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees Details http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables 31 false false R32.htm 031 - Disclosure - Financial Highlights (Details) Sheet http://www.vts.com/role/FinancialHighlightsDetails Financial Highlights (Details) Details http://www.vts.com/role/FinancialHighlightsTables 32 false false R33.htm 032 - Disclosure - Financial Highlights (Details) - Schedule of Share Outstanding Sheet http://www.vts.com/role/ScheduleofShareOutstandingTable Financial Highlights (Details) - Schedule of Share Outstanding Details http://www.vts.com/role/FinancialHighlightsTables 33 false false R34.htm 033 - Disclosure - Risk (Details) Sheet http://www.vts.com/role/RiskDetails Risk (Details) Details http://www.vts.com/role/Risk 34 false false All Reports Book All Reports cik0001793497-20230930.xsd cik0001793497-20230930_cal.xml cik0001793497-20230930_def.xml cik0001793497-20230930_lab.xml cik0001793497-20230930_pre.xml f10q0923_vstrust.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 52 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "f10q0923_vstrust.htm": { "nsprefix": "cik0001793497", "nsuri": "http://www.vts.com/20230930", "dts": { "schema": { "local": [ "cik0001793497-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd" ] }, "calculationLink": { "local": [ "cik0001793497-20230930_cal.xml" ] }, "definitionLink": { "local": [ "cik0001793497-20230930_def.xml" ] }, "labelLink": { "local": [ "cik0001793497-20230930_lab.xml" ] }, "presentationLink": { "local": [ "cik0001793497-20230930_pre.xml" ] }, "inline": { "local": [ "f10q0923_vstrust.htm" ] } }, "keyStandard": 110, "keyCustom": 66, "axisStandard": 12, "axisCustom": 0, "memberStandard": 7, "memberCustom": 15, "hidden": { "total": 74, "http://fasb.org/us-gaap/2023": 30, "http://www.vts.com/20230930": 40, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 110, "entityCount": 1, "segmentCount": 26, "elementCount": 289, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 413, "http://xbrl.sec.gov/dei/2023": 34 }, "report": { "R1": { "role": "http://www.vts.com/role/DocumentAndEntityInformation", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c0", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.vts.com/role/ConsolidatedBalanceSheet", "longName": "001 - Statement - Statements of Assets and Liabilities (Unaudited)", "shortName": "Statements of Assets and Liabilities (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c6", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c6", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.vts.com/role/ConsolidatedIncomeStatement", "longName": "002 - Statement - Statements of Operations (Unaudited)", "shortName": "Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c8", "name": "us-gaap:InterestAndOtherIncome", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c8", "name": "us-gaap:InterestAndOtherIncome", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.vts.com/role/ConsolidatedIncomeStatement0", "longName": "003 - Statement - Statement of Changes in Net Assets (Unaudited)", "shortName": "Statement of Changes in Net Assets (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c8", "name": "us-gaap:GainLossOnInvestments", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c8", "name": "us-gaap:GainLossOnInvestments", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.vts.com/role/ConsolidatedCashFlow", "longName": "004 - Statement - Statements of Cash Flows (Unaudited)", "shortName": "Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c8", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c8", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable", "longName": "005 - Statement - Schedule of Investments (Unaudited)", "shortName": "Schedule of Investments (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:OtherShortTermInvestments", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:OtherShortTermInvestments", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals", "longName": "006 - Statement - Schedule of Investments (Unaudited) (Parentheticals)", "shortName": "Schedule of Investments (Unaudited) (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c32", "name": "cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c32", "name": "cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.vts.com/role/Organization", "longName": "007 - Disclosure - Organization", "shortName": "Organization", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.vts.com/role/SignificantAccountingPolicies", "longName": "008 - Disclosure - Significant Accounting Policies", "shortName": "Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.vts.com/role/Investments", "longName": "009 - Disclosure - Investments", "shortName": "Investments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.vts.com/role/Agreements", "longName": "010 - Disclosure - Agreements", "shortName": "Agreements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c0", "name": "cik0001793497:AgreementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cik0001793497:AgreementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.vts.com/role/OfferingCosts", "longName": "011 - Disclosure - Offering Costs", "shortName": "Offering Costs", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c0", "name": "cik0001793497:OfferingCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cik0001793497:OfferingCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.vts.com/role/CreationandRedemptionofCreationUnits", "longName": "012 - Disclosure - Creation and Redemption of Creation Units", "shortName": "Creation and Redemption of Creation Units", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.vts.com/role/FinancialHighlights", "longName": "013 - Disclosure - Financial Highlights", "shortName": "Financial Highlights", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.vts.com/role/Risk", "longName": "014 - Disclosure - Risk", "shortName": "Risk", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.vts.com/role/SubsequentEvents", "longName": "015 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.vts.com/role/AccountingPoliciesByPolicy", "longName": "016 - Disclosure - Accounting Policies, by Policy (Policies)", "shortName": "Accounting Policies, by Policy (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "17", "firstAnchor": { "contextRef": "c0", "name": "cik0001793497:EmergingGrowthCompanyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cik0001793497:EmergingGrowthCompanyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.vts.com/role/SignificantAccountingPoliciesTables", "longName": "017 - Disclosure - Significant Accounting Policies (Tables)", "shortName": "Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "18", "firstAnchor": { "contextRef": "c0", "name": "cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.vts.com/role/InvestmentsTables", "longName": "018 - Disclosure - Investments (Tables)", "shortName": "Investments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables", "longName": "019 - Disclosure - Creation and Redemption of Creation Units (Tables)", "shortName": "Creation and Redemption of Creation Units (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "c0", "name": "cik0001793497:ScheduleOfTransactionFeesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cik0001793497:ScheduleOfTransactionFeesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.vts.com/role/FinancialHighlightsTables", "longName": "020 - Disclosure - Financial Highlights (Tables)", "shortName": "Financial Highlights (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "c0", "name": "cik0001793497:ScheduleOfShareOutstandingTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:QuarterlyFinancialInformationTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cik0001793497:ScheduleOfShareOutstandingTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:QuarterlyFinancialInformationTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.vts.com/role/SignificantAccountingPoliciesDetails", "longName": "021 - Disclosure - Significant Accounting Policies (Details)", "shortName": "Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "c0", "name": "cik0001793497:GrossRevenue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-7", "ancestors": [ "span", "p", "ix:continuation", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cik0001793497:GrossRevenue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-7", "ancestors": [ "span", "p", "ix:continuation", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable", "longName": "022 - Disclosure - Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds", "shortName": "Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "c8", "name": "cik0001793497:CreateRedeemCutoffDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c8", "name": "cik0001793497:CreateRedeemCutoffDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable", "longName": "023 - Disclosure - Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy", "shortName": "Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "c3", "name": "cik0001793497:AmountOfTotalTrust", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "cik0001793497:AmountOfTotalTrust", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable", "longName": "024 - Disclosure - Investments (Details) - Schedule of Fair Value of Derivative Instruments", "shortName": "Investments (Details) - Schedule of Fair Value of Derivative Instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "c65", "name": "cik0001793497:TotalTrust", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c65", "name": "cik0001793497:TotalTrust", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable", "longName": "025 - Disclosure - Investments (Details) - Schedule of Effect of Derivative Instruments on the Statement of Operations", "shortName": "Investments (Details) - Schedule of Effect of Derivative Instruments on the Statement of Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "c77", "name": "cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "span", "td", "tr", "table", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c77", "name": "cik0001793497:RealizedGainLossOnDerivativesRecognizedInIncome", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "span", "td", "tr", "table", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable", "longName": "026 - Disclosure - Investments (Details) - Schedule of Pledged by Funds Fair Values of Derivative Instruments", "shortName": "Investments (Details) - Schedule of Pledged by Funds Fair Values of Derivative Instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "c82", "name": "cik0001793497:GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c82", "name": "cik0001793497:GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable", "longName": "027 - Disclosure - Investments (Details) - Schedule of Gross Amounts Not Offset in the Statements of Financial Condition", "shortName": "Investments (Details) - Schedule of Gross Amounts Not Offset in the Statements of Financial Condition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "c12", "name": "cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c12", "name": "cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.vts.com/role/AgreementsDetails", "longName": "028 - Disclosure - Agreements (Details)", "shortName": "Agreements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "c3", "name": "cik0001793497:SubadvisoryFeeRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "p", "cik0001793497:AgreementsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "cik0001793497:SubadvisoryFeeRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "p", "cik0001793497:AgreementsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails", "longName": "029 - Disclosure - Creation and Redemption of Creation Units (Details)", "shortName": "Creation and Redemption of Creation Units (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:SharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:SharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.vts.com/role/ScheduleofTransactionFeesTable", "longName": "030 - Disclosure - Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees", "shortName": "Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "c77", "name": "us-gaap:SaleOfTrustAssetsToPayExpenses", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c77", "name": "us-gaap:SaleOfTrustAssetsToPayExpenses", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.vts.com/role/FinancialHighlightsDetails", "longName": "031 - Disclosure - Financial Highlights (Details)", "shortName": "Financial Highlights (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "c92", "name": "us-gaap:GeneralAndAdministrativeExpenseRatio", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "link:footnote", "td", "tr", "table", "ix:continuation", "us-gaap:QuarterlyFinancialInformationTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c92", "name": "us-gaap:GeneralAndAdministrativeExpenseRatio", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "link:footnote", "td", "tr", "table", "ix:continuation", "us-gaap:QuarterlyFinancialInformationTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.vts.com/role/ScheduleofShareOutstandingTable", "longName": "032 - Disclosure - Financial Highlights (Details) - Schedule of Share Outstanding", "shortName": "Financial Highlights (Details) - Schedule of Share Outstanding", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c100", "name": "us-gaap:InvestmentCompanyMarketValuePerShare", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:QuarterlyFinancialInformationTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c100", "name": "us-gaap:InvestmentCompanyMarketValuePerShare", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:QuarterlyFinancialInformationTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.vts.com/role/RiskDetails", "longName": "033 - Disclosure - Risk (Details)", "shortName": "Risk (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c0", "name": "cik0001793497:RelevantBenchmark", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cik0001793497:RelevantBenchmark", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q0923_vstrust.htm", "first": true, "unique": true } } }, "tag": { "cik0001793497_TotalTrust": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "TotalTrust", "presentation": [ "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total Trust", "documentation": "Total Trust amount.", "label": "Total Trust" } } }, "auth_ref": [] }, "cik0001793497_SignificantAccountingPoliciesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "SignificantAccountingPoliciesDetailsTable", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_InvestmentCompanyTotalReturnAfterIncentiveFees": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyTotalReturnAfterIncentiveFees", "presentation": [ "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net Investment Loss", "label": "Investment Company, Total Return after Incentive Fees", "documentation": "Percentage increase (decrease), after deduction of incentive fee, in fund net asset value. Includes, but is not limited to, interest and dividend income (loss) and realized and unrealized gain (loss)." } } }, "auth_ref": [ "r194" ] }, "cik0001793497_TotalReturnAtMarketValue": { "xbrltype": "percentItemType", "nsuri": "http://www.vts.com/20230930", "localname": "TotalReturnAtMarketValue", "presentation": [ "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total Return at Market Value", "documentation": "Percentage of return at market value", "label": "Total Return At Market Value" } } }, "auth_ref": [] }, "cik0001793497_AgreementsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "AgreementsDetailsTable", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Agreements (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_OtherShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherShortTermInvestments", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "terseLabel": "TOTAL SHORT TERM INVESTMENT", "label": "Other Short-Term Investments", "documentation": "Amount of short-term investments classified as other." } } }, "auth_ref": [ "r30", "r168", "r343" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r16", "r63", "r306" ] }, "cik0001793497_AssetDerivativesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "AssetDerivativesMember", "presentation": [ "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Derivatives [Member]", "label": "Asset Derivatives Member" } } }, "auth_ref": [] }, "cik0001793497_FinancialHighlightsTablesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "FinancialHighlightsTablesLineItems", "presentation": [ "http://www.vts.com/role/FinancialHighlightsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Highlights [Abstract]", "label": "Financial Highlights Tables Line Items" } } }, "auth_ref": [] }, "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsLineItems", "presentation": [ "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds [Line Items]" } } }, "auth_ref": [] }, "cik0001793497_GrossRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "GrossRevenue", "crdr": "debit", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual gross revenue", "documentation": "The amount of gross revenue.", "label": "Gross Revenue" } } }, "auth_ref": [] }, "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "SignificantAccountingPoliciesDetailsScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable", "presentation": [ "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies (Details) - Schedule of Cut-Off Times and the Times of the Calculation of the Funds [Table]" } } }, "auth_ref": [] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cash - 1.1% (a)", "label": "Cash Equivalents, at Carrying Value", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r339", "r426" ] }, "cik0001793497_NAVCalculationTimeESTDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NAVCalculationTimeESTDescription", "presentation": [ "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" ], "lang": { "en-us": { "role": { "terseLabel": "NAV Calculation Time (EST)", "documentation": "NAV Calculation Time (EST), description.", "label": "NAVCalculation Time ESTDescription" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://www.vts.com/role/Risk" ], "lang": { "en-us": { "role": { "terseLabel": "RISK", "label": "Concentration Risk Disclosure [Text Block]", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r46" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.vts.com/role/FinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r108", "r109", "r110", "r111", "r127", "r134", "r137", "r138", "r139", "r165", "r166", "r175", "r215", "r216", "r266", "r273", "r276", "r277", "r290", "r304", "r305", "r310", "r314", "r318", "r321", "r323", "r349", "r355", "r420", "r421", "r422", "r423", "r424" ] }, "cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfFairValueOfDerivativeInstrumentsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Fair Value Of Derivative Instruments Abstract" } } }, "auth_ref": [] }, "us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyExpenseRatioAfterIncentiveAllocation", "presentation": [ "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expense ratio", "label": "Investment Company, Expense Ratio after Incentive Allocation", "documentation": "Percentage of expense, after incentive allocation, to average net assets." } } }, "auth_ref": [ "r427" ] }, "cik0001793497_NonconvertibleDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NonconvertibleDebtSecurities", "crdr": "debit", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-convertible debt securities", "documentation": "The amount of non-convertible debt securities.", "label": "Nonconvertible Debt Securities" } } }, "auth_ref": [] }, "cik0001793497_CreateRedeemCutoffDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "CreateRedeemCutoffDescription", "presentation": [ "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Create/Redeem Cut-off (EST)", "documentation": "Create/Redeem Cut-off (EST) 2x Long VIX Futures ETF, description", "label": "Create Redeem Cutoff Description" } } }, "auth_ref": [] }, "cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Valuation Of Investments At Using The Fair Value Hierarchy Abstract" } } }, "auth_ref": [] }, "cik0001793497_NonaffiliatesExceeded": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NonaffiliatesExceeded", "crdr": "debit", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-affiliates exceeded", "documentation": "The amount of non-affiliates exceeded.", "label": "Nonaffiliates Exceeded" } } }, "auth_ref": [] }, "cik0001793497_PayablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "PayablesAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Payables", "label": "Payables Abstract" } } }, "auth_ref": [] }, "us-gaap_FloorBrokerageExchangeAndClearanceFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FloorBrokerageExchangeAndClearanceFees", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Broker interest expense", "label": "Floor Brokerage, Exchange and Clearance Fees", "documentation": "The amount of expense during the period for floor brokerage fees paid to other broker-dealers to execute trades on their behalf, stock exchange fees, order flow fees, and clearance fees." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.vts.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Effect of Derivative Instruments on the Statement of Operations", "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position." } } }, "auth_ref": [ "r25" ] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfessionalFees", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Professional fees", "label": "Professional Fees", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r325", "r432", "r433" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.vts.com/role/CreationandRedemptionofCreationUnits" ], "lang": { "en-us": { "role": { "terseLabel": "CREATION AND REDEMPTION OF CREATION UNITS", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r135", "r136", "r140", "r141", "r142", "r319" ] }, "cik0001793497_NAVCalculationDate": { "xbrltype": "dateItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NAVCalculationDate", "presentation": [ "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable" ], "lang": { "en-us": { "role": { "terseLabel": "NAV Calculation Date", "documentation": "Date the NAV calculation date.", "label": "NAVCalculation Date" } } }, "auth_ref": [] }, "us-gaap_FloorBrokeragePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FloorBrokeragePolicy", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Brokerage Commissions and Futures Account Fees", "label": "Floor Brokerage, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the recognition and recording of fees paid to other broker dealers for executing trades. Broker-dealers often use other brokers to execute trades on their behalf. The trading broker-dealer becomes a customer of the executing broker-dealer and pays a floor brokerage fee. Such fees are paid periodically either directly to the executing broker-dealer or through a clearinghouse. These include fees paid to clearing brokers and market specialists." } } }, "auth_ref": [ "r1" ] }, "cik0001793497_AverageDailyNetAssetsRate": { "xbrltype": "percentItemType", "nsuri": "http://www.vts.com/20230930", "localname": "AverageDailyNetAssetsRate", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average daily net assets rate", "documentation": "Average daily net assets rate.", "label": "Average Daily Net Assets Rate" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.vts.com/role/FinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum [Member]", "label": "Maximum [Member]" } } }, "auth_ref": [ "r108", "r109", "r110", "r111", "r134", "r166", "r175", "r215", "r216", "r266", "r273", "r276", "r277", "r290", "r304", "r305", "r310", "r314", "r318", "r321", "r355", "r419", "r420", "r421", "r422", "r423", "r424" ] }, "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable", "presentation": [ "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Table]" } } }, "auth_ref": [] }, "cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Effect Of Derivative Instruments On The Statement Of Operations Abstract" } } }, "auth_ref": [] }, "cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Pledged By Funds Fair Values Of Derivative Instruments Abstract" } } }, "auth_ref": [] }, "cik0001793497_AmountOfTotalTrust": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "AmountOfTotalTrust", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total Trust", "documentation": "Total amount of trust.", "label": "Amount Of Total Trust" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMember", "presentation": [ "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other Assets [Member]", "label": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r20", "r27" ] }, "cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Gross Amounts Not Offset In The Statements Of Financial Condition Abstract" } } }, "auth_ref": [] }, "cik0001793497_SubadvisoryFeeRate": { "xbrltype": "percentItemType", "nsuri": "http://www.vts.com/20230930", "localname": "SubadvisoryFeeRate", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sub-advisory fee rate", "documentation": "Percentage of sub-advisory fee rate.", "label": "Subadvisory Fee Rate" } } }, "auth_ref": [] }, "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "SignificantAccountingPoliciesDetailsScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyLineItems", "presentation": [ "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies (Details) - Schedule of Valuation of Investments at Using the Fair Value Hierarchy [Line Items]" } } }, "auth_ref": [] }, "cik0001793497_ScheduleOfTransactionFeesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfTransactionFeesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Transaction Fees Abstract" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.vts.com/role/FinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum [Member]", "label": "Minimum [Member]" } } }, "auth_ref": [ "r108", "r109", "r110", "r111", "r134", "r166", "r175", "r215", "r216", "r266", "r273", "r276", "r277", "r290", "r304", "r305", "r310", "r314", "r318", "r321", "r355", "r419", "r420", "r421", "r422", "r423", "r424" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedCashFlow", "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r77", "r78", "r79", "r93", "r167", "r180", "r204", "r217", "r219", "r220", "r221", "r222", "r223", "r225", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r238", "r239", "r240", "r241", "r242", "r244", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r324" ] }, "cik0001793497_ScheduleOfShareOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfShareOutstandingAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Share Outstanding Abstract" } } }, "auth_ref": [] }, "cik0001793497_AuthorizedParticipantsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.vts.com/20230930", "localname": "AuthorizedParticipantsPercentage", "presentation": [ "http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Authorized participants percentage", "documentation": "Percentage of authorized participants percentage.", "label": "Authorized Participants Percentage" } } }, "auth_ref": [] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Domain]", "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r63" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "cik0001793497_TotalTrust1": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "TotalTrust1", "presentation": [ "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total Trust", "documentation": "Total Trust amount.", "label": "Total Trust1" } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedProfessionalFeesCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Professional fees payable", "label": "Accrued Professional Fees", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received." } } }, "auth_ref": [ "r29" ] }, "us-gaap_CollateralizedAgreementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollateralizedAgreementsAbstract", "lang": { "en-us": { "role": { "label": "CollateralizedAgreementsAbstract" } } }, "auth_ref": [] }, "us-gaap_ManagementFeeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ManagementFeeExpense", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Management fees", "label": "Management Fee Expense", "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment." } } }, "auth_ref": [ "r28", "r249", "r325", "r431" ] }, "us-gaap_InterestAndOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndOtherIncome", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_InvestmentIncomeNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Interest and Other Income", "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [] }, "cik0001793497_RelevantBenchmark": { "xbrltype": "percentItemType", "nsuri": "http://www.vts.com/20230930", "localname": "RelevantBenchmark", "presentation": [ "http://www.vts.com/role/RiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Relevant benchmark percentage", "documentation": "Percentage of relevant benchmark.", "label": "Relevant Benchmark" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesTable", "presentation": [ "http://www.vts.com/role/ScheduleofTransactionFeesTable" ], "lang": { "en-us": { "role": { "label": "Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees [Table]" } } }, "auth_ref": [] }, "cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsLineItems", "presentation": [ "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable" ], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of Effect of Derivative Instruments on the Statement of Operations [Line Items]" } } }, "auth_ref": [] }, "cik0001793497_InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "InvestmentsDetailsScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable", "presentation": [ "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable" ], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of Effect of Derivative Instruments on the Statement of Operations [Table]" } } }, "auth_ref": [] }, "cik0001793497_FinancialHighlightsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "FinancialHighlightsDetailsTable", "presentation": [ "http://www.vts.com/role/FinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Financial Highlights (Details) [Table]" } } }, "auth_ref": [] }, "cik0001793497_BrokerageCommissionsRate": { "xbrltype": "percentItemType", "nsuri": "http://www.vts.com/20230930", "localname": "BrokerageCommissionsRate", "presentation": [ "http://www.vts.com/role/FinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Brokerage commissions rate", "documentation": "Brokerage commissions rate.", "label": "Brokerage Commissions Rate" } } }, "auth_ref": [] }, "cik0001793497_NetAssetsConsistOfAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NetAssetsConsistOfAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "NET ASSETS CONSIST OF:", "label": "Net Assets Consist Of Abstract" } } }, "auth_ref": [] }, "cik0001793497_RealizedGainLossOnDerivativesRecognizedInIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "RealizedGainLossOnDerivativesRecognizedInIncome", "crdr": "credit", "presentation": [ "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Realized Gain (Loss) on Derivatives Recognized in Income", "documentation": "Amount of realized gain (loss) on derivatives recognized in income.", "label": "Realized Gain Loss On Derivatives Recognized In Income" } } }, "auth_ref": [] }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "QuarterlyFinancialInformationDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Financial Highlights [Abstract]" } } }, "auth_ref": [] }, "cik0001793497_ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ChangeInUnrealizedAppreciationDepreciationsOnDerivativesRecognizedInIncome", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income", "documentation": "Change in unrealized appreciation (depreciation) on derivatives recognized in income.", "label": "Change In Unrealized Appreciation Depreciations On Derivatives Recognized In Income" } } }, "auth_ref": [] }, "cik0001793497_InvestmentsDetailsScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "InvestmentsDetailsScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable", "presentation": [ "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of Pledged by Funds Fair Values of Derivative Instruments [Table]" } } }, "auth_ref": [] }, "cik0001793497_InvestmentsDetailsScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "InvestmentsDetailsScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsLineItems", "presentation": [ "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of Pledged by Funds Fair Values of Derivative Instruments [Line Items]" } } }, "auth_ref": [] }, "cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts of Recognized Assets presented in the Statements of Financial Condition", "documentation": "The amount of gross amounts of recognized assets presented.", "label": "Gross Amounts Of Recognized Assets Presented In The Statements Of Financial Condition" } } }, "auth_ref": [] }, "cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "GrossAmountsOffsetInTheStatementsOfFinancialCondition", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts Offset in the Statements of Financial Condition", "documentation": "The amount of gross amounts offset in the statements of financial condition.", "label": "Gross Amounts Offset In The Statements Of Financial Condition" } } }, "auth_ref": [] }, "cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net Amounts of Assets presented in the Statements of Financial Condition", "documentation": "The amount of net assets presented.", "label": "Net Amounts Of Assets Presented In The Statements Of Financial Condition" } } }, "auth_ref": [] }, "cik0001793497_OnexShortVIXFuturesETFMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "OnexShortVIXFuturesETFMember", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation", "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals", "http://www.vts.com/role/ScheduleofTransactionFeesTable" ], "lang": { "en-us": { "role": { "terseLabel": "-1x Short VIX Futures ETF", "verboseLabel": "1 x Short VIX Futures ETF [Member]", "netLabel": "-1 x Short VIX Futures ETF [Member]", "label": "Onex Short VIXFutures ETFMember" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r14", "r75", "r105", "r112", "r113", "r114", "r115", "r116", "r117", "r118", "r119", "r120", "r150", "r151", "r152", "r156", "r224", "r308", "r326", "r351", "r417", "r418" ] }, "cik0001793497_GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "GrossAmountsOfRecognizedLiabilitiesPresentedInTheStatementsOfFinancialCondition", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts of Recognized Liabilities presented in the Statements of Financial Condition", "documentation": "The amount of gross Amounts of Recognized Liabilities presented in the Statements of Financial Condition.", "label": "Gross Amounts Of Recognized Liabilities Presented In The Statements Of Financial Condition" } } }, "auth_ref": [] }, "cik0001793497_CBOEVIXFuturesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "CBOEVIXFuturesMember", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "terseLabel": "CBOE VIX Futures\t[Member]", "label": "CBOEVIXFutures Member" } } }, "auth_ref": [] }, "cik0001793497_GrossAmountsOffsetInTheStatementsOfFinancialCondition1": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "GrossAmountsOffsetInTheStatementsOfFinancialCondition1", "crdr": "credit", "presentation": [ "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts Offset in the Statements of Financial Condition", "documentation": "The amount of gross amounts offset in the statements of financial condition.", "label": "Gross Amounts Offset In The Statements Of Financial Condition1" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivablesPeriodPastDueAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivablesPeriodPastDueAxis", "presentation": [ "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "label": "Financial Asset, Aging [Axis]", "documentation": "Information by period in which financial asset is past due or not past due." } } }, "auth_ref": [ "r60", "r106", "r311" ] }, "cik0001793497_NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NetAmountsOfLiabilitiesPresentedInTheStatementsOfFinancialCondition", "crdr": "credit", "presentation": [ "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net Amounts of Liabilities presented in the Statements of Financial Condition", "documentation": "Amounts of liabilities presented in the statements of financial condition.", "label": "Net Amounts Of Liabilities Presented In The Statements Of Financial Condition" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.vts.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "SUBSEQUENT EVENTS", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r160", "r161" ] }, "us-gaap_DerivativesFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesFairValueLineItems", "presentation": [ "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value of Derivative Instruments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesMember", "presentation": [ "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other Liabilities [Member]", "label": "Other Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other liabilities." } } }, "auth_ref": [ "r20", "r27" ] }, "cik0001793497_CBOEVIXFuturesOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "CBOEVIXFuturesOneMember", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "terseLabel": "CBOE VIX Futures [Member]", "label": "CBOEVIXFutures One Member" } } }, "auth_ref": [] }, "cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ClassIUnlimitedSharesAuthorizedAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Class I (unlimited shares authorized):", "label": "Class IUnlimited Shares Authorized Abstract" } } }, "auth_ref": [] }, "cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "InvestmentsDetailsScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable", "presentation": [ "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable" ], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of Gross Amounts Not Offset in the Statements of Financial Condition [Table]" } } }, "auth_ref": [] }, "us-gaap_InvestmentOwnedUnrecognizedUnrealizedAppreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedUnrecognizedUnrealizedAppreciation", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Appreciation/ (Depreciation)", "label": "Investment Owned, Unrecognized Unrealized Appreciation", "documentation": "This element represents the excess of the cost (face amount, notional amount) of an investment (security, contract) over its fair value which deficiency has not been recognized in earnings of the entity." } } }, "auth_ref": [ "r54" ] }, "cik0001793497_IncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "IncomeAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Income:", "label": "Income Abstract" } } }, "auth_ref": [] }, "cik0001793497_InvestmentsDetailsScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "InvestmentsDetailsScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionLineItems", "presentation": [ "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable" ], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of Gross Amounts Not Offset in the Statements of Financial Condition [Line Items]" } } }, "auth_ref": [] }, "cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne", "crdr": "credit", "presentation": [ "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition", "documentation": "The sales price you receive with any selling costs you paid deducted.", "label": "Amounts Of Recognized Assets Liabilities Presented In The Statements Of Financial Condition One" } } }, "auth_ref": [] }, "cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo", "crdr": "credit", "presentation": [ "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments for the Benefit of (the Funds) / the Counterparties", "documentation": "The amount of financial instruments.", "label": "Financial Instruments For The Benefit Ofthe Funds The Counterparties Two" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Axis]", "documentation": "Information by type of cash and cash equivalent balance." } } }, "auth_ref": [ "r63" ] }, "cik0001793497_FirstAmericanGovernmentObligationsFundMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "FirstAmericanGovernmentObligationsFundMember", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "First American Government Obligations Fund [Member]", "label": "First American Government Obligations Fund Member" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES", "label": "Liabilities [Abstract]" } } }, "auth_ref": [] }, "cik0001793497_CashCollateralForTheBenefitOftheFundsTheCounterparties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "CashCollateralForTheBenefitOftheFundsTheCounterparties", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Collateral for the Benefit of (the Funds) / the Counterparties", "documentation": "Amount of cash collateral for the benefit of (the funds) / the counterparties.", "label": "Cash Collateral For The Benefit Ofthe Funds The Counterparties" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "presentation": [ "http://www.vts.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Gross Amounts Not Offset in the Statements of Financial Condition", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented." } } }, "auth_ref": [] }, "cik0001793497_CapitalUnitNetAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "CapitalUnitNetAmount", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net Amount", "documentation": "The amount of capital unit net amount.", "label": "Capital Unit Net Amount" } } }, "auth_ref": [] }, "cik0001793497_MinusOnexShortVIXFuturesETFMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "MinusOnexShortVIXFuturesETFMember", "presentation": [ "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable", "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable", "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "-1x Short VIX Futures ETF [Member]", "label": "Minus Onex Short VIXFutures ETFMember" } } }, "auth_ref": [] }, "cik0001793497_FuturesContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "FuturesContractsMember", "presentation": [ "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "terseLabel": "Futures Contracts [Member]", "label": "Futures Contracts Member" } } }, "auth_ref": [] }, "cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "FinancialHighlightsDetailsScheduleofShareOutstandingTable", "presentation": [ "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "label": "Financial Highlights (Details) - Schedule of Share Outstanding [Table]" } } }, "auth_ref": [] }, "cik0001793497_LiabilityDerivativesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "LiabilityDerivativesMember", "presentation": [ "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Liability Derivatives [Member]", "label": "Liability Derivatives Member" } } }, "auth_ref": [] }, "cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "CreationandRedemptionofCreationUnitsDetailsScheduleofTransactionFeesLineItems", "presentation": [ "http://www.vts.com/role/ScheduleofTransactionFeesTable" ], "lang": { "en-us": { "role": { "label": "Creation and Redemption of Creation Units (Details) - Schedule of Transaction Fees [Line Items]" } } }, "auth_ref": [] }, "cik0001793497_ExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ExpensesAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Expenses:", "label": "Expenses Abstract" } } }, "auth_ref": [] }, "cik0001793497_FinancialHighlightsDetailsScheduleofShareOutstandingLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "FinancialHighlightsDetailsScheduleofShareOutstandingLineItems", "presentation": [ "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "label": "Financial Highlights (Details) - Schedule of Share Outstanding [Line Items]" } } }, "auth_ref": [] }, "cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts": { "xbrltype": "perShareItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts", "presentation": [ "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts", "documentation": "Amount of realized and unrealized gain (loss) on investment, and future contracts.", "label": "Net Realized And Unrealized Gain Loss On Investments And Futures Contracts" } } }, "auth_ref": [] }, "us-gaap_OtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInvestments", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "terseLabel": "TOTAL INVESTMENTS", "label": "Other Investments", "documentation": "Amount of investments classified as other." } } }, "auth_ref": [ "r340" ] }, "cik0001793497_MarketValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.vts.com/20230930", "localname": "MarketValuePerShare", "presentation": [ "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Market Value Per Share, at September 30, 2023 and September 30, 2022", "documentation": "Per share excess of market value per share.", "label": "Market Value Per Share" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheetAlt0": { "parentTag": "us-gaap_AssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "negatedLabel": "Paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r32", "r320", "r430" ] }, "cik0001793497_OneShortVIXFuturesETFMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "OneShortVIXFuturesETFMember", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedCashFlow", "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable", "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable", "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "terseLabel": "-1x Short VIX Futures ETF", "verboseLabel": "1x Short VIX Futures ETF", "netLabel": "-1x Short VIX Futures ETF [Member]", "label": "One Short VIXFutures ETFMember" } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates & Indemnifications", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r17", "r18", "r19", "r56", "r57", "r58", "r59" ] }, "cik0001793497_FuturesContractsUnrealizedAppreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "FuturesContractsUnrealizedAppreciation", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_UnrealizedGainLossOnDerivatives", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "negatedLabel": "Futures", "documentation": "The amount of futures contracts unrealized appreciation.", "label": "Futures Contracts Unrealized Appreciation" } } }, "auth_ref": [] }, "us-gaap_RetirementPlanFundingStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanFundingStatusAxis", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Funding Status [Axis]", "documentation": "Information by status of funding for defined benefit plan designed to provide retirement benefits." } } }, "auth_ref": [ "r336", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "auth_ref": [ "r102", "r103", "r104" ] }, "cik0001793497_IncreasedecreaseInNetAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "IncreasedecreaseInNetAssets", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "lang": { "en-us": { "role": { "totalLabel": "Total increase (decrease) in net assets", "documentation": "Amount of total increase (decrease) in net assets.", "label": "Increasedecrease In Net Assets" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheetAlt0": { "parentTag": "us-gaap_AssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "negatedLabel": "Total distributable earnings (accumulated deficit)", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r33", "r47", "r171", "r176", "r177", "r189", "r226", "r320" ] }, "us-gaap_RetirementPlanFundingStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanFundingStatusDomain", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Funding Status [Domain]", "documentation": "Status of funding for defined benefit plan designed to provide retirement benefits." } } }, "auth_ref": [ "r336", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Variation margin payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r13", "r320" ] }, "cik0001793497_ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Cut Off Times And The Times Of The Calculation Of The Funds Abstract" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "cik0001793497_AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "AdjustmentsToReconcileNetIncomeLossToNetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities", "label": "Adjustments To Reconcile Net Income Loss To Net Cash Provided By Used In Operating Activities Abstract" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r121", "r128", "r129", "r130", "r131", "r132", "r133", "r162", "r163", "r164", "r312", "r313", "r315", "r316", "r317" ] }, "us-gaap_GeneralAndAdministrativeExpenseRatio": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpenseRatio", "presentation": [ "http://www.vts.com/role/FinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expense ratio percentage", "label": "General and Administrative Expense Ratio", "documentation": "Ratio of non-life general and administrative expenses to non-life net premiums earned." } } }, "auth_ref": [] }, "us-gaap_InvestmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTextBlock", "presentation": [ "http://www.vts.com/role/Investments" ], "lang": { "en-us": { "role": { "terseLabel": "INVESTMENTS", "label": "Investment [Text Block]", "documentation": "The entire disclosure for investment." } } }, "auth_ref": [ "r337", "r338", "r346" ] }, "cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "VixFuturesContractsNetRealizedGainLossOnFuturesContractsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAbstract", "presentation": [ "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "VIX Futures Contracts Net realized gain (loss) on futures contracts/changes in unrealized appreciation (depreciation) on futures contracts", "label": "Vix Futures Contracts Net Realized Gain Loss On Futures Contracts Changes In Unrealized Appreciation Depreciation On Futures Contracts Abstract" } } }, "auth_ref": [] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r121", "r128", "r129", "r130", "r131", "r132", "r133", "r155", "r162", "r163", "r164", "r312", "r313", "r315", "r316", "r317" ] }, "cik0001793497_ScheduleOfInvestmentsUnauditedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfInvestmentsUnauditedAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Investments Unaudited Abstract" } } }, "auth_ref": [] }, "cik0001793497_RatiosToAverageNetAssets5Abstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "RatiosToAverageNetAssets5Abstract", "presentation": [ "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Ratios to Average Net Assets: (5)", "label": "Ratios To Average Net Assets5 Abstract" } } }, "auth_ref": [] }, "us-gaap_GainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnInvestments", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "parentTag": "cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "lang": { "en-us": { "role": { "terseLabel": "Net investment loss", "label": "Gain (Loss) on Investments", "documentation": "Amount of realized and unrealized gain (loss) on investment." } } }, "auth_ref": [ "r39", "r334" ] }, "us-gaap_UnrealizedGainLossOnDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedGainLossOnDerivatives", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": "cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Net realized and unrealized gain (loss) on investments and futures contracts", "label": "Unrealized Gain (Loss) on Derivatives", "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period." } } }, "auth_ref": [ "r6", "r258", "r259", "r260", "r261", "r285" ] }, "us-gaap_InvestmentOwnedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtFairValue", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in securities, at value", "label": "Investment Owned, Fair Value", "documentation": "Fair value of investment in security owned." } } }, "auth_ref": [ "r180", "r205", "r206", "r207", "r209", "r210", "r211", "r212", "r214", "r217", "r218", "r228", "r229", "r265", "r268", "r269", "r270", "r278", "r279", "r280", "r281", "r282", "r288", "r289", "r295", "r296", "r297", "r323", "r326", "r429" ] }, "cik0001793497_DueFromOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "DueFromOther", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "negatedLabel": "Due to Other", "documentation": "Amount of due from others.", "label": "Due From Other" } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r50", "r65", "r75", "r96", "r98", "r100", "r105", "r112", "r113", "r114", "r115", "r116", "r117", "r118", "r119", "r120", "r149", "r151", "r156", "r170", "r237", "r320", "r326", "r351", "r352", "r417" ] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Cost of shares redeemed", "label": "Payments of Stock Issuance Costs", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r15" ] }, "us-gaap_PrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other assets", "label": "Prepaid Expense and Other Assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets." } } }, "auth_ref": [] }, "us-gaap_AssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNet", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.vts.com/role/ConsolidatedBalanceSheetAlt0": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "totalLabel": "NET ASSETS", "periodStartLabel": "Beginning of Period", "periodEndLabel": "End of Period", "terseLabel": "TOTAL NET ASSETS - 100%", "verboseLabel": "Net Assets", "label": "Net Assets", "documentation": "Amount of net assets (liabilities)." } } }, "auth_ref": [ "r8" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "cik0001793497_ReceivableForSharesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ReceivableForSharesSold", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Receivable for shares sold", "documentation": "It represent receivable for shares sold.", "label": "Receivable For Shares Sold" } } }, "auth_ref": [] }, "cik0001793497_VariationMarginReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "VariationMarginReceivable", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Variation margin receivable", "documentation": "Amount of variation margin receivable.", "label": "Variation Margin Receivable" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDueToRelatedPartiesCurrent", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Variation margin payable", "label": "Increase (Decrease) in Due to Related Parties, Current", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r61", "r66", "r67", "r68", "r75", "r87", "r88", "r90", "r91", "r94", "r95", "r105", "r112", "r114", "r115", "r116", "r119", "r120", "r122", "r123", "r124", "r125", "r126", "r156", "r185", "r186", "r187", "r188", "r191", "r193", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r225", "r246", "r264", "r298", "r299", "r300", "r301", "r302", "r335", "r344", "r345" ] }, "us-gaap_DerivativeNetAssetsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNetAssetsPercentage", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals", "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total net assets, percentage", "verboseLabel": "Fund's average net assets percentage", "label": "Derivative, Net Assets, Percentage", "documentation": "Percentage of value of derivative contract to net assets." } } }, "auth_ref": [ "r208", "r211", "r212", "r213", "r323", "r429" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r61", "r66", "r67", "r68", "r75", "r87", "r88", "r90", "r91", "r94", "r95", "r105", "r112", "r114", "r115", "r116", "r119", "r120", "r122", "r123", "r124", "r125", "r126", "r156", "r185", "r186", "r187", "r188", "r191", "r193", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r225", "r246", "r264", "r298", "r299", "r300", "r301", "r302", "r335", "r344", "r345" ] }, "us-gaap_NetAssetValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetAssetValuePerShare", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Net Asset Value, Offering and Redemption Price per Share (in Dollars per share)", "label": "Net Asset Value Per Share", "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure." } } }, "auth_ref": [ "r2", "r3", "r10", "r196", "r203", "r204", "r227", "r243", "r298", "r326" ] }, "us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInEarnestMoneyDepositsOutstanding", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease (Increase) in Deposits at broker for futures contracts", "label": "Increase (Decrease) in Earnest Money Deposits Outstanding", "documentation": "The increase (decrease) during the reporting period in the amount of deposits given by the reporting entity to a seller which shows that the prospective buyer is serious about purchasing a property." } } }, "auth_ref": [ "r5" ] }, "cik0001793497_PayableToBroker": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "PayableToBroker", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Payable to Broker", "label": "Payable To Broker" } } }, "auth_ref": [] }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "QuarterlyFinancialInformationTextBlock", "presentation": [ "http://www.vts.com/role/FinancialHighlights" ], "lang": { "en-us": { "role": { "terseLabel": "FINANCIAL HIGHLIGHTS", "label": "Quarterly Financial Information [Text Block]", "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information." } } }, "auth_ref": [ "r45", "r92" ] }, "cik0001793497_LicensingAndRegistrationFeesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "LicensingAndRegistrationFeesPayable", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Licensing and registration fees payable", "documentation": "The amount of licensing and registration fees payable.", "label": "Licensing And Registration Fees Payable" } } }, "auth_ref": [] }, "us-gaap_UnremittedEarningsInForeignInvestmentPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnremittedEarningsInForeignInvestmentPolicy", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Transactions and Related Income", "label": "Unremitted Earnings in Foreign Investment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for tax treatment of unremitted earnings in a foreign investment." } } }, "auth_ref": [ "r0" ] }, "cik0001793497_AdministrativeAccountingAndCustodianFeesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "AdministrativeAccountingAndCustodianFeesPayable", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Administrative, accounting and custodian fees payable", "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Administrative Accounting And Custodian Fees Payable" } } }, "auth_ref": [] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "label": "Risk [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LegalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LegalFees", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Licensing and registration fees", "label": "Legal Fees", "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings." } } }, "auth_ref": [ "r36" ] }, "cik0001793497_FuturesContracts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "FuturesContracts", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_UnrealizedGainLossOnDerivatives", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "negatedLabel": "Futures", "documentation": "The amount of futures contracts.", "label": "Futures Contracts" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Valuation of Investments at Using the Fair Value Hierarchy", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r154", "r155" ] }, "cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "SharesSoldNetOfSharesRedeemedinDollarsPerShare", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "parentTag": "cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares redeemed", "documentation": "The amount of shares sold, net of shares redeemed.", "label": "Shares Sold Net Of Shares Redeemedin Dollars Per Share" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NetRealizedGainlossOnInvestmentsAndFuturesContracts", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "parentTag": "cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "lang": { "en-us": { "role": { "terseLabel": "Net realized gain (loss) on investments and futures contracts", "documentation": "Amount of realized gain (loss) on investment.", "label": "Net Realized Gainloss On Investments And Futures Contracts" } } }, "auth_ref": [] }, "cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NetIncreasedecreaseInNetAssetsResultingFromOperations", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "parentTag": "cik0001793497_IncreasedecreaseInNetAssets", "weight": 1.0, "order": 1.0 }, "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "lang": { "en-us": { "role": { "totalLabel": "NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS", "terseLabel": "Net increase (decrease) in net assets resulting from operations", "documentation": "Amount of increase (decrease) in net assets from operations of investment company.", "label": "Net Increasedecrease In Net Assets Resulting From Operations" } } }, "auth_ref": [] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cost", "label": "Other Assets", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r49", "r64", "r169", "r326" ] }, "us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease", "presentation": [ "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net Increase (Decrease) in Net Asset Value Resulting from Operations", "label": "Investment Company, Net Asset Value Per Share, Period Increase (Decrease)", "documentation": "Per share or unit amount of increase (decrease) in net asset value." } } }, "auth_ref": [ "r428" ] }, "cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NetIncreaseInNetAssetsFromCapitalShareTransactions", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "parentTag": "cik0001793497_IncreasedecreaseInNetAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in net assets from capital share transactions", "documentation": "The amount of net increase in net assets from capital share transactions.", "label": "Net Increase In Net Assets From Capital Share Transactions" } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "parentTag": "cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "lang": { "en-us": { "role": { "terseLabel": "Net change in unrealized appreciation (depreciation) of investments and futures contracts", "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Net Change In Unrealized Appreciationdepreciation Of Investments And Futures Contracts" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable", "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals", "http://www.vts.com/role/ScheduleofTransactionFeesTable", "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "auth_ref": [ "r76", "r149", "r150", "r151", "r152", "r159", "r303", "r350", "r353", "r354" ] }, "cik0001793497_SharesSoldinShares": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "SharesSoldinShares", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "parentTag": "cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares sold", "label": "Shares Soldin Shares" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedCashFlow", "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable", "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable", "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable", "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals", "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable", "http://www.vts.com/role/ScheduleofShareOutstandingTable", "http://www.vts.com/role/ScheduleofTransactionFeesTable", "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r76", "r149", "r150", "r151", "r152", "r159", "r303", "r350", "r353", "r354" ] }, "cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ProceedsFromSalesOrMaturitiesOfInvestments", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sales or maturities of investments held", "documentation": "Proceeds from sales or maturities of investments.", "label": "Proceeds From Sales Or Maturities Of Investments" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r328" ] }, "cik0001793497_SVIXMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "SVIXMember", "presentation": [ "http://www.vts.com/role/AgreementsDetails", "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SVIX [Member]", "label": "SVIXMember" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherReceivables", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease (Increase) in other receivables", "label": "Increase (Decrease) in Other Receivables", "documentation": "Amount of increase (decrease) in receivables classified as other." } } }, "auth_ref": [ "r5" ] }, "us-gaap_InvestmentIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeNet", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Total Income", "label": "Investment Income, Net", "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities." } } }, "auth_ref": [ "r38", "r40" ] }, "cik0001793497_UnderlyingFaceAmountAtMarketValues": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "UnderlyingFaceAmountAtMarketValues", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Appreciation/ (Depreciation)", "documentation": "The nominal value of any stock at its issuing is termed its face value. The market value of any stock refers to the current market price of that stock as stated on the stock exchange. This value remains unaffected by the market conditions. Market conditions (such as government policies) can alter the market value.", "label": "Underlying Face Amount At Market Values" } } }, "auth_ref": [] }, "cik0001793497_UVIXMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "UVIXMember", "presentation": [ "http://www.vts.com/role/AgreementsDetails", "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "UVIX [Member]", "label": "UVIXMember" } } }, "auth_ref": [] }, "cik0001793497_OfferingCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "OfferingCostsTable", "presentation": [ "http://www.vts.com/role/OfferingCosts" ], "lang": { "en-us": { "role": { "label": "Offering Costs [Table]" } } }, "auth_ref": [] }, "cik0001793497_PurchasesOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "PurchasesOfInvestments", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of investments", "documentation": "The cash outflow associated with the purchase of all investments during the period.", "label": "Purchases Of Investments" } } }, "auth_ref": [] }, "us-gaap_InvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentPolicyTextBlock", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Valuation", "label": "Investment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for investment in financial asset." } } }, "auth_ref": [ "r173", "r180", "r181", "r182", "r183", "r271", "r272" ] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "cik0001793497_TwoxLongVIXFuturesETFMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "TwoxLongVIXFuturesETFMember", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedCashFlow", "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/DocumentAndEntityInformation", "http://www.vts.com/role/ScheduleofCutOffTimesandtheTimesoftheCalculationoftheFundsTable", "http://www.vts.com/role/ScheduleofEffectofDerivativeInstrumentsontheStatementofOperationsTable", "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable", "http://www.vts.com/role/ScheduleofGrossAmountsNotOffsetintheStatementsofFinancialConditionTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals", "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable", "http://www.vts.com/role/ScheduleofShareOutstandingTable", "http://www.vts.com/role/ScheduleofTransactionFeesTable", "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "terseLabel": "2x Long VIX Futures ETF", "verboseLabel": "2x Long VIX Futures ETF [Member]", "label": "Twox Long VIXFutures ETFMember" } } }, "auth_ref": [] }, "cik0001793497_StatementsOfFinancialConditionLocationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "StatementsOfFinancialConditionLocationMember", "presentation": [ "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Statements of Financial Condition Location [Member]", "label": "Statements Of Financial Condition Location Member" } } }, "auth_ref": [] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r7", "r11" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "cik0001793497_NumberOfContracts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NumberOfContracts", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "documentation": "Amount of number of contracts.", "label": "Number Of Contracts" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "cik0001793497_IncreaseDecreaseInDueToCustodian": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "IncreaseDecreaseInDueToCustodian", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Due to Custodian", "documentation": "Increase decrease in due to custodian.", "label": "Increase Decrease In Due To Custodian" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r328" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r102", "r103", "r104" ] }, "cik0001793497_IncreaseDecreaseInVariationMarginPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "IncreaseDecreaseInVariationMarginPayable", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease (Increase) in Prepaid expenses and other assets", "documentation": "Increase decrease in variation margin payable.", "label": "Increase Decrease In Variation Margin Payable" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInCustomerAdvances": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInCustomerAdvances", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Due to Other", "label": "Increase (Decrease) in Customer Advances", "documentation": "The increase (decrease) during the reporting period in the amount of prepayments by customers for goods or services to be provided at a later date." } } }, "auth_ref": [ "r55" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedCashFlow", "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable", "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r77", "r78", "r79", "r93", "r167", "r180", "r204", "r217", "r219", "r220", "r221", "r222", "r223", "r225", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r238", "r239", "r240", "r241", "r242", "r244", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r324" ] }, "us-gaap_InvestmentCompanyMarketValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyMarketValuePerShare", "presentation": [ "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Net Asset Value, Beginning of Period", "periodEndLabel": "Net Asset Value, End of Period", "label": "Investment Company, Market Value, Per Share", "documentation": "Market value per share of investment portfolio by investment company. Includes, but is not limited to, per unit, membership interest, or other ownership interest." } } }, "auth_ref": [ "r428" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r330" ] }, "us-gaap_OtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncome", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_InvestmentIncomeNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Other Income", "label": "Other Income", "documentation": "Amount of revenue and income classified as other." } } }, "auth_ref": [ "r174", "r247", "r292", "r293", "r294" ] }, "cik0001793497_IncreaseDecreaseInPayableToSponsor": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "IncreaseDecreaseInPayableToSponsor", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Increase (Decrease) in Payable to Sponsor", "label": "Increase Decrease In Payable To Sponsor" } } }, "auth_ref": [] }, "cik0001793497_IncreaseInProfessionalFeesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "IncreaseInProfessionalFeesPayable", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Professional fees payable", "documentation": "Increase in professional fees payable.", "label": "Increase In Professional Fees Payable" } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "cik0001793497_UnrealizedAppreciationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "UnrealizedAppreciationMember", "presentation": [ "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Appreciation [Member]", "label": "Unrealized Appreciation Member" } } }, "auth_ref": [] }, "cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "IncreaseInLicensingAndRegistrationFeesPayable", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Licensing and registration fees payable", "documentation": "Increase in licensing and registration fees payable.", "label": "Increase In Licensing And Registration Fees Payable" } } }, "auth_ref": [] }, "cik0001793497_ProceedsFromSaleOfUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ProceedsFromSaleOfUnits", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from shares sold, net of cost from shares purchased", "documentation": "Proceeds from sale of units.", "label": "Proceeds From Sale Of Units" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Administrative, accounting and custodian fees payable", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid." } } }, "auth_ref": [ "r5" ] }, "cik0001793497_UnrealizedDepreciationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.vts.com/20230930", "localname": "UnrealizedDepreciationMember", "presentation": [ "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Depreciation [Member]", "label": "Unrealized Depreciation Member" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r331" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2 [Member]", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r121", "r128", "r133", "r155", "r163", "r312", "r313", "r315", "r316", "r317" ] }, "us-gaap_MoneyMarketFundsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" ], "lang": { "en-us": { "role": { "terseLabel": "First American Government Obligations Fund", "label": "Money Market Funds, at Carrying Value", "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months." } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1 [Member]", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r121", "r128", "r133", "r155", "r162", "r315", "r316", "r317" ] }, "cik0001793497_AgreementsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "AgreementsLineItems", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Agreements [Line Items]" } } }, "auth_ref": [] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsMember", "presentation": [ "http://www.vts.com/role/ScheduleofValuationofInvestmentsatUsingtheFairValueHierarchyTable" ], "lang": { "en-us": { "role": { "terseLabel": "Money Market Fund [Member]", "label": "Money Market Funds [Member]", "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities." } } }, "auth_ref": [ "r378" ] }, "cik0001793497_CashPledgedAsCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "CashPledgedAsCollateral", "crdr": "credit", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Cost (in Dollars)", "documentation": "Amount of cash pledged as collateral.", "label": "Cash Pledged As Collateral" } } }, "auth_ref": [] }, "cik0001793497_CreationAndRedemptionOfCreationUnitsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "CreationAndRedemptionOfCreationUnitsAbstract", "lang": { "en-us": { "role": { "label": "CreationAndRedemptionOfCreationUnits [Abstract]" } } }, "auth_ref": [] }, "cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.vts.com/20230930", "localname": "OtherAssetsInExcessOfLiabilitiesPercentage", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets in excess of liabilities", "documentation": "Percentage of other assets in excess of liabilities.", "label": "Other Assets In Excess Of Liabilities Percentage" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r328" ] }, "us-gaap_InvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAbstract", "lang": { "en-us": { "role": { "label": "Investments [Abstract]" } } }, "auth_ref": [] }, "cik0001793497_SignificantAccountingPoliciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "SignificantAccountingPoliciesLineItems", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Line Items]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r73" ] }, "cik0001793497_Cash1": { "xbrltype": "monetaryItemType", "nsuri": "http://www.vts.com/20230930", "localname": "Cash1", "crdr": "credit", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Cash (in Dollars)", "documentation": "The amount of cash.", "label": "Cash1" } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Shares Outstanding (in Shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOW FROM FINANCING ACTIVITIES", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "cik0001793497_FinancialHighlightsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "FinancialHighlightsLineItems", "presentation": [ "http://www.vts.com/role/FinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Financial Highlights [Line Items]" } } }, "auth_ref": [] }, "cik0001793497_AgreementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.vts.com/20230930", "localname": "AgreementsDisclosureTextBlock", "presentation": [ "http://www.vts.com/role/Agreements" ], "lang": { "en-us": { "role": { "terseLabel": "AGREEMENTS", "documentation": "The entire disclosure of agreements disclosure.", "label": "Agreements Disclosure Text Block" } } }, "auth_ref": [] }, "us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentInLeaseAccruedInterestWriteoff", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Net Investment loss", "label": "Net Investment in Lease, Accrued Interest, Writeoff", "documentation": "Amount of writeoff of accrued interest on net investment in sales-type and direct financing leases recognized by reversing interest income." } } }, "auth_ref": [ "r107" ] }, "cik0001793497_OfferingCostsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "OfferingCostsAbstract", "lang": { "en-us": { "role": { "label": "OfferingCosts [Abstract]" } } }, "auth_ref": [] }, "cik0001793497_OfferingCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.vts.com/20230930", "localname": "OfferingCostsTextBlock", "presentation": [ "http://www.vts.com/role/OfferingCosts" ], "lang": { "en-us": { "role": { "terseLabel": "OFFERING COSTS", "documentation": "The entire disclosure of offering costs .", "label": "Offering Costs Text Block" } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r332" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r41", "r42", "r43" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOW FROM OPERATING ACTIVITIES", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivable", "label": "Other Receivables, Net, Current", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "cik0001793497_OfferingCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "OfferingCostsLineItems", "presentation": [ "http://www.vts.com/role/OfferingCosts" ], "lang": { "en-us": { "role": { "label": "Offering Costs [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InterestReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestReceivable", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Interest receivable", "label": "Interest Receivable", "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable." } } }, "auth_ref": [ "r342", "r434" ] }, "cik0001793497_DocumentAndEntityInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "DocumentAndEntityInformationAbstract", "auth_ref": [] }, "us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyGainLossOnInvestmentPerShare", "presentation": [ "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net investment loss", "label": "Investment Company, Gain (Loss) on Investment, Per Share", "documentation": "Per share or unit amount of realized and unrealized gain (loss) on investment." } } }, "auth_ref": [ "r198" ] }, "cik0001793497_RiskTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "RiskTable", "presentation": [ "http://www.vts.com/role/Risk" ], "lang": { "en-us": { "role": { "label": "Risk [Table]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInReceivables", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease (Increase) in Due from Other", "label": "Increase (Decrease) in Receivables", "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r5" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "cik0001793497_RiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "RiskLineItems", "presentation": [ "http://www.vts.com/role/Risk" ], "lang": { "en-us": { "role": { "terseLabel": "Risk [Abstract]", "label": "Risk Line Items" } } }, "auth_ref": [] }, "cik0001793497_FinancialHighlightsTablesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "FinancialHighlightsTablesTable", "presentation": [ "http://www.vts.com/role/FinancialHighlightsTables" ], "lang": { "en-us": { "role": { "label": "Financial Highlights (Tables) [Table]" } } }, "auth_ref": [] }, "cik0001793497_StatementsOfCashFlowsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.vts.com/20230930", "localname": "StatementsOfCashFlowsPolicyTextBlock", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Statements of Cash Flows", "documentation": "The entire disclosure of statements of cash flows.", "label": "Statements Of Cash Flows Policy Text Block" } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.vts.com/role/SignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r44" ] }, "cik0001793497_EmergingGrowthCompanyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.vts.com/20230930", "localname": "EmergingGrowthCompanyPolicyTextBlock", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Emerging growth company", "documentation": "Disclosure of accounting policy for emerging growth company.", "label": "Emerging Growth Company Policy Text Block" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedInterestReceivableNet", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease (Increase) in interest receivable", "label": "Increase (Decrease) in Accrued Interest Receivable, Net", "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments." } } }, "auth_ref": [ "r5" ] }, "cik0001793497_ScheduleOfShareOutstandingTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfShareOutstandingTableTextBlock", "presentation": [ "http://www.vts.com/role/FinancialHighlightsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share Outstanding", "documentation": "The entire disclosure of share outstanding.", "label": "Schedule Of Share Outstanding Table Text Block" } } }, "auth_ref": [] }, "us-gaap_InvestmentCompanyTotalReturn": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyTotalReturn", "presentation": [ "http://www.vts.com/role/ScheduleofShareOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total Return at Net Asset Value", "label": "Investment Company, Total Return", "documentation": "Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions." } } }, "auth_ref": [ "r190", "r192", "r195" ] }, "cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.vts.com/20230930", "localname": "FinalNetAssetValueForFiscalPeriodPolcyTextBlock", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Final Net Asset Value for Fiscal Period", "documentation": "The entire disclosure of final net asset value for fiscal period.", "label": "Final Net Asset Value For Fiscal Period Polcy Text Block" } } }, "auth_ref": [] }, "us-gaap_SaleOfTrustAssetsToPayExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfTrustAssetsToPayExpenses", "crdr": "credit", "presentation": [ "http://www.vts.com/role/ScheduleofTransactionFeesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total Trust", "label": "Sale of Trust Assets to Pay Expenses", "documentation": "Amount of sale of trust assets (includes, but is not limited to, gold and silver) to pay trust expenses." } } }, "auth_ref": [] }, "cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cut-Off Times and the Times of the Calculation of the Funds", "documentation": "The entire disclosure of cut-off times and times of calculation.", "label": "Schedule Of Cutoff Times And Times Of Calculation Table Text Block" } } }, "auth_ref": [] }, "cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock", "presentation": [ "http://www.vts.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Pledged by Funds Fair Values of Derivative Instruments", "documentation": "The entire disclosure of pledged by funds fair values of derivative instruments.", "label": "Schedule Of Pledged By Funds Fair Values Of Derivative Instruments Table Text Block" } } }, "auth_ref": [] }, "cik0001793497_ScheduleOfTransactionFeesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.vts.com/20230930", "localname": "ScheduleOfTransactionFeesTableTextBlock", "presentation": [ "http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Transaction Fees", "documentation": "The entire disclosure of transaction fees.", "label": "Schedule Of Transaction Fees Table Text Block" } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "us-gaap_OtherNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNotesPayable", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Payable to Sponsor", "label": "Other Notes Payable", "documentation": "Amount of long-term notes payable classified as other." } } }, "auth_ref": [ "r12", "r51", "r425" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r328" ] }, "cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NetChangeInUnrealizedAppreciationDepreciationOfAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Net change in unrealized appreciation (depreciation) of:", "label": "Net Change In Unrealized Appreciation Depreciation Of Abstract" } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "cik0001793497_NetRealizedGainLossOnAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NetRealizedGainLossOnAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Net realized gain (loss) on:", "label": "Net Realized Gain Loss On Abstract" } } }, "auth_ref": [] }, "us-gaap_CommodityContractAssetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommodityContractAssetCurrent", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Deposit at Broker for Futures", "label": "Commodity Contract Asset, Current", "documentation": "Carrying amount as of the balance sheet date of the asset arising from commodity contracts such as futures contracts tied to the movement of a particular commodity, which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r343" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r328" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.vts.com/role/Organization" ], "lang": { "en-us": { "role": { "terseLabel": "ORGANIZATION", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r31", "r48", "r178", "r179" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "NET INCREASE (DECREASE) IN CASH", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r4", "r41" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r328" ] }, "us-gaap_OtherInvestmentsAndSecuritiesAtCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInvestmentsAndSecuritiesAtCost", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in securities, at cost", "label": "Other Investments and Securities, at Cost", "documentation": "Includes other investments and securities that are not at fair value as of the balance sheet date and those that are not accounted for under the equity method." } } }, "auth_ref": [ "r52", "r341" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r328" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r333" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning of Period", "periodEndLabel": "End of Period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r16", "r41", "r74" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Net increase (decrease) in net assets resulting from operations", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r34", "r43", "r53", "r62", "r69", "r70", "r72", "r75", "r80", "r81", "r82", "r83", "r84", "r85", "r86", "r89", "r96", "r97", "r99", "r101", "r105", "r112", "r113", "r114", "r115", "r116", "r117", "r118", "r119", "r120", "r153", "r156", "r172", "r245", "r262", "r263", "r309", "r325", "r351" ] }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "presentation": [ "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r20", "r22", "r27" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.vts.com/role/ScheduleofPledgedbyFundsFairValuesofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Market Value per Share (Note 2) (in Dollars per share)", "label": "Auction Market Preferred Securities, Stock Series, Par Value Per Share", "documentation": "The par value of the auction market preferred security." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "presentation": [ "http://www.vts.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value of Derivative Instruments", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r22" ] }, "us-gaap_InvestmentInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentInterestRate", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Money market fund, percentage", "label": "Investment Interest Rate", "documentation": "Rate of interest on investment." } } }, "auth_ref": [ "r266", "r267", "r273", "r274", "r275", "r276", "r290", "r291", "r323", "r347", "r348" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Administrative, accounting and custodian fees", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r37", "r249" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidExpensesOther", "crdr": "credit", "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease (Increase) in Variation margin receivable", "label": "Increase (Decrease) in Prepaid Expenses, Other", "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r327" ] }, "cik0001793497_CapitalShareTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "CapitalShareTransactionsAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "lang": { "en-us": { "role": { "terseLabel": "CAPITAL SHARE TRANSACTIONS", "label": "Capital Share Transactions Abstract" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.vts.com/role/ScheduleofFairValueofDerivativeInstrumentsTable" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r21", "r23", "r24", "r26", "r213", "r216", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r238", "r239", "r240", "r241", "r252", "r253", "r254", "r255", "r258", "r259", "r260", "r261", "r283", "r284", "r286", "r287", "r307", "r322", "r323" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "parentTag": "cik0001793497_NetIncreasedecreaseInNetAssetsResultingFromOperations", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Total Expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r35" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Federal Income Tax", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r71", "r143", "r144", "r145", "r146", "r147", "r148", "r184" ] }, "cik0001793497_OperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "OperationsAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "lang": { "en-us": { "role": { "terseLabel": "OPERATIONS", "label": "Operations Abstract" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r329" ] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares of fund", "label": "Shares, Issued", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r9" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r157", "r158", "r416" ] }, "cik0001793497_NetAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.vts.com/20230930", "localname": "NetAssetsAbstract", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "lang": { "en-us": { "role": { "terseLabel": "NET ASSETS", "label": "Net Assets Abstract" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6", "SubTopic": "30", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482655/740-30-25-6" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "8", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-8" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "59", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-59" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479910/205-30-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "270", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//270/tableOfContent" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-22" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-1B" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3D" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-18" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-22" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "12", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r308": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r309": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r310": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r311": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "80", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-80" }, "r312": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r313": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r314": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r315": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r318": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r319": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r320": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r321": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r322": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r326": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r327": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r328": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r331": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r333": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r334": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r335": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r336": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r337": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "321", "Publisher": "FASB", "URI": "https://asc.fasb.org//321/tableOfContent" }, "r338": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "325", "Publisher": "FASB", "URI": "https://asc.fasb.org//325/tableOfContent" }, "r339": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r340": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r341": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r342": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r343": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r344": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r345": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r346": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r347": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r348": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r349": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r350": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r351": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r352": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r353": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r354": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r355": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r356": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r357": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r358": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r359": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r360": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r361": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r362": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r363": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r364": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r365": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r366": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r367": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r368": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r369": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r370": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r371": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r372": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r373": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r374": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r375": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r376": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r377": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r378": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r379": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r380": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r381": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r382": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r383": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r384": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r385": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r386": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r387": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r388": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r389": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r390": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r391": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r392": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r393": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r394": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r395": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r396": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r397": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r398": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r399": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r400": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r401": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r402": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r403": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r404": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r405": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r406": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r407": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r408": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r409": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r410": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r411": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r412": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r413": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r414": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r415": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r416": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r417": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r418": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r419": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r420": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r421": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r422": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r423": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r424": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r425": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r426": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r427": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-13" }, "r428": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r429": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r430": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r431": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r432": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r433": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r434": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" } } } ZIP 53 0001213900-23-087514-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-087514-xbrl.zip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